108-93-0 | Cyclohexanol

Packsize	Purity	Availability	Price	Discounted Price
5g	95%	in stock	$25.00	$17.00
25g	95%	in stock	$39.00	$27.00
100g	95%	in stock	$60.00	$42.00
500g	95%	in stock	$88.00	$62.00

Description

• Catalog Number: AB72341
• Chemical Name: Cyclohexanol
• CAS Number: 108-93-0
• Molecular Formula: C6H12O
• Molecular Weight: 100.1589
• MDL Number: MFCD00003855
• SMILES: OC1CCCCC1
• NSC Number: 403656

Computed Properties

• Complexity: 46.1
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• XLogP3: 1.2

Upstream Synthesis Route

Cyclohexanol, a versatile chemical compound commonly used in chemical synthesis, serves as a crucial building block in various industries. In the field of organic chemistry, it is widely employed as a precursor for the manufacture of adipic acid, which is essential in the production of nylon. Additionally, Cyclohexanol is a key component in the synthesis of cyclohexanone, a valuable intermediate used in the production of caprolactam, another essential material for nylon production. Moreover, it finds applications in the pharmaceutical industry, where it serves as a starting material for the synthesis of various medications. Its ability to undergo oxidation reactions further expands its utility in the field of organic synthesis, making it a fundamental compound in the realm of chemistry.

Literature

• Discovery of Ezrin Expression as a Potential Biomarker for Chemically Induced Ocular Irritation Using Human Corneal Epithelium Cell Line and a Reconstructed Human Cornea-like Epithelium Model.

  Toxicological sciences : an official journal of the Society of Toxicology 20181001

• Cannabinoid receptor interacting protein suppresses agonist-driven CB(1) receptor internalization and regulates receptor replenishment in an agonist-biased manner.

  Journal of neurochemistry 20161101

• A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.

  The Journal of urology 20160901

• Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage.

  Archives of toxicology 20160601

• Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).

  Journal of medicinal chemistry 20160114

• The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20150701

• De novo synthesis of a sunscreen compound in vertebrates.

  eLife 20150101

• Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8.

  Toxicology and applied pharmacology 20140601

• Synergistic antiproliferative and anticholesterogenic effects of linalool, 1,8-cineole, and simvastatin on human cell lines.

  Chemico-biological interactions 20140505

• Syndrome of inappropriate antidiuretic hormone secretion associated with desvenlafaxine.

  International journal of clinical pharmacy 20140401

• Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.

  Neuroscience letters 20130826

• Crystal structure and site-directed mutagenesis analyses of haloalkane dehalogenase LinB from Sphingobium sp. strain MI1205.

  Journal of bacteriology 20130601

• Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.

  Addiction biology 20130301

• Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.

  British journal of pharmacology 20130301

• Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

  Synapse (New York, N.Y.) 20130301

• Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.

  Pharmacological research 20130201

• Sonochemical synthesis of silver vanadium oxide micro/nanorods: solvent and surfactant effects.

  Ultrasonics sonochemistry 20130101

• Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.

  The Biochemical journal 20121115

• Synthesis of 2-azaspiro[4.6]undec-7-enes from N-tosyl-N-(3-arylpropargyl)-tethered 3-methylcyclohex-2-en-1-ols.

  The Journal of organic chemistry 20121102

• Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.

  Psychopharmacology 20121101

• Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.

  The Journal of pharmacology and experimental therapeutics 20121101

• Esterification of bio-oil from mallee (Eucalyptus loxophleba ssp. gratiae) leaves with a solid acid catalyst: Conversion of the cyclic ether and terpenoids into hydrocarbons.

  Bioresource technology 20121101

• Exploring the myth of nascent hydrogen and its implications for biomass conversions.

  Chemistry, an Asian journal 20121101

• Venlafaxine-induced cholestatic hepatitis: case report and review of literature.

  The American journal of surgical pathology 20121101

• Preparation of molecularly imprinted polymers for organophosphates and their application to the recognition of organophosphorus compounds and phosphopeptides.

  Analytica chimica acta 20121020

• Chronic serotonin-norepinephrine reuptake transporter inhibition modifies basal respiratory output in adult mouse in vitro and in vivo.

  Respiratory physiology & neurobiology 20121015

• Structuring of interfacial water on silica surface in cyclohexane studied by surface forces measurement and sum frequency generation vibrational spectroscopy.

  Langmuir : the ACS journal of surfaces and colloids 20121009

• Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.

  The international journal of neuropsychopharmacology 20121001

• Time-dependent aroma changes in breast milk after oral intake of a pharmacological preparation containing 1,8-cineole.

  Clinical nutrition (Edinburgh, Scotland) 20121001

• Does prior antidepressant treatment of major depression impact brain function during current treatment?

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20121001

• The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.

  Psychopharmacology 20121001

• Thermal expansion of the cryoprotectant cocktail DP6 combined with synthetic ice modulators in presence and absence of biological tissues.

  Cryobiology 20121001

• Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• Absolute configuration determination and convenient asymmetric synthesis of cis-3-(9-Anthryl)cyclohexanol with proline as a catalyst.

  Chirality 20121001

• A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.

  International journal of clinical pharmacy 20121001

• Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.

  Molecular and cellular biochemistry 20121001

• 1,8-cineole protected human lipoproteins from modification by oxidation and glycation and exhibited serum lipid-lowering and anti-inflammatory activity in zebrafish.

  BMB reports 20121001

• Zeolitic microcapsule with encapsulated platinum nanoparticles for one-pot tandem reaction of alcohol to hydrazone.

  Chemical communications (Cambridge, England) 20120904

• Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.

  Molecular psychiatry 20120901

• The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.

  Pharmacopsychiatry 20120901

• 4-(2-Hydroxypropan-2-yl)-1-methylcyclohexane-1,2-diol prevents xenobiotic induced cytotoxicity.

  Toxicology in vitro : an international journal published in association with BIBRA 20120901

• Ultradeformable liposomes with terpenes for delivery of hydrophilic compound.

  Journal of liposome research 20120901

• Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.

  The Journal of pharmacology and experimental therapeutics 20120901

• Metabolites: novel therapeutics or 'me-too' drugs? Using desvenlafaxine as an example.

  CNS spectrums 20120901

• High-dose desvenlafaxine in outpatients with major depressive disorder.

  CNS spectrums 20120901

• An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator.

  CNS spectrums 20120901

• Myrtus communis L. infusions: the effect of infusion time on phytochemical composition, antioxidant, and antimicrobial activities.

  Journal of food science 20120901

• Bilateral pallidal necrosis and cardiac toxicity in a patient with venlafaxine and bupropion overdose.

  The American journal of psychiatry 20120901

• Mechanisms for eliminating monoterpenes of sagebrush by specialist and generalist rabbits.

  Journal of chemical ecology 20120901

• Catalytic and molecular properties of rabbit liver carboxylesterase acting on 1,8-cineole derivatives.

  Natural product communications 20120901

• Electrochemical characterization of the marine antioxidant gadusol.

  Natural product communications 20120901

• Carbonate, acetate and phenolate phosphonium salts as catalysts in transesterification reactions for the synthesis of non-symmetric dialkyl carbonates.

  Organic & biomolecular chemistry 20120828

• Antimicrobial activity of a traditionally used complex essential oil distillate (Olbas(®) Tropfen) in comparison to its individual essential oil ingredients.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20120815

• Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.

  Menopause (New York, N.Y.) 20120801

• Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment.

  Environmental toxicology and chemistry 20120801

• Chronic cannabinoid treatment during young adulthood induces sex-specific behavioural deficits in maternally separated rats.

  Behavioural brain research 20120801

• Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study.

  Journal of clinical psychopharmacology 20120801

• Carvacrol and 1,8-cineole alone or in combination at sublethal concentrations induce changes in the cell morphology and membrane permeability of Pseudomonas fluorescens in a vegetable-based broth.

  International journal of food microbiology 20120801

• Rosmarinus officinalis L. essential oil and the related compound 1,8-cineole do not induce direct or cross-protection in Listeria monocytogenes ATCC 7644 cultivated in meat broth.

  Canadian journal of microbiology 20120801

• Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.

  Psychiatry and clinical neurosciences 20120801

• Essential oils of three taxa of the Nepeta argolica aggregate from Greece.

  Chemistry & biodiversity 20120801

• Morphology regulatory metabolites from Arthrobotrys oligospora.

  Journal of natural products 20120727

• Intensely luminescent homoleptic alkynyl decanuclear gold(I) clusters and their cationic octanuclear phosphine derivatives.

  Inorganic chemistry 20120702

• Persistence of resinous cement residues in dentin treated with different chemical removal protocols.

  Microscopy research and technique 20120701

• Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.

  The Journal of pharmacology and experimental therapeutics 20120701

• The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

  The journal of physiological sciences : JPS 20120701

• Cloning, functional characterization and genomic organization of 1,8-cineole synthases from Lavandula.

  Plant molecular biology 20120701

• C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

  Bioorganic & medicinal chemistry 20120701

• The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

  The Journal of clinical psychiatry 20120701

• Assessment of the nuclear pore dilating agent trans-cyclohexane-1,2-diol in differentiated airway epithelium.

  The journal of gene medicine 20120701

• On the formation of carbonate adducts of fatty alcohols, sterols, and sugars in biological conditions.

  Electrophoresis 20120701

• Synchrotron photoionization measurements of OH-initiated cyclohexene oxidation: ring-preserving products in OH + cyclohexene and hydroxycyclohexyl + O2 reactions.

  The journal of physical chemistry. A 20120628

• Phomentrioloxin: A phytotoxic pentasubstituted geranylcyclohexentriol produced by Phomopsis sp., a potential mycoherbicide for Carthamus lanatus Biocontrol.

  Journal of natural products 20120622

• Inhibition of cholinesterase by essential oil from food plant.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20120615

• Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.

  Behavioural brain research 20120615

• Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

  The international journal of neuropsychopharmacology 20120601

• A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

  The international journal of neuropsychopharmacology 20120601

• Cannabinoids disrupt hippocampal sharp wave-ripples via inhibition of glutamate release.

  Hippocampus 20120601

• Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.

  Journal of psychopharmacology (Oxford, England) 20120601

• Modulation by octopamine of olfactory responses to nonpheromone odorants in the cockroach, Periplaneta americana L.

  Chemical senses 20120601

• Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

  Archives of general psychiatry 20120601

• Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.

  Neuropharmacology 20120601

• Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions.

  Chemosphere 20120601

• A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

  Nordic journal of psychiatry 20120601

• Recovery and subsequent recurrence in patients with recurrent major depressive disorder.

  Journal of psychiatric research 20120601

• Bioinformatics evidence for the transfer of mycosporine-like amino acid core (4-deoxygadusol) synthesizing gene from cyanobacteria to dinoflagellates and an attempt to mutate the same gene (YP_324358) in Anabaena variabilis PCC 7937.

  Gene 20120601

• Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.

  Canadian journal of physiology and pharmacology 20120601

• Implication of free cholesterol in LC-MS response enhancement.

  Bioanalysis 20120601

• [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].

  Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20120601

• Highly basic CaO nanoparticles in mesoporous carbon materials and their excellent catalytic activity.

  Journal of nanoscience and nanotechnology 20120601

• [Diagnostic and therapeutic update in narcolepsy].

  Revista de neurologia 20120521

• Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.

  Behavioural brain research 20120516

• Fatal agranulocytosis associated with psychotropic medication use.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120515

• The analysis of binary longitudinal data with time-dependent covariates.

  Statistics in medicine 20120510

• Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.

  International journal of pharmaceutics 20120510

• The substrate-bound crystal structure of a Baeyer-Villiger monooxygenase exhibits a Criegee-like conformation.

  Journal of the American Chemical Society 20120509

• Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.

  Journal of ethnopharmacology 20120507

• Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.

  Journal of psychopharmacology (Oxford, England) 20120501

• Venlafaxin-associated post-ictal asystole during electroconvulsive therapy.

  Pharmacopsychiatry 20120501

• Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.

  European journal of clinical pharmacology 20120501

• Clinical evaluation of chlorhexidine and essential oils for adjunctive effects in ultrasonic instrumentation of furcation involvements: a randomized controlled clinical trial.

  International journal of dental hygiene 20120501

• Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.

  Annals of the rheumatic diseases 20120501

• Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.

  International clinical psychopharmacology 20120501

• Optimized light therapy for non-seasonal major depressive disorder: effects of timing and season.

  Journal of affective disorders 20120501

• Compositional analysis and insecticidal activity of Eucalyptus globulus (family: Myrtaceae) essential oil against housefly (Musca domestica).

  Acta tropica 20120501

• Effective and clinically meaningful non-hormonal hot flash therapies.

  Maturitas 20120501

• Rice BGlu1 glycosynthase and wild type transglycosylation activities distinguished by cyclophellitol inhibition.

  Carbohydrate research 20120501

• Diplogelasinospora grovesii IMI 171018 immobilized in polyurethane foam. An efficient biocatalyst for stereoselective reduction of ketones.

  Bioresource technology 20120501

• Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater.

  Journal of environmental monitoring : JEM 20120501

• [A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].

  Deutsche medizinische Wochenschrift (1946) 20120501

• Evidence for short-term psychodynamic psychotherapy for depression.

  The Journal of clinical psychiatry 20120501

• Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501

• Long-lasting increase in [³H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats.

  Brain research 20120427

• Kinetics and mechanisms of the tropospheric reactions of menthol, borneol, fenchol, camphor, and fenchone with hydroxyl radicals (OH) and chlorine atoms (Cl).

  The journal of physical chemistry. A 20120426

• Effects of CP 55,940--agonist of CB1 cannabinoid receptors on ghrelin and somatostatin producing cells in the rat pancreas.

  Folia histochemica et cytobiologica 20120424

• Venlafaxine facilitates between-session extinction and prevents reinstatement of auditory-cue conditioned fear.

  Behavioural brain research 20120421

• Glad about SAD (PD).

  Neurology 20120417

• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

  Neurology 20120417

• Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.

  International journal of pharmaceutics 20120415

• A role for solvents in the toxicity of agricultural organophosphorus pesticides.

  Toxicology 20120411

• Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.

  The Journal of biological chemistry 20120406

• AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.

  British journal of pharmacology 20120401

• Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.

  Neuropharmacology 20120401

• Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure.

  Neuropharmacology 20120401

• Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors.

  Heart, lung & circulation 20120401

• Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.

  Heart, lung & circulation 20120401

• High venlafaxine serum levels after prior fluoxetine medication.

  Journal of clinical psychopharmacology 20120401

• Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.

  The Journal of pharmacy and pharmacology 20120401

• A case of primary progressive aphasia associated with depression.

  International journal of geriatric psychiatry 20120401

• Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats.

  Pakistan journal of pharmaceutical sciences 20120401

• Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.

  Advances in therapy 20120401

• A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.

  Journal of separation science 20120401

• Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120401

• Rapid dechlorination of chlorophenols in aqueous solution by [Ni|Cu] microcell.

  Journal of hazardous materials 20120330

• The effect of a P123 template in mesopores of mesocellular foam on the controlled-release of venlafaxine.

  International journal of pharmaceutics 20120315

• Synergies of carvacrol and 1,8-cineole to inhibit bacteria associated with minimally processed vegetables.

  International journal of food microbiology 20120315

• Vineyard and fermentation studies to elucidate the origin of 1,8-cineole in Australian red wine.

  Journal of agricultural and food chemistry 20120307

• Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components.

  Molecules (Basel, Switzerland) 20120305

• Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways.

  Neuroscience 20120301

• Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.

  Environmental science and pollution research international 20120301

• Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120301

• Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.

  Psychopharmacology 20120301

• Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.

  Drug metabolism and disposition: the biological fate of chemicals 20120301

• Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.

  The Journal of pharmacology and experimental therapeutics 20120301

• Seasonal influence on gene expression of monoterpene synthases in Salvia officinalis (Lamiaceae).

  Journal of plant physiology 20120301

• Cress seed mucilage based buccal mucoadhesive gel of venlafaxine: in vivo, in vitro evaluation.

  Journal of materials science. Materials in medicine 20120301

• A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.

  Brain, behavior, and immunity 20120301

• Addressing both depression and pain in late life: the methodology of the ADAPT study.

  Pain medicine (Malden, Mass.) 20120301

• Hypoglycaemia: a little known effect of Venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20120301

• Does aripiprazole protect from serotonin syndrome?

  Psychiatria Danubina 20120301

• Fliposomes: pH-controlled release from liposomes containing new trans-2-morpholinocyclohexanol-based amphiphiles that perform a conformational flip and trigger an instant cargo release upon acidification.

  Natural product communications 20120301

• [Extraction technology optimization and quality analysis of volatile oil in Rhizoma Curcumae].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20120301

• Volatile organic compounds from Centaurium erythraea Rafn (Croatia) and the antimicrobial potential of its essential oil.

  Molecules (Basel, Switzerland) 20120220

• Effects of synthetic cannabinoids on electroencephalogram power spectra in rats.

  Forensic science international 20120210

• Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPD.

  Forensic science international 20120210

• Enantiomeric profiling of chiral drugs in wastewater and receiving waters.

  Environmental science & technology 20120207

• Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituents.

  The Journal of biological chemistry 20120203

• Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.

  British journal of pharmacology 20120201

• Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201

• Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density.

  Physiology & behavior 20120201

• The effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopause.

  Journal of women's health (2002) 20120201

• A novel toxic alkaloid from poison hemlock (Conium maculatum L., Apiaceae): identification, synthesis and antinociceptive activity.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120201

• Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.

  Climacteric : the journal of the International Menopause Society 20120201

• 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.

  The Journal of pharmacology and experimental therapeutics 20120201

• HS-SPME-GC×GC-qMS volatile metabolite profiling of Chrysolina herbacea frass and Mentha spp. leaves.

  Analytical and bioanalytical chemistry 20120201

• Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.

  British journal of haematology 20120201

• Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

  Journal of clinical psychopharmacology 20120201

• Treatment with duloxetine in adults and the incidence of cardiovascular events.

  Journal of clinical psychopharmacology 20120201

• Treatment of night eating syndrome with topiramate: dawn of a new day.

  Journal of clinical psychopharmacology 20120201

• Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.

  Bioorganic & medicinal chemistry letters 20120201

• Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.

  Psychiatry and clinical neurosciences 20120201

• Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.

  Journal of child and adolescent psychopharmacology 20120201

• Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.

  Journal of child and adolescent psychopharmacology 20120201

• (9H-Fluoren-9-yl)methyl N-{(2R,3R,4S)-4-hy-droxy-2-[(2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]-5-oxooxolan-3-yl}carbamate propan-2-ol 0.334-solvate.

  Acta crystallographica. Section E, Structure reports online 20120201

• Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.

  Depression and anxiety 20120201

• The antimicrobial profile of extracts of a Phormidium-like cyanobacterium changes with phosphate levels.

  World journal of microbiology & biotechnology 20120201

• Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.

  Neuroscience letters 20120124

• Mechanistic investigation of cyclohexane oxidation by a non-heme iron complex: evidence of product inhibition by UV/vis stopped-flow studies.

  Dalton transactions (Cambridge, England : 2003) 20120121

• Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes.

  Aquatic toxicology (Amsterdam, Netherlands) 20120115

• Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.

  Forensic science international 20120110

• SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.

  Nature neuroscience 20120108

• A tandem enyne/ring closing metathesis approach to 4-methylene-2-cyclohexenols: an efficient entry to otteliones and loloanolides.

  Organic letters 20120106

• Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20120101

• Seasonal variation in essential oil yield and composition from Thymus vulgaris L. during different growth stages in the south of Jordan.

  Natural product research 20120101

• Essential oil composition of Eucalyptus procera Dehnh. leaves from central Iran.

  Natural product research 20120101

• Proinflammatory and 'resiliency' proteins in the CSF of patients with major depression.

  Depression and anxiety 20120101

• Long lasting phantosmia treated with venlafaxine.

  Neurocase 20120101

• Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.

  International clinical psychopharmacology 20120101

• Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis.

  International clinical psychopharmacology 20120101

• Chemical composition of essential oil and in vitro antioxidant activities of the essential oil and methanol extracts of Eucalyptus loxophleba.

  Natural product research 20120101

• Phenolic acid contents, essential oil compositions and antioxidant activities of two varieties of Salvia euphratica from Turkey.

  Natural product research 20120101

• Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20120101

• Essential oil composition and antioxidant activities of the various extracts of Tanacetum sonbolii Mozaff. (Asteraceae) from Iran.

  Natural product research 20120101

• Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

  The Journal of clinical psychiatry 20120101

• The effect of harvest periods on the chemical compositions of essential oils of sage (Salvia aucheri L.) leaves.

  Natural product research 20120101

• Depression treatment in patients with general medical conditions: results from the CO-MED trial.

  Annals of family medicine 20120101

• Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.

  Human psychopharmacology 20120101

• In vitro antifungal activity of terpinen-4-ol, eugenol, carvone, 1,8-cineole (eucalyptol) and thymol against mycotoxigenic plant pathogens.

  Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20120101

• Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.

  The Journal of clinical psychiatry 20120101

• Imidazolines as non-classical bioisosteres of N-acyl homoserine lactones and quorum sensing inhibitors.

  International journal of molecular sciences 20120101

• Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Microfluidic chip for molecular amplification of influenza A RNA in human respiratory specimens.

  PloS one 20120101

• Low-dose venlafaxine-induced severe rhabdomyolysis: a case report.

  General hospital psychiatry 20120101

• Antidepressants and menstruation disorders in women: a cross-sectional study in three centers.

  General hospital psychiatry 20120101

• Changes of peel essential oil composition of four Tunisian citrus during fruit maturation.

  TheScientificWorldJournal 20120101

• Effect of functional group and carbon chain length on the odor detection threshold of aliphatic compounds.

  Sensors (Basel, Switzerland) 20120101

• Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.

  PloS one 20120101

• Citalopram versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

  Psychiatrike = Psychiatriki 20120101

• CB1 receptor autoradiographic characterization of the individual differences in approach and avoidance motivation.

  PloS one 20120101

• Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.

  BMJ case reports 20120101

• Warfarin: pharmacological profile and drug interactions with antidepressants.

  Einstein (Sao Paulo, Brazil) 20120101

• Duloxetine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.

  Pharmacological reports : PR 20120101

• Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.

  Journal of psychopharmacology (Oxford, England) 20111201

• Curcumin, myrecen and cineol modulate the percentage of lymphocyte subsets altered by 2,3,7, 8-tetracholorodibenzo-p-dioxins (TCDD) in rats.

  Human & experimental toxicology 20111201

• Venlafaxine in somatopsychic and autopsychic depersonalization.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• Artemisia princeps Pamp. Essential oil and its constituents eucalyptol and α-terpineol ameliorate bacterial vaginosis and vulvovaginal candidiasis in mice by inhibiting bacterial growth and NF-κB activation.

  Planta medica 20111201

• Combined medication and cognitive therapy for generalized anxiety disorder.

  Journal of anxiety disorders 20111201

• Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20111201

• Ruthenium(II) hydrazone Schiff base complexes: synthesis, spectral study and catalytic applications.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111201

• Chemical composition and antimicrobial effects of essential oils of Eucalyptus globulus, Myrtus communis and Satureja hortensis against Escherichia coli O157:H7 and Staphylococcus aureus in minced beef.

  Food science and technology international = Ciencia y tecnologia de los alimentos internacional 20111201

• Desvenlafaxine in the treatment of major depressive disorder.

  Expert opinion on pharmacotherapy 20111201

• Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.

  Psychiatry and clinical neurosciences 20111201

• Dichloridobis{2-[(dimethyl-amino)-meth-yl]phen-yl}bis-{2-[(dimethyl-aza-nium-yl)meth-yl]phen-yl}di-μ-hydroxido-di-μ(3)-oxido-tetra-phenyl-tetra-tin(IV) dichloride deuterochloro-form deca-solvate.

  Acta crystallographica. Section E, Structure reports online 20111201

• [Analysis on the compositions of volatile oil of Alpinia henryi with GC-MS method].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20111201

• Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.

  Journal of chemical information and modeling 20111128

• Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.

  Neuroscience 20111124

• Oxidative decarboxylation of benzilic acid by a biomimetic iron(II) complex: evidence for an iron(IV)-oxo-hydroxo oxidant from O2.

  Angewandte Chemie (International ed. in English) 20111118

• Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model.

  European journal of pharmacology 20111116

• Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder.

  Biological psychiatry 20111115

• Cytotoxicity of synthetic cannabinoids found in 'Spice' products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line.

  Toxicology letters 20111110

• Chemical study and antimalarial, antioxidant, and anticancer activities of Melaleuca armillaris (Sol Ex Gateau) Sm essential oil.

  Journal of medicinal food 20111101

• Product variability of the 'cineole cassette' monoterpene synthases of related Nicotiana species.

  Molecular plant 20111101

• Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

  British journal of clinical pharmacology 20111101

• Chemical composition and antimicrobial activity of essential oils of Thymus algeriensis, Eucalyptus globulus and Rosmarinus officinalis from Morocco.

  Journal of the science of food and agriculture 20111101

• Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.

  Pharmacology, biochemistry, and behavior 20111101

• Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.

  European journal of pharmacology 20111101

• Paroxysmal cervical myoclonus.

  Movement disorders : official journal of the Movement Disorder Society 20111101

• Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

  Depression and anxiety 20111101

• [Cardiogenic shock after venlafaxine poisoning].

  Annales francaises d'anesthesie et de reanimation 20111101

• Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111101

• Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111101

• Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.

  Clinical toxicology (Philadelphia, Pa.) 20111101

• Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.

  International journal of pharmaceutics 20111031

• Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20111026

• Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells.

  The Journal of physiology 20111015

• Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

  Neuroscience letters 20111010

• Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Nonestrogenic management of hot flashes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Highly luminescent octanuclear Au(I)-Cu(I) clusters adopting two structural motifs: the effect of aliphatic alkynyl ligands.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20111004

• Antidepressant-like effect of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a putative trace amine receptor ligand involves l-arginine-nitric oxide-cyclic guanosine monophosphate pathway.

  Neuroscience letters 20111003

• Rac-dependent doubling of HeLa cell area and impairment of cell migration and cell cycle by compounds from Iris germanica.

  Protoplasma 20111001

• Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour.

  Addiction biology 20111001

• Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

  Journal of affective disorders 20111001

• High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.

  Molecular & cellular proteomics : MCP 20111001

• A rapid column technique for trapping and collecting of volatile fungal hydrocarbons and hydrocarbon derivatives.

  Biotechnology letters 20111001

• Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs.

  American journal of physiology. Gastrointestinal and liver physiology 20111001

• The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro.

  Neurochemistry international 20111001

• Selective hydroxylation of alkanes by an extracellular fungal peroxygenase.

  The FEBS journal 20111001

• Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.

  Journal of clinical psychopharmacology 20111001

• Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.

  The Journal of pharmacy and pharmacology 20111001

• Measuring adherence in TORDIA.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111001

• Measuring adherence in TORDIA.

  Journal of the American Academy of Child and Adolescent Psychiatry 20111001

• Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

  The Journal of clinical psychiatry 20111001

• [Clinical observation of mucoregulatory agents' application after chronic rhinosinusitis surgery].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20111001

• Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.

  Psychiatry research 20110930

• Cyclohexanol analogues are positive modulators of GABA(A) receptor currents and act as general anaesthetics in vivo.

  European journal of pharmacology 20110930

• Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

  The Journal of biological chemistry 20110923

• Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.

  Bioorganic & medicinal chemistry 20110915

• Selective oxidation of cyclohexanol to cyclohexanone in the ionic liquid 1-octyl-3-methylimidazolium chloride.

  Chemical communications (Cambridge, England) 20110907

• Antioxidant and antiacetylcholinesterase activities of some commercial essential oils and their major compounds.

  Molecules (Basel, Switzerland) 20110907

• The interaction of cannabinoid receptor agonists, CP55940 and WIN55212-2 with membranes using solid state 2H NMR.

  Biochimica et biophysica acta 20110901

• Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110901

• Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20110901

• Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor.

  International immunopharmacology 20110901

• Efficacy of essential oils of Lippia alba (Mill.) N.E. Brown and Callistemon lanceolatus (Sm.) Sweet and their major constituents on mortality, oviposition and feeding behaviour of pulse beetle, Callosobruchus chinensis L.

  Journal of the science of food and agriculture 20110901

• Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens.

  Pharmaceutical biology 20110901

• Venlafaxine inhibits the development and differentiation of dendritic cells through the regulation of P-glycoprotein.

  International immunopharmacology 20110901

• The molecular basis of quantitative variation in foliar secondary metabolites in Eucalyptus globulus.

  The New phytologist 20110901

• Modulation of genotoxicity and DNA repair by plant monoterpenes camphor, eucalyptol and thujone in Escherichia coli and mammalian cells.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110901

• Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

  Behavioural pharmacology 20110901

• Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.

  Journal of ethnopharmacology 20110901

• Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders.

  Current medical research and opinion 20110901

• [Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20110901

• The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.

  Clinics (Sao Paulo, Brazil) 20110901

• Synergistic effect of 1,4-cyclohexanediol and 1,2-hexanediol on percutaneous absorption and penetration of metronidazole.

  International journal of pharmaceutics 20110830

• Perception of specific trigeminal chemosensory agonists.

  Neuroscience 20110825

• Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine.

  Journal of colloid and interface science 20110815

• Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20110815

• Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20110815

• Metal-free oxygenation of cyclohexane with oxygen catalyzed by 9-mesityl-10-methylacridinium and hydrogen chloride under visible light irradiation.

  Chemical communications (Cambridge, England) 20110814

• Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors.

  Assay and drug development technologies 20110801

• Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.

  British journal of pharmacology 20110801

• Characterization and identification of mycosporines-like compounds in cyanolichens. Isolation of mycosporine hydroxyglutamicol from Nephroma laevigatum Ach.

  Phytochemistry 20110801

• Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice.

  Pain 20110801

• Daytime reactions of 1,8-cineole in the troposphere.

  Chemphyschem : a European journal of chemical physics and physical chemistry 20110801

• Post-mortem volatiles of vertebrate tissue.

  Applied microbiology and biotechnology 20110801

• Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.

  Bioorganic & medicinal chemistry letters 20110801

• Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.

  The Journal of membrane biology 20110801

• Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20110801

• A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum.

  Bioanalysis 20110801

• Studies on the chemical composition and possible mechanisms underlying the antispasmodic and bronchodilatory activities of the essential oil of Artemisia maritima L.

  Archives of pharmacal research 20110801

• Vomifoliol 9-O-α-arabinofuranosyl (1→6)-β-D-glucopyranoside from the leaves of Diospyros Kaki stimulates the glucose uptake in HepG2 and 3T3-L1 cells.

  Carbohydrate research 20110715

• Novel biodegradation pathways of cyclohexane by Rhodococcus sp. EC1.

  Journal of hazardous materials 20110715

• Theoretical study of oxidation of cyclohexane diol to adipic anhydride by [Ru(IV)(O)(tpa)(H2O)]2+ complex (tpa ═ tris(2-pyridylmethyl)amine).

  Inorganic chemistry 20110704

• Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

  The Journal of clinical psychiatry 20110701

• The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose.

  British journal of clinical pharmacology 20110701

• Venlafaxine-induced delirium.

  The Australian and New Zealand journal of psychiatry 20110701

• Subgingival ultrasonic instrumentation of residual pockets irrigated with essential oils: a randomized controlled trial.

  Journal of clinical periodontology 20110701

• Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.

  Aquatic toxicology (Amsterdam, Netherlands) 20110701

• Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

  The American journal of psychiatry 20110701

• Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.

  Current medical research and opinion 20110701

• Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.

  International journal of clinical pharmacology and therapeutics 20110701

• Chemical composition and antimicrobial activity of the essential oil of Rosemary.

  Environmental toxicology and pharmacology 20110701

• Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.

  Psychiatry research 20110630

• Efficient catalytic cycloalkane oxidation employing a 'helmet' phthalocyaninato iron(III) complex.

  Dalton transactions (Cambridge, England : 2003) 20110614

• Development of miracle medicines from sialic acids.

  Proceedings of the Japan Academy. Series B, Physical and biological sciences 20110610

• Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

  Journal of medicinal chemistry 20110609

• Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine.

  The New England journal of medicine 20110609

• Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.

  Pharmaceutical development and technology 20110601

• The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.

  The international journal of neuropsychopharmacology 20110601

• Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.

  The journal of ECT 20110601

• Antioxidative effects of curcumin, β-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver.

  Toxicology and industrial health 20110601

• (Co-)solvent selection for single-wall carbon nanotubes: best solvents, acids, superacids and guest-host inclusion complexes.

  Nanoscale 20110601

• CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists.

  European journal of pharmacology 20110601

• Artemisia annua extracts, artemisinin and 1,8-cineole, prevent fruit infestation by a major, cosmopolitan pest of apples.

  Pharmaceutical biology 20110601

• Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.

  Current medical research and opinion 20110601

• Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.

  Journal of neurochemistry 20110601

• Heterometallic Cu/Co and Cu/Co/Zn complexes bearing rare asymmetric tetranuclear cores: synthesis, structures, and magnetic and catalytic properties toward the peroxidative oxidation of cycloalkanes.

  Inorganic chemistry 20110516

• Antidepressant use during pregnancy. FPIN’s clinical inquiries.

  American family physician 20110515

• Cognitive deterioration after venlafaxine overdose.

  The Journal of emergency medicine 20110501

• Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.

  International journal of legal medicine 20110501

• Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.

  Psychopharmacology 20110501

• Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

  Psychopharmacology 20110501

• Neural correlates of treatment outcome in major depression.

  The international journal of neuropsychopharmacology 20110501

• Therapeutic effects of inhaled 1,8-cineole on allergic airway inflammation.

  Basic & clinical pharmacology & toxicology 20110501

• Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.

  Biopharmaceutics & drug disposition 20110501

• A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.

  The Journal of pharmacy and pharmacology 20110501

• Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20110501

• Chemical characterization and antimicrobial activity of rhizome essential oils of very closely allied Zingiberaceae species endemic to Borneo: Alpinia ligulata K. Schum. and Alpinia nieuwenhuizii Val.

  Chemistry & biodiversity 20110501

• Gastroprotective and ulcer healing effects of essential oil from Hyptis spicigera Lam. (Lamiaceae).

  Journal of ethnopharmacology 20110426

• Severe mania complicating treatment of narcolepsy with cataplexy.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110415

• Computational exploration of natural sunscreens.

  Physical chemistry chemical physics : PCCP 20110407

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.

  Acta psychiatrica Scandinavica 20110401

• Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.

  The Journal of clinical psychiatry 20110401

• Mechanisms of chloride uptake in frog olfactory receptor neurons.

  Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology 20110401

• CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?

  Journal of clinical psychopharmacology 20110401

• What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies.

  Journal of clinical psychopharmacology 20110401

• Paliperidone augmentation for treatment-resistant depression: a case report.

  Journal of clinical psychopharmacology 20110401

• Acute eosinophilic pneumonia after venlafaxine overdose.

  Journal of clinical psychopharmacology 20110401

• The psychoactive effects of antidepressants and their association with suicidality.

  Current drug safety 20110401

• Mixed ligand monolithic columns for reversed-phase capillary electrochromatography via hydrophobic and π interactions.

  Electrophoresis 20110401

• Antidepressant-mediated gastroesophageal reflux disease.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110401

• Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

  The American journal of geriatric pharmacotherapy 20110401

• Insecticidal activity of essential oils from eleven Eucalyptus spp. and two hybrids: lethal and sublethal effects of their major components on Blattella germanica.

  Journal of economic entomology 20110401

• Electroconvulsive therapy in older adults.

  Medicine and health, Rhode Island 20110401

• (S)-2-Amino-2-(2-chloro-phen-yl)cyclo-hexa-none.

  Acta crystallographica. Section E, Structure reports online 20110401

• Complexes of copper(II) with 3-(ortho-substituted phenylhydrazo)pentane-2,4-diones: syntheses, properties and catalytic activity for cyclohexane oxidation.

  Dalton transactions (Cambridge, England : 2003) 20110328

• The extent of conformational rigidity determines hydration in nonaromatic hexacyclic systems.

  The journal of physical chemistry. B 20110324

• The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.

  Behavioural brain research 20110317

• Dioxygenase-catalysed cis-dihydroxylation of meta-substituted phenols to yield cyclohexenone cis-diol and derived enantiopure cis-triol metabolites.

  Organic & biomolecular chemistry 20110307

• Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.

  Journal of psychiatric research 20110301

• Oxygen activation by P450(cin): Protein and substrate mutagenesis.

  Archives of biochemistry and biophysics 20110301

• Dual neuroprotective and neurotoxic effects of cannabinoid drugs in vitro.

  Cellular and molecular neurobiology 20110301

• Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.

  British journal of pharmacology 20110301

• Tolerance to desvenlafaxine in rapid metabolizing depressed patients.

  International clinical psychopharmacology 20110301

• Purification, characterization, and cloning of a bifunctional molybdoenzyme with hydratase and alcohol dehydrogenase activity.

  Applied microbiology and biotechnology 20110301

• CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.

  Neuropharmacology 20110301

• Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.

  British journal of pharmacology 20110301

• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

  The Journal of clinical psychiatry 20110301

• Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.

  Human psychopharmacology 20110301

• Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.

  Biomedical chromatography : BMC 20110301

• Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

  CNS drugs 20110301

• Role of volatile and non-volatile plant secondary metabolites in host tree selection by Christmas beetles.

  Journal of chemical ecology 20110301

• 1,8-cineole inhibits both proliferation and elongation of BY-2 cultured tobacco cells.

  Journal of chemical ecology 20110301

• Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.

  Archives of general psychiatry 20110301

• Salvia officinalis L. essential oils: effect of hydrodistillation time on the chemical composition, antioxidant and antimicrobial activities.

  Natural product research 20110301

• Dermatitis artefacta--a long way from the first clinical symptoms to diagnosis.

  Psychiatria Danubina 20110301

• Venlafaxine withdrawal syndrome.

  Psychiatria Danubina 20110301

• Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.

  Pharmacogenomics 20110301

• Chemical composition and antimicrobial and spasmolytic properties of Poliomintha longiflora and Lippia graveolens essential oils.

  Journal of food science 20110301

• Theoretical insights into heme-catalyzed oxidation of cyclohexane to adipic acid.

  Inorganic chemistry 20110221

• Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats.

  Brain research 20110210

• Evolution and occurrence of 1,8-cineole (eucalyptol) in Australian wine.

  Journal of agricultural and food chemistry 20110209

• Ortho-hydroxyphenylhydrazo-β-diketones: tautomery, coordination ability, and catalytic activity of their copper(II) complexes toward oxidation of cyclohexane and benzylic alcohols.

  Inorganic chemistry 20110207

• Volatile oil constituents and antibacterial activity of different parts of Falcaria vulgaris Bernh. growing wild in two localities from Iran.

  Natural product research 20110201

• TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.

  Psychopharmacology 20110201

• In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine.

  Drug delivery 20110201

• Production of the UVB-absorbing compound mycosporine-glutaminol-glucoside by Xanthophyllomyces dendrorhous (Phaffia rhodozyma).

  FEMS yeast research 20110201

• Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression.

  Archives of women's mental health 20110201

• Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.

  Therapeutic drug monitoring 20110201

• A facile synthesis of (1S,5R,6S)-5-azido-6-benzyloxycyclohex-2-en-1-ol.

  Carbohydrate research 20110201

• Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.

  Bioorganic & medicinal chemistry letters 20110201

• Variation in the volatile constituents of Artemisia annua var. CIM-Arogya during plant ontogeny.

  Natural product communications 20110201

• Micromorphology of glandular hairs, biological activity and composition of the essential oil of Tanacetum fisherae (Asteraceae-Anthemideae) from Iran.

  Natural product communications 20110201

• Hemisynthesis of dihydroumbellulols from umbellulone: new cooling compounds.

  Journal of agricultural and food chemistry 20110126

• Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

  Blood 20110120

• Adsorption of divalent heavy metal ions from water using carbon nanotube sheets.

  Journal of hazardous materials 20110115

• A case of venlafaxine-induced bruxism alleviated by duloxetine substitution.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Tuning the conversion of cyclohexane into cyclohexanol/one by molecular dioxygen, protons and reducing agents at a single non-porphyrinic iron centre and chemical versatility of the tris(2-pyridylmethyl)amine TPAFe(II)Cl2 complex in mild oxidation chemistry.

  Dalton transactions (Cambridge, England : 2003) 20110107

• Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge.

  Journal of psychopharmacology (Oxford, England) 20110101

• Inhaled 1,8-cineole reduces inflammatory parameters in airways of ovalbumin-challenged Guinea pigs.

  Basic & clinical pharmacology & toxicology 20110101

• The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.

  Neuropharmacology 20110101

• Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.

  Neuropharmacology 20110101

• Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam.

  Minerva anestesiologica 20110101

• Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue.

  Neurochemistry international 20110101

• Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy.

  Bioorganic & medicinal chemistry letters 20110101

• Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110101

• UVB photoprotective role of mycosporines in yeast: photostability and antioxidant activity of mycosporine-glutaminol-glucoside.

  Radiation research 20110101

• Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.

  Bioanalysis 20110101

• The pharmacokinetics and safety of desvenlafaxine in subjects with chronic renal impairment.

  International journal of clinical pharmacology and therapeutics 20110101

• International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

  Trials 20110101

• Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain.

  Nature reviews. Gastroenterology & hepatology 20110101

• Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

  BMC psychiatry 20110101

• Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.

  Clinical drug investigation 20110101

• Development and characterization of eucalyptol microemulsions for topic delivery of curcumin.

  Chemical & pharmaceutical bulletin 20110101

• CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site.

  PloS one 20110101

• [Patch testing increases the likelihood of recognizing lamotrigine as a cause of drug-induced rash].

  Actas dermo-sifiliograficas 20110101

• Composition of a monoterpenoid-rich essential oil from the rhizome of Zingiber officinale from north western Himalayas.

  Natural product communications 20110101

• Comparison of Eucalyptus cinerea essential oils produced by hydrodistillation and supercritical carbon dioxide extraction.

  Natural product communications 20110101

• 2-undecanone rich leaf essential oil from Zanthoxylum armatum.

  Natural product communications 20110101

• The lin genes for γ-hexachlorocyclohexane degradation in Sphingomonas sp. MM-1 proved to be dispersed across multiple plasmids.

  Bioscience, biotechnology, and biochemistry 20110101

• Novel regulator MphX represses activation of phenol hydroxylase genes caused by a XylR/DmpR-type regulator MphR in Acinetobacter calcoaceticus.

  PloS one 20110101

• The stimulatory Gα(s) protein is involved in olfactory signal transduction in Drosophila.

  PloS one 20110101

• [Treatment-resistant depressions in borderline psychiatry].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• Introgression of Swertia mussotii gene into Bupleurum scorzonerifolium via somatic hybridization.

  BMC plant biology 20110101

• Effectiveness of three solvents and two associations of solvents on gutta-percha and resilon.

  Brazilian dental journal 20110101

• Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus.

  PloS one 20110101

• Treatment of neuropathic pain in patients with chronic kidney disease.

  CANNT journal = Journal ACITN 20110101

• Psychological factors affecting response to antidepressant drugs in fibromyalgia.

  Psychosomatics 20110101

• Two cases of serotonin syndrome with venlafaxine and calcineurin inhibitors.

  Psychosomatics 20110101

• Comments on 'Desvenlafaxine as a possible cause of acquired hemophilia'.

  General hospital psychiatry 20110101

• Repetitive transcranial magnetic stimulation or venlafaxine-induced mania?

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Venlafaxine and excessive yawning: is there any link?

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Venlafaxine-induced acute eosinophilic pneumonia.

  General hospital psychiatry 20110101

• Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.

  American journal of nephrology 20110101

• Early syphilitic meningoencephalitis masquerading as postclimacteric endogenous depression--a unique dermatologic presentation.

  Akusherstvo i ginekologiia 20110101

• Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domain.

  Journal of nucleic acids 20110101

• [Serotonin syndrome in the course of drug-poisoning--case presentation].

  Przeglad lekarski 20110101

• Facile preparation of highly-dispersed cobalt-silicon mixed oxide nanosphere and its catalytic application in cyclohexane selective oxidation.

  Nanoscale research letters 20110101

• Analysis of volatile compositions of Magnolia biondii pamp by steam distillation and headspace solid phase micro-extraction.

  Journal of oleo science 20110101

• Mirtazapine versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20110101

• [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].

  Psychiatria polska 20110101

• [The state of nociceptive and antinociceptive brain systems in patients with the pain form of diabetic polyneuropathy].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells.

  ACS chemical biology 20101217

• Assessment of ion imprinted polymers based on Pd(II) chelate complexes for preconcentration and FAAS determination of palladium.

  Talanta 20101215

• Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210

• Adsorption and separation of organic six-membered ring analogues on neutral Cd(II)-MOF generated from asymmetric schiff-base ligand.

  Inorganic chemistry 20101206

• Self-assembled 3D heterometallic Cu(II)/Fe(II) coordination polymers with octahedral net skeletons: structural features, molecular magnetism, thermal and oxidation catalytic properties.

  Inorganic chemistry 20101206

• A new class of fluorescent boronic acids that have extraordinarily high affinities for diols in aqueous solution at physiological pH.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20101203

• Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.

  Acta psychiatrica Scandinavica 20101201

• Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.

  European psychiatry : the journal of the Association of European Psychiatrists 20101201

• Toxic effects on and structure-toxicity relationships of phenylpropanoids, terpenes, and related compounds in Aedes aegypti larvae.

  Vector borne and zoonotic diseases (Larchmont, N.Y.) 20101201

• Antidepressants for neuropathic pain: a Cochrane review.

  Journal of neurology, neurosurgery, and psychiatry 20101201

• Electroconvulsive therapy for lycanthropy and Cotard syndrome: a case report.

  The journal of ECT 20101201

• Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101201

• Chemical detoxification vs mechanical removal of host plant toxins in Eucalyptus feeding sawfly larvae (Hymenoptera: Pergidae).

  Journal of insect physiology 20101201

• Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.

  British journal of pharmacology 20101201

• Evaluation of cannabinoid receptor 2 and metabotropic glutamate receptor 1 functional responses using a cell impedance-based technology.

  Journal of biomolecular screening 20101201

• Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect on nucleocapsid (N) protein.

  Journal of biomolecular structure & dynamics 20101201

• Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.

  Therapeutic drug monitoring 20101201

• Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences.

  Current medical research and opinion 20101201

• Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.

  Journal of clinical psychopharmacology 20101201

• Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.

  Journal of clinical psychopharmacology 20101201

• Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.

  Expert opinion on drug metabolism & toxicology 20101201

• Venlafaxine associated urinary symptoms.

  The Australian and New Zealand journal of psychiatry 20101201

• Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.

  Archives of general psychiatry 20101201

• Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.

  Journal of psychopharmacology (Oxford, England) 20101201

• Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

  British journal of clinical pharmacology 20101201

• Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.

  The Journal of biological chemistry 20101112

• Asymmetric synthesis of 3,4-diaminocyclohexanol and endo-7-azabicyclo[2.2.1]heptan-2-amine.

  Organic letters 20101105

• Computational investigation of reactive to nonreactive capture of carbon dioxide by oxygen-containing Lewis bases.

  The journal of physical chemistry. A 20101104

• Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction.

  Journal of pharmaceutical and biomedical analysis 20101102

• A novel glycosyl donor for synthesis of 2-acetamido-4-amino-2,4,6-trideoxy-α-D-galactopyranosides.

  Carbohydrate research 20101102

• Selective oxidation of cyclohexanol and 2-cyclohexen-1-ol on O/Au(111): the effect of molecular structure.

  Langmuir : the ACS journal of surfaces and colloids 20101102

• Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.

  The Journal of clinical psychiatry 20101101

• Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.

  Journal of affective disorders 20101101

• Inhibition of TRPV1 for the treatment of sensitive skin.

  Experimental dermatology 20101101

• Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.

  Neuropharmacology 20101101

• Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.

  Journal of affective disorders 20101101

• Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20101101

• HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder.

  Pharmacopsychiatry 20101101

• Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.

  Synapse (New York, N.Y.) 20101101

• Human platelets express authentic CB₁ and CB₂ receptors.

  Current neurovascular research 20101101

• Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

  Human psychopharmacology 20101101

• Hypoxylon sp., an endophyte of Persea indica, producing 1,8-cineole and other bioactive volatiles with fuel potential.

  Microbial ecology 20101101

• Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.

  Psychiatria Danubina 20101101

• Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.

  Sleep 20101101

• Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.

  Clinical therapeutics 20101101

• hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.

  Chemistry & biology 20101029

• Antibacterial effects of the essential oils of commonly consumed medicinal herbs using an in vitro model.

  Molecules (Basel, Switzerland) 20101027

• Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.

  Journal of medicinal chemistry 20101014

• Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.

  Journal of psychiatric research 20101001

• Quantification of 1,8-cineole and of its metabolites in humans using stable isotope dilution assays.

  Molecular nutrition & food research 20101001

• Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.

  Journal of clinical psychopharmacology 20101001

• Peripheral modulation of pheromone response by inhibitory host compound in a beetle.

  The Journal of experimental biology 20101001

• Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.

  Journal of clinical psychopharmacology 20101001

• Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

  British journal of pharmacology 20101001

• Pediatric emergency medicine: legal briefs.

  Pediatric emergency care 20101001

• Association between antidepressant use during pregnancy and infants born small for gestational age.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20101001

• A catalytic reactor for the trapping of free radicals from gas phase oxidation reactions.

  The Review of scientific instruments 20101001

• Naphthyl methacrylate-phenylene diacrylate-based monolithic column for reversed-phase capillary electrochromatography via hydrophobic and π interactions.

  Electrophoresis 20101001

• Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway.

  Brain research 20100924

• The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria.

  Science (New York, N.Y.) 20100924

• Herbicidal activity of cineole derivatives.

  Journal of agricultural and food chemistry 20100922

• Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.

  Journal of pharmacological sciences 20100916

• Poly(divinylbenzene-alkyl methacrylate) monolithic stationary phases in capillary electrochromatography.

  Journal of chromatography. A 20100910

• Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.

  European journal of clinical pharmacology 20100901

• Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100901

• Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure.

  Neurochemical research 20100901

• Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

  AAPS PharmSciTech 20100901

• The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats.

  Hearing research 20100901

• Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.

  Pharmacoepidemiology and drug safety 20100901

• Neonatal seizures on EEG after in utero exposure to venlafaxine.

  British journal of clinical pharmacology 20100901

• Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.

  British journal of pharmacology 20100901

• Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder.

  Psychiatria Danubina 20100901

• The bipolar spectrum: do we need a single algorithm for affective disorders?

  Psychiatria Danubina 20100901

• Gambling on acamprosate: a case report.

  The Journal of clinical psychiatry 20100901

• Cyclo-hexane-1,3-diyl bis-(N-phenyl-carbamate).

  Acta crystallographica. Section E, Structure reports online 20100901

• Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

  Journal of psychopharmacology (Oxford, England) 20100801

• Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats.

  Journal of psychopharmacology (Oxford, England) 20100801

• Novel alternative to antibiotics in shrimp hatchery: effects of the essential oil of Cinnamosma fragrans on survival and bacterial concentration of Penaeus monodon larvae.

  Journal of applied microbiology 20100801

• Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin.

  Drug development and industrial pharmacy 20100801

• Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100801

• Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

  Journal of clinical psychopharmacology 20100801

• Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.

  Journal of clinical psychopharmacology 20100801

• Treatment of psychotic depression in the elderly compared with nonpsychotic depression.

  Journal of clinical psychopharmacology 20100801

• Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.

  Journal of clinical psychopharmacology 20100801

• Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20100801

• Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

  Drugs & aging 20100801

• Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.

  Neuropsychobiology 20100801

• Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.

  The Journal of clinical psychiatry 20100801

• Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

  Blood 20100722

• Mechanism of reductive decomposition of pentachlorophenol by Ti-doped beta-Bi(2)O(3) under visible light irradiation.

  Environmental science & technology 20100715

• Use of antidepressants during pregnancy and the risk of spontaneous abortion.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20100713

• Localisation of unilateral nasal stimuli across sensory systems.

  Neuroscience letters 20100705

• [Delayed seizures after topiramate, venlafaxine and quetiapine overdose].

  Medicina clinica 20100703

• Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry.

  Journal of chromatography. A 20100702

• Sensitive spectrofluorimetric method of analysis for venlafaxine in spiked rat plasma and formulations.

  Journal of fluorescence 20100701

• Does night-time cortisol excretion normalize in the long-term course of depression?

  Pharmacopsychiatry 20100701

• Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.

  The American journal of gastroenterology 20100701

• Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

  International clinical psychopharmacology 20100701

• Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

  The Journal of pharmacology and experimental therapeutics 20100701

• Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

  The American journal of psychiatry 20100701

• Antidepressant 'treatment'.

  Menopause (New York, N.Y.) 20100701

• The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.

  Menopause (New York, N.Y.) 20100701

• Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.

  Menopause (New York, N.Y.) 20100701

• Effects of long-term treatment with fluoxetine and venlafaxine on rat isolated vas deferens.

  Autonomic & autacoid pharmacology 20100701

• Editorial: venlafaxine for functional chest pain: hope or hype?

  The American journal of gastroenterology 20100701

• Volatile profiles of Artemisia alba from contrasting serpentine and calcareous habitats.

  Natural product communications 20100701

• Solvent effect in the chromatographic enantioseparation of 1,1'-bi-2-naphthol on a polysaccharide-based chiral stationary phase.

  Journal of chromatography. A 20100625

• [A painful weaning].

  Revue medicale suisse 20100623

• A very active cu-catalytic system for the synthesis of aryl, heteroaryl, and vinyl sulfides.

  The Journal of organic chemistry 20100604

• Syntheses of optically pure conduramines via the strategy of hetero Diels-Alder reaction of masked o-benzoquinones with homochiral nitroso dienophiles.

  Organic letters 20100604

• A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England.

  Journal of affective disorders 20100601

• Long-term response to successful acute pharmacological treatment of psychotic depression.

  Journal of affective disorders 20100601

• Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.

  Journal of psychiatric research 20100601

• Intralipid reverses coma associated with zopiclone and venlafaxine overdose.

  European journal of anaesthesiology 20100601

• Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.

  Ophthalmology 20100601

• Ultrasound-assisted solvent-free synthesis of lactic acid esters in novel SO3H-functionalized Brønsted acidic ionic liquids.

  Ultrasonics sonochemistry 20100601

• A comparison of venlafaxine and SSRIs in deliberate self-poisoning.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20100601

• Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.

  The Clinical journal of pain 20100601

• Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.

  Journal of clinical psychopharmacology 20100601

• An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.

  Psychiatria Danubina 20100601

• An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.

  Psychiatria Danubina 20100601

• Suicide risk and choice of antidepressant.

  Psychiatria Danubina 20100601

• Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.

  Psychiatria Danubina 20100601

• Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601

• Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis.

  Recent patents on food, nutrition & agriculture 20100601

• Real-time breath gas analysis for pharmacokinetics: monitoring exhaled breath by on-line proton-transfer-reaction mass spectrometry after ingestion of eucalyptol-containing capsules.

  Journal of breath research 20100601

• Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.

  Brain research bulletin 20100531

• Fast preparation of photopolymerized poly(benzyl methacrylate-co-bisphenol A dimethacrylate) monoliths for capillary electrochromatography.

  Journal of chromatography. A 20100528

• The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20100526

• Deaths involving serotonergic drugs.

  Forensic science international 20100520

• Cloning, expression and purification of cindoxin, an unusual Fmn-containing cytochrome p450 redox partner.

  Chembiochem : a European journal of chemical biology 20100517

• Correlation between patient and clinician assessments of depression severity in the PREVENT study.

  Psychiatry research 20100515

• Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.

  Psychiatry research 20100515

• [Idiopathic intracranial hypertension and pregnancy. A report of two cases].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20100501

• Water-solvent partition coefficients and Delta Log P values as predictors for blood-brain distribution; application of the Akaike information criterion.

  Journal of pharmaceutical sciences 20100501

• A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.

  Pharmacological research 20100501

• Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes.

  Maturitas 20100501

• [Risperidone intoxication in a patient with a genetic predisposition as 'poor [non]metabolizer'].

  Psychiatrische Praxis 20100501

• Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.

  Current medical research and opinion 20100501

• TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation.

  The Journal of urology 20100501

• A strong inorganic acid-initiated methacrylate polymerization strategy for room temperature preparation of monolithic columns for capillary electrochromatography.

  Electrophoresis 20100501

• Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.

  Journal of psychiatric practice 20100501

• Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.

  Indian journal of experimental biology 20100501

• Conventional and complementary therapies: a tale of two research standards?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• Praziquantel analogs with activity against juvenile Schistosoma mansoni.

  Bioorganic & medicinal chemistry letters 20100415

• The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20100401

• Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.

  Journal of psychopharmacology (Oxford, England) 20100401

• Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.

  The international journal of neuropsychopharmacology 20100401

• In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists.

  Pharmacological research 20100401

• Cineole biodegradation: molecular cloning, expression and characterisation of (1R)-6beta-hydroxycineole dehydrogenase from Citrobacter braakii.

  Bioorganic chemistry 20100401

• Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

  The Journal of pharmacology and experimental therapeutics 20100401

• Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.

  International immunology 20100401

• [Depressive symptoms in a case of 'posterior cortical atrophy'].

  Fortschritte der Neurologie-Psychiatrie 20100401

• Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

  British journal of pharmacology 20100401

• The venlafaxine 'heart revenge:' a short report.

  Clinical cardiology 20100401

• Lack of preparation, physical health after childbirth, and early postpartum depressive symptoms.

  Journal of women's health (2002) 20100401

• Predicting odor pleasantness with an electronic nose.

  PLoS computational biology 20100401

• Psychiatric concerns in pediatric epilepsy.

  Child and adolescent psychiatric clinics of North America 20100401

• (R(P))-Menthyl (1-hydroxy-cyclo-hexyl)phenyl-phosphinate.

  Acta crystallographica. Section E, Structure reports online 20100401

• Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.

  Forensic science international 20100320

• Liquid-phase synthesis of cyanuric acid from urea.

  Molecules (Basel, Switzerland) 20100316

• Psychogenic movement disorder after a venlafaxine-induced dystonia.

  Movement disorders : official journal of the Movement Disorder Society 20100315

• Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid.

  International journal of pharmaceutics 20100315

• Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.

  Acta psychiatrica Scandinavica 20100301

• Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.

  Acta psychiatrica Scandinavica 20100301

• Measuring depth of injury (DOI) in an isolated rabbit eye irritation test (IRE) using biomarkers of cell death and viability.

  Toxicology in vitro : an international journal published in association with BIBRA 20100301

• Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

  The American journal of psychiatry 20100301

• Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.

  Journal of neurochemistry 20100301

• Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100301

• Combining antidepressant medications: a good idea?

  The American journal of psychiatry 20100301

• Management of depression in the presence of pain symptoms.

  Psychiatria Danubina 20100301

• Analysis of the effect of desvenlafaxine on anxiety symptoms associated with major depressive disorder: pooled data from 9 short-term, double-blind, placebo-controlled trials.

  CNS spectrums 20100301

• Fragment-based screen against HIV protease.

  Chemical biology & drug design 20100301

• Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.

  Life sciences 20100227

• Tetranuclear copper(ii)-Schiff-base complexes as active catalysts for oxidation of cyclohexane and toluene.

  Dalton transactions (Cambridge, England : 2003) 20100214

• Venlafaxine and cardiovascular toxicity.

  BMJ (Clinical research ed.) 20100205

• Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants.

  The international journal of neuropsychopharmacology 20100201

• Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.

  The European journal of health economics : HEPAC : health economics in prevention and care 20100201

• Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.

  Neuropharmacology 20100201

• Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20100201

• Time-dependent density functional theory-assisted absolute configuration determination of cis-dihydrodiol metabolite produced from isoflavone by biphenyl dioxygenase.

  Analytical biochemistry 20100201

• Neonatal hair analysis by liquid chromatography-high-resolution mass spectrometry to reveal gestational exposure to venlafaxine.

  Therapeutic drug monitoring 20100201

• Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.

  The Lancet. Oncology 20100201

• Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.

  The American journal of psychiatry 20100201

• Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201

• Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trial.

  Journal of clinical psychopharmacology 20100201

• Use of venlafaxine in the treatment of a canine narcolepsy-cataplexy case.

  The Journal of small animal practice 20100201

• [Cholinesterase inhibitors and depression in the elderly].

  L'Encephale 20100201

• Cardiogenic shock associated with reversible dilated cardiomyopathy during therapy with regular doses of venlafaxine.

  The American journal of emergency medicine 20100201

• When is a 'generic' medication not really a generic?

  Journal of psychosocial nursing and mental health services 20100201

• Teaching case: menopausal migraine.

  Headache 20100201

• [Optimization of preparation of poly ( glycidyl methacrylate-divinylbenzene) monolithic column with orthogonal experiments for separation of small molecules].

  Se pu = Chinese journal of chromatography 20100201

• [Discontinuation of antidepressant serotonergic antidepressant].

  Ugeskrift for laeger 20100125

• Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.

  Brain research 20100122

• Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.

  Journal of pharmaceutical and biomedical analysis 20100105

• Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.

  Social psychiatry and psychiatric epidemiology 20100101

• Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.

  Journal of affective disorders 20100101

• Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.

  Journal of psychiatric research 20100101

• Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.

  Journal of affective disorders 20100101

• To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs.

  Medical hypotheses 20100101

• Risperidone treatment increases CB1 receptor binding in rat brain.

  Neuroendocrinology 20100101

• Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

  Current medical research and opinion 20100101

• Acute cannabinoid administration attenuates female socio-sexual motivation.

  Pharmacology, biochemistry, and behavior 20100101

• Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study.

  Analytical and bioanalytical chemistry 20100101

• Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.

  International clinical psychopharmacology 20100101

• Mycosporine-like amino acids in freshwater copepods: potential sources and some factors that affect their bioaccumulation.

  Photochemistry and photobiology 20100101

• Monoterpene engineering in a woody plant Eucalyptus camaldulensis using a limonene synthase cDNA.

  Plant biotechnology journal 20100101

• The effects of some permeability enhancers on the percutaneous absorption of lidocaine.

  Pakistan journal of pharmaceutical sciences 20100101

• Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.

  Psychotherapy and psychosomatics 20100101

• The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.

  PloS one 20100101

• Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it matters.

  Journal of psychiatric practice 20100101

• Mania possibly induced by desvenlafaxine.

  Journal of psychiatric practice 20100101

• Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.

  Postgraduate medicine 20100101

• Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.

  The Journal of clinical psychiatry 20100101

• Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

  BMJ (Clinical research ed.) 20100101

• Fabrication of a carbon sphere-modified electrode and sensitive determination of cadmium(II).

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101

• Complementary UV-absorption of mycosporine-like amino acids and scytonemin is responsible for the UV-insensitivity of photosynthesis in Nostoc flagelliforme.

  Marine drugs 20100101

• Concise synthesis of an antifeedant sesquiterpene against Locusta migratoria.

  Bioscience, biotechnology, and biochemistry 20100101

• Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome.

  CNS spectrums 20100101

• Repeated angioedema following administration of venlafaxine and mirtazapine.

  General hospital psychiatry 20100101

• Sulfur deficiency changes mycosporine-like amino acid (MAA) composition of Anabaena variabilis PCC 7937: a possible role of sulfur in MAA bioconversion.

  Photochemistry and photobiology 20100101

• Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Solvent capacity of different substances on gutta-percha and Resilon.

  Brazilian dental journal 20100101

• Antimicrobial activity and essential oil composition of a new T. argyrophyllum (C. Koch) Tvzel var. argyrophyllum chemotype.

  Journal of oleo science 20100101

• [Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Multifactorial QT interval prolongation.

  Cardiology journal 20100101

• Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.

  Journal of negative results in biomedicine 20100101

• Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.

  BMC cancer 20100101

• Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.

  Menopause (New York, N.Y.) 20100101

• Perimenopausal postpartum depression after conception by assisted reproductive technology.

  Psychosomatics 20100101

• Pharmacologic management of trigeminal nerve injury pain after dental implant surgery.

  The International journal of prosthodontics 20100101

• The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.

  International journal of immunopathology and pharmacology 20100101

• The Catalytic Function of Nonheme Iron (III) Complex for Hydrocarbon Oxidation.

  Bioinorganic chemistry and applications 20100101

• Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.

  Journal of medical economics 20100101

• Behavioural and genetic evidence for C. elegans' ability to detect volatile chemicals associated with explosives.

  PloS one 20100101

• Multiple pulmonary thromboembolism and severe depression.

  General hospital psychiatry 20100101

• ETM-ANN approach application for thiobenzamide and quinolizidine derivatives.

  Journal of biomedicine & biotechnology 20100101

• Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.

  La Clinica terapeutica 20100101

• Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder.

  Psychopharmacology bulletin 20100101

• Gene expression in the scleractinian Acropora microphthalma exposed to high solar irradiance reveals elements of photoprotection and coral bleaching.

  PloS one 20100101

• Desvenlafaxine as a possible cause of acquired hemophilia.

  General hospital psychiatry 20100101

• [Clinical features of headache of tension type and principles of treatment].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• [New approaches to the treatment of chronic daily headache].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Comparison of the effectiveness of venlafaxine in peri- and postmenopausal patients with major depressive disorder.

  Actas espanolas de psiquiatria 20100101

• Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.

  Neuro endocrinology letters 20100101

• Biological activity of volatiles from marine and terrestrial bacteria.

  Marine drugs 20100101

• [Acute lethal poisoning with venlafaxine].

  Przeglad lekarski 20100101

• IFN-gamma reduction by tricyclic antidepressants.

  International journal of psychiatry in medicine 20100101

• Poly[tetra-kis(μ-cyclo-hexa-ne-1,4-di-carboxyl-ato)di-μ-hydroxido-penta-zinc(II)].

  Acta crystallographica. Section E, Structure reports online 20100101

• Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.

  Neuroscience letters 20091225

• Brain creatine kinase activity is increased by chronic administration of paroxetine.

  Brain research bulletin 20091216

• Rapid high-performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of venlafaxine and O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability study.

  Biomedical chromatography : BMC 20091201

• Endothelium-dependent vasorelaxant effects of the essential oil from aerial parts of Alpinia zerumbet and its main constituent 1,8-cineole in rats.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20091201

• Sensitivity of Aedes aegypti adults (Diptera: Culicidae) to the vapors of Eucalyptus essential oils.

  Bioresource technology 20091201

• Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures.

  The Journal of antimicrobial chemotherapy 20091201

• Substance use and the treatment of resistant depression in adolescents.

  Journal of the American Academy of Child and Adolescent Psychiatry 20091201

• [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

  L'Encephale 20091201

• Agomelatine: new drug. Adverse effects and no proven efficacy.

  Prescrire international 20091201

• Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments.

  Journal of neurochemistry 20091201

• Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20091201

• Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

  The Journal of clinical psychiatry 20091201

• 1-(3-p-Tolyl-isoxazol-5-yl)cyclo-hexa-nol.

  Acta crystallographica. Section E, Structure reports online 20091201

• Selective phenol hydrogenation to cyclohexanone over a dual supported Pd-Lewis acid catalyst.

  Science (New York, N.Y.) 20091127

• Cu(II) complexes bearing the 2,2,2-tris(1-pyrazolyl)ethanol or 2,2,2-tris(1-pyrazolyl)ethyl methanesulfonate scorpionates. X-Ray structural characterization and application in the mild catalytic peroxidative oxidation of cyclohexane.

  Dalton transactions (Cambridge, England : 2003) 20091114

• Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid-induced colitis.

  Journal of ethnopharmacology 20091112

• Central cannabinoid signaling mediating food intake: a pharmacological-challenge magnetic resonance imaging and functional histology study in rat.

  Neuroscience 20091110

• Oxidation of cyclohexane by high-valent iron bispidine complexes: tetradentate versus pentadentate ligands.

  Inorganic chemistry 20091102

• Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.

  Journal of affective disorders 20091101

• Early response as predictor of final remission in elderly depressed patients.

  International journal of geriatric psychiatry 20091101

• Inhibitory effect of 1,8-cineole on guinea-pig airway challenged with ovalbumin involves a preferential action on electromechanical coupling.

  Clinical and experimental pharmacology & physiology 20091101

• Effects of 1,8-cineole on electrophysiological parameters of neurons of the rat superior cervical ganglion.

  Clinical and experimental pharmacology & physiology 20091101

• Frontal EEG predictors of treatment outcome in major depressive disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091101

• Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.

  Drug and alcohol dependence 20091101

• Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder.

  International clinical psychopharmacology 20091101

• Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.

  Annals of clinical biochemistry 20091101

• Cleanliness of dentinal tubules following gutta-percha removal with and without solvents: a scanning electron microscopic study.

  International endodontic journal 20091101

• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  Psychiatric services (Washington, D.C.) 20091101

• Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

  Psychiatric services (Washington, D.C.) 20091101

• [Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].

  Fortschritte der Neurologie-Psychiatrie 20091101

• Tricyclic antidepressant toxicity treated with massive sodium bicarbonate.

  The American journal of emergency medicine 20091101

• Suppression of linalool acetate production in Lavandula x intermedia.

  Natural product communications 20091101

• Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.

  Clinical therapeutics 20091101

• The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.

  Journal of the American Geriatrics Society 20091101

• [Simultaneous determination of alpha-pinene, beta-pinene, eucalyptol and alpha-terpineolin in essential oil from Alpinia officinarum Hance by GC].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20091101

• Study of supercooled orientationally disordered binary solid solutions II: cyclohexyl derivatives, neopentanol and neopentylglycol.

  Physical chemistry chemical physics : PCCP 20091028

• Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

  The Journal of biological chemistry 20091023

• Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20091007

• Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats.

  Autonomic neuroscience : basic & clinical 20091005

• Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.

  Acta psychiatrica Scandinavica 20091001

• Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory.

  Pharmacology, biochemistry, and behavior 20091001

• Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.

  International journal of pharmaceutics 20091001

• Studies on the antioxidant activity of essential oil and different solvent extracts of Vitexagnuscastus L. fruits from Turkey.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20091001

• The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose.

  Clinical pharmacology and therapeutics 20091001

• Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization.

  Molecular pharmacology 20091001

• Spectral characteristics of tramadol in different solvents and beta-cyclodextrin.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091001

• A flexible strategy based on a C2-symmetric pool of chiral substrates: concise synthesis of (+)-valienamine, key intermediate of (+)- pancratistatin, and conduramines A-1 and E.

  Organic letters 20091001

• Preparation and evaluation of the highly cross-linked poly(1-hexadecane-co-trimethylolpropane trimethacrylate) monolithic column for capillary electrochromatography.

  Electrophoresis 20091001

• Simultaneous determination of venlafaxine and its main active metabolite O-desmethyl venlafaxine in rat plasma by LC-MS/MS.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20091001

• Development and validation of a stability-indicating LC method for the determination of venlafaxine in extended-release capsules and dissolution kinetic studies.

  Journal of chromatographic science 20091001

• Fulminant hepatic failure induced by venlafaxine and trazodone therapy: a case report.

  Transplantation proceedings 20091001

• Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also.

  Prescrire international 20091001

• [Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine].

  Ginecologia y obstetricia de Mexico 20091001

• Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.

  The Journal of clinical psychiatry 20091001

• The Pd-catalyzed hydrodechlorination of chlorophenols in aqueous solutions under mild conditions: a promising approach to practical use in wastewater.

  Journal of hazardous materials 20090930

• Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.

  Psychiatry research 20090930

• Synthesis and interconversions of digold(I), tetragold(I), digold(II), gold(I)-gold(III) and digold(III) complexes of fluorine-substituted aryl carbanions.

  Dalton transactions (Cambridge, England : 2003) 20090928

• Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.

  Neuroscience 20090915

• Venlafaxine-associated tinnitus.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090915

• Observed enhancement of the reactivity of a biomimetic diiron complex by the addition of water - mechanistic insights from theoretical modeling.

  Dalton transactions (Cambridge, England : 2003) 20090914

• A structurally diverse series of aluminum chloride alkoxides [Cl(x)Al(mu-OR)(y)](n) (R = (n)Bu, (c)Hex, Ph, 2,4-(t)Bu2C6H3).

  Inorganic chemistry 20090907

• High-dose venlafaxine in delusional and severely depressed patients.

  Journal of psychopharmacology (Oxford, England) 20090901

• Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity.

  European archives of psychiatry and clinical neuroscience 20090901

• Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20090901

• Chemical composition and toxicity of the essential oils from Cunila species (Lamiaceae) on the cattle tick Rhipicephalus (Boophilus) microplus.

  Parasitology research 20090901

• Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.

  Psychopharmacology 20090901

• Regarding 'Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs'.

  Biological psychiatry 20090901

• Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.

  British journal of pharmacology 20090901

• Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.

  The Journal of clinical psychiatry 20090901

• Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.

  Archives italiennes de biologie 20090901

• Domino synthesis of bridged bicyclic tetrahydro-1,2-oxazines: access to stereodefined 4-aminocyclohexanols.

  Organic letters 20090820

• Evolution of the yields and composition of essential oil from Portuguese myrtle (Myrtus comunis L.) through the vegetative cycle.

  Molecules (Basel, Switzerland) 20090820

• A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data.

  Statistics in medicine 20090815

• Determination of tetracyclines in food samples by molecularly imprinted monolithic column coupling with high performance liquid chromatography.

  Talanta 20090815

• On the origins of kinetic resolution of cyclohexane-1,2-diols through stereoselective acylation by chiral tetrapeptides.

  Organic letters 20090806

• Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.

  Journal of psychopharmacology (Oxford, England) 20090801

• Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090801

• Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.

  Clinical biochemistry 20090801

• Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.

  Journal of biomolecular screening 20090801

• Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.

  Journal of clinical psychopharmacology 20090801

• Polymeric strong cation-exchange monolithic column for capillary liquid chromatography of peptides and proteins.

  Journal of separation science 20090801

• Preparation and evaluation of a sulfoalkylbetaine-based zwitterionic monolithic column for CEC of polar analytes.

  Electrophoresis 20090801

• TORDIA: unique opportunity to explore half-life theory.

  The American journal of psychiatry 20090801

• Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic.

  British journal of pharmacology 20090801

• The composition of the essential oil from Cyperus distans rhizome.

  Natural product communications 20090801

• Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.

  Bioanalysis 20090801

• Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats.

  Chemico-biological interactions 20090715

• Chemoselective and biomimetic hydroxylation of hydrocarbons by non-heme micro-oxo-bridged diiron(III) catalysts using m-CPBA as oxidant.

  Dalton transactions (Cambridge, England : 2003) 20090714

• Dielectric and calorimetric investigation of an unusual two-component plastic crystal: cyclohexanol-neopentylglycol.

  Physical chemistry chemical physics : PCCP 20090707

• Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

  Journal of psychopharmacology (Oxford, England) 20090701

• HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.

  Neurochemical research 20090701

• (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells.

  Naunyn-Schmiedeberg's archives of pharmacology 20090701

• Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.

  British journal of pharmacology 20090701

• Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.

  Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20090701

• Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.

  Archives of general psychiatry 20090701

• Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.

  The Journal of clinical psychiatry 20090701

• [Venlafaxine-containing prolonged release: critical exchange?].

  Medizinische Monatsschrift fur Pharmazeuten 20090701

• New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20090625

• Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.

  International journal of pharmaceutics 20090622

• Location, structure, and dynamics of the synthetic cannabinoid ligand CP-55,940 in lipid bilayers.

  Biophysical journal 20090617

• Venlafaxine-induced excessive yawning: a thermoregulatory connection.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Dose-related hyperprolactinemia induced by venlafaxine.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Chemical composition of the essential oils of the flowers, leaves and stems of two senecio polyanthemoides Sch. Bip. samples from South Africa.

  Molecules (Basel, Switzerland) 20090609

• Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.

  Breast cancer research and treatment 20090601

• Direct high-performance liquid chromatographic separation of the enantiomers of venlafaxine and 11 analogs using amylose-derived chiral stationary phases.

  Chirality 20090601

• PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090601

• The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression.

  Human psychopharmacology 20090601

• Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.

  AAPS PharmSciTech 20090601

• Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations.

  Therapeutic drug monitoring 20090601

• [Horner's syndrome unmasked by venlafaxine].

  Revista de neurologia 20090601

• Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.

  The American journal of gastroenterology 20090601

• Gas chromatography study of reagent degradation during chemical vapor deposition of carbon nanotubes.

  Journal of nanoscience and nanotechnology 20090601

• Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

  CNS spectrums 20090601

• Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.

  Clinical therapeutics 20090601

• Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

  Clinical therapeutics 20090601

• Three novel terpenoids from the rhizomes of Curcuma longa.

  Journal of Asian natural products research 20090601

• Preparation and evaluation of a neutral methacrylate-based monolithic column for hydrophilic interaction stationary phase by pressurized capillary electrochromatography.

  Journal of chromatography. A 20090522

• Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonists.

  Journal of medicinal chemistry 20090514

• [Psycho- and pharmacotherapy of depressions. So you combine correctly].

  MMW Fortschritte der Medizin 20090507

• Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?

  Journal of affective disorders 20090501

• The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines.

  The international journal of neuropsychopharmacology 20090501

• Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501

• Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.

  International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20090501

• Estimating the lipophilicity of a number of 2-amino-1-cyclohexanol derivatives exhibiting anticonvulsant activity.

  Biomedical chromatography : BMC 20090501

• Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine.

  Current medical research and opinion 20090501

• Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

  The American journal of psychiatry 20090501

• Antidepressant switching among adherent patients treated for depression.

  Psychiatric services (Washington, D.C.) 20090501

• Nontricyclic antidepressants for neuropathic pain #187.

  Journal of palliative medicine 20090501

• [Venlafaxine-induced cholestatic hepatitis].

  Gastroenterologia y hepatologia 20090501

• Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

  Journal of psychiatry & neuroscience : JPN 20090501

• Borderline personality disorder: inpatient psychiatric nursing management.

  Journal of psychosocial nursing and mental health services 20090501

• Electrocardiogram changes and arrhythmias in venlafaxine overdose.

  British journal of clinical pharmacology 20090501

• Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays.

  Journal of medicinal chemistry 20090423

• Essential oil composition of Artemisia herba-alba from southern Tunisia.

  Molecules (Basel, Switzerland) 20090420

• A novel stir bar sorptive extraction coating based on monolithic material for apolar, polar organic compounds and heavy metal ions.

  Talanta 20090415

• Outcome of late-life depression after 3 years of sequential treatment.

  Acta psychiatrica Scandinavica 20090401

• Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.

  Acta psychiatrica Scandinavica 20090401

• The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

  European archives of psychiatry and clinical neuroscience 20090401

• Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

  The American journal of psychiatry 20090401

• Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.

  British journal of pharmacology 20090401

• Teenaged, depressed, and treatment resistant: what predicts self-harm?

  The American journal of psychiatry 20090401

• Desvenlafaxine: a new antidepressant or just another one?

  Expert opinion on pharmacotherapy 20090401

• A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.

  The Journal of clinical psychiatry 20090401

• Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.

  The Journal of clinical psychiatry 20090401

• Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.

  Journal of child and adolescent psychopharmacology 20090401

• [Severe forms of depression: the efficacy of escitalopram].

  L'Encephale 20090401

• Venlafaxine-induced complex visual hallucinations in a 17-year-old boy.

  The Journal of clinical psychiatry 20090401

• An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.

  CNS spectrums 20090401

• New drug update: 2008.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20090401

• Mono-, di- and polynuclear copper(II) compounds derived from N-butyldiethanolamine: structural features, magnetism and catalytic activity for the mild peroxidative oxidation of cyclohexane.

  Dalton transactions (Cambridge, England : 2003) 20090328

• Determining organic impurities in mother liquors from oxidative terephthalic acid synthesis by microemulsion electrokinetic chromatography.

  Journal of chromatography. A 20090320

• Big interest in heavy drugs.

  Nature 20090319

• Invivo antioxidant status: a putative target of antidepressant action.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Palythine-threonine, a major novel mycosporine-like amino acid (MAA) isolated from the hermatypic coral Pocillopora capitata.

  Journal of photochemistry and photobiology. B, Biology 20090303

• The influences of depression and venlafaxine use at therapeutic doses on atrial conduction.

  Journal of psychopharmacology (Oxford, England) 20090301

• The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.

  Archives of gynecology and obstetrics 20090301

• Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.

  Neurochemical research 20090301

• Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.

  Neurobiology of disease 20090301

• Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.

  Human psychopharmacology 20090301

• Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.

  American journal of obstetrics and gynecology 20090301

• Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.

  Journal of the American Academy of Child and Adolescent Psychiatry 20090301

• Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

  Journal of neurochemistry 20090301

• 1,8-Cineole induces relaxation in rat and guinea-pig airway smooth muscle.

  The Journal of pharmacy and pharmacology 20090301

• Experience of the use of velaxin (venlafaxine) in anxious depression.

  Neuroscience and behavioral physiology 20090301

• Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.

  International clinical psychopharmacology 20090301

• An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.

  The Journal of clinical psychiatry 20090301

• Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).

  Journal of the American Association for Laboratory Animal Science : JAALAS 20090301

• Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression.

  Psychotherapy research : journal of the Society for Psychotherapy Research 20090301

• Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.

  CNS spectrums 20090301

• An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.

  CNS spectrums 20090301

• Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.

  International clinical psychopharmacology 20090301

• The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.

  International journal of pharmaceutics 20090223

• Selective inhibition of carotenoid cleavage dioxygenases: phenotypic effects on shoot branching.

  The Journal of biological chemistry 20090220

• N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors.

  Journal of medicinal chemistry 20090212

• Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

  The Journal of clinical psychiatry 20090210

• Practical ruthenium-catalyzed cyclocarbonylation of allenyl alcohols in 2,4,6-collidine leading to alpha,beta-unsaturated lactones: concise stereoselective synthesis of (+)-isomintlactone.

  The Journal of organic chemistry 20090206

• Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.

  The international journal of neuropsychopharmacology 20090201

• Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.

  Psychological medicine 20090201

• Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.

  The international journal of neuropsychopharmacology 20090201

• CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.

  Glia 20090201

• Venlafaxine-induced excessive yawning.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Odor localization and sniffing.

  Chemical senses 20090201

• The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.

  Journal of clinical pharmacology 20090201

• Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

  The American journal of psychiatry 20090201

• Rhusonoside A, a new megastigmane glycoside from Rhus sylvestris, increases the function of osteoblastic MC3T3-E1 cells.

  Planta medica 20090201

• Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

  Nature clinical practice. Gastroenterology & hepatology 20090201

• A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.

  American journal of obstetrics and gynecology 20090201

• Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.

  Journal of clinical psychopharmacology 20090201

• Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.

  Psychiatry and clinical neurosciences 20090201

• Drug approvals: '08 in review. Desvenlafaxine (Pristiq).

  The Nurse practitioner 20090201

• Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

  World journal of pediatrics : WJP 20090201

• Psychosis in the elderly.

  The American journal of psychiatry 20090201

• Automated determination of venlafaxine in human plasma by on-line SPE-LC-MS/MS. Application to a bioequivalence study.

  Journal of separation science 20090201

• The effects of terpenes on the permeation of lidocaine and ofloxacin from moisture-activated patches.

  Drug delivery 20090201

• A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.

  Drug delivery 20090201

• Understanding the importance of the viscosity contrast between the sample solvent plug and the mobile phase and its potential consequence in two-dimensional high-performance liquid chromatography.

  Journal of chromatography. A 20090130

• Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.

  Forensic science international 20090130

• Magnetophotoselection in the spin-polarized triplet state radical-ion pair formed in the photo-induced solvent-mediated electron transfer reaction from N,N-diethylaniline to xanthone in viscous solution.

  The journal of physical chemistry. A 20090129

• Inductive and resonance effects on the acidities of phenol, enols, and carbonyl alpha-hydrogens.

  The Journal of organic chemistry 20090116

• Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.

  Biochemical pharmacology 20090115

• Diaterebic acid acetate and diaterpenylic acid acetate: atmospheric tracers for secondary organic aerosol formation from 1,8-cineole oxidation.

  Environmental science & technology 20090115

• Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

  Journal of affective disorders 20090101

• [Microscopic colitis associated with celiac disease probably triggered by the administration of venlafaxine].

  La Revue de medecine interne 20090101

• Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

  Journal of psychiatric research 20090101

• Newer antidepressants for hot flashes--should their efficacy still be up for debate?

  Menopause (New York, N.Y.) 20090101

• Venlafaxine-induced gynecomastia in a young patient: a case report.

  Clinical neuropharmacology 20090101

• Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090101

• Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.

  Current opinion in investigational drugs (London, England : 2000) 20090101

• Effect of cannabinoids upon the uptake of folic acid by BeWo cells.

  Pharmacology 20090101

• A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.

  CNS spectrums 20090101

• A circuit supporting concentration-invariant odor perception in Drosophila.

  Journal of biology 20090101

• Biological activity evaluation of the oils from Laurus nobilis of Tunisia and Algeria extracted by supercritical carbon dioxide.

  Natural product research 20090101

• Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy.

  Advances in experimental medicine and biology 20090101

• Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.

  Depression and anxiety 20090101

• Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.

  Clinical drug investigation 20090101

• Essential oil composition and variability of Laurus nobilis L. growing in Tunisia, comparison and chemometric investigation of different plant organs.

  Natural product research 20090101

• [Multidrug intoxication].

  Annales de biologie clinique 20090101

• Major depression, antidepressant medication and the risk of obesity.

  Psychotherapy and psychosomatics 20090101

• Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.

  Nordic journal of psychiatry 20090101

• Postpartum depression co-occurring with lactation-related osteoporosis.

  Psychosomatics 20090101

• Acute tamoxifen-induced depression and its prevention with venlafaxine.

  Psychosomatics 20090101

• Oxidation of cyclohexanediol derivatives with 12-tungstophosphoric acid-hydrogen peroxide system.

  Journal of oleo science 20090101

• Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.

  Depression and anxiety 20090101

• [Results of a study of velaxin (venlafaxine) efficacy in patients with subacute and chronic spondylogenic dorsalgia].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• A single-blind placebo run-in study of venlafaxine XR for activity-limiting osteoarthritis pain.

  Pain medicine (Malden, Mass.) 20090101

• Bruxism possibly induced by venlafaxine.

  Clinical neuropharmacology 20090101

• [Treatment with venlafaxine extended release for climacteric women with depression or anxiety diagnosis. An open-label study].

  Actas espanolas de psiquiatria 20090101

• Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.

  Molecular vision 20090101

• Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole.

  General hospital psychiatry 20090101

• Improvement of paradoxical vocal cord dysfunction with integrated psychiatric care.

  Psychosomatics 20090101

• Venlafaxine induced acute myocardial infarction with normal coronary arteries.

  American journal of therapeutics 20090101

• Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial.

  Respiratory research 20090101

• Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.

  Psychopharmacology bulletin 20090101

• Evaluation of monoterpenes for the control of Tribolium castaneum (Herbst) and Sitophilus zeamaise Motschulsky.

  Natural product research 20090101

• Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders.

  Clinical neuropharmacology 20090101

• Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Cortisol metabolism in depressed patients and healthy controls.

  Neuroendocrinology 20090101

• Pharmacotherapy for social anxiety disorder: an update.

  The Israel journal of psychiatry and related sciences 20090101

• Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.

  Psychopharmacology bulletin 20090101

• Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo.

  Psychopharmacology bulletin 20090101

• [Misuse of substances theoretically without abuse potential--case series].

  Przeglad lekarski 20090101

• The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

  Depression and anxiety 20090101

• Venlafaxine-induced hepatotoxicity in a patient with ulcerative colitis.

  Annals of hepatology 20090101

• Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.

  Pharmaceutical development and technology 20090101

• Wavelet and fractal analysis of rat brain activity in seizures evoked by camphor essential oil and 1,8-cineole.

  General physiology and biophysics 20090101

• Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Neurotrophic factors in serum following ECT: a pilot study.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Pro-inflammatory biomakers in depression: treatment with venlafaxine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine.

  Psychosomatics 20090101

• Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF).

  Pharmacological reports : PR 20090101

• A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation.

  Behavioural brain research 20081212

• Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2.

  Neuroscience letters 20081205

• Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs.

  Journal of cellular and molecular medicine 20081201

• Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.

  Psychopharmacology 20081201

• Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.

  Journal of neurochemistry 20081201

• An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.

  Drug metabolism and disposition: the biological fate of chemicals 20081201

• Mycosporine-like amino acids (MAAs) profile of a rice-field cyanobacterium Anabaena doliolum as influenced by PAR and UVR.

  Planta 20081201

• Fragrance material review on 4-tert-butylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 1-methyl-2-(1-methylpropyl) cyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 1-ethynylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 2-(1-methylpropyl)-1-vinylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 3-tert-butylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 4-(isopropyl)-1-methylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 2-tert-butylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on cyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on cis-2-tert-butylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on 1-methyl-4-(1-methylvinyl)cyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Fragrance material review on amylcyclohexyl acetate.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20081201

• Predictive factors for generalized seizures after deliberate citalopram overdose.

  British journal of clinical pharmacology 20081201

• Recent NIMH clinical trials and implications for practice.

  Journal of the American Academy of Child and Adolescent Psychiatry 20081201

• Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence.

  Expert review of neurotherapeutics 20081201

• Venlafaxine induced-myoclonus in a patient with mixed dementia.

  Arquivos de neuro-psiquiatria 20081201

• Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells.

  FEBS letters 20081126

• Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.

  Journal of medicinal chemistry 20081113

• Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.

  Neuroscience letters 20081107

• Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disorders.

  Addictive behaviors 20081101

• Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.

  Toxicology and applied pharmacology 20081101

• Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

  International clinical psychopharmacology 20081101

• The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro.

  The European journal of neuroscience 20081101

• mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis.

  Journal of pharmacological sciences 20081101

• Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.

  Journal of psychiatric practice 20081101

• Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty.

  Orthopedics 20081101

• [Analysis of the chemical constituents of essential oil from Magnolia biondii by GC-MS].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20081101

• Stimulus properties of venlafaxine in a conditioned taste aversion procedure.

  European journal of pharmacology 20081031

• [Mood disorders].

  La Revue du praticien 20081031

• Selected regiocontrolled transformations applied to the synthesis of (1S)-cis-chrysanthemic acid from (1S)-3,4-epoxy-2,2,5,5-tetramethylcyclohexanol.

  Chemical communications (Cambridge, England) 20081021

• trans-2-Aminocyclohexanol as a pH-sensitive conformational switch in lipid amphiphiles.

  Chemical communications (Cambridge, England) 20081021

• Ammonium-directed dihydroxylation: metal-free synthesis of the diastereoisomers of 3-aminocyclohexane-1,2-diol.

  Organic & biomolecular chemistry 20081021

• The subtle electronic effects of alkyl groups on the conformational equilibria and intramolecular hydrogen-bond strength in cis-3-alkoxycyclohexanols.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081001

• Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics.

  European journal of clinical pharmacology 20081001

• Desvenlafaxine: another 'me too' drug?

  The Annals of pharmacotherapy 20081001

• A case of venlafaxine-induced galactorrhea?

  Journal of clinical psychopharmacology 20081001

• Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.

  Journal of clinical psychopharmacology 20081001

• Polymorphism in cyclohexanol.

  Acta crystallographica. Section B, Structural science 20081001

• Hydrogen-bond patterns and the structures of 1,4-cyclohexanediol: 2:1 cis:trans-1,4-cyclohexanediol.

  Acta crystallographica. Section B, Structural science 20081001

• Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

  The American journal of psychiatry 20081001

• Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.

  Canadian journal of physiology and pharmacology 20081001

• Adsorption of phenolic compounds by carbon nanotubes: role of aromaticity and substitution of hydroxyl groups.

  Environmental science & technology 20081001

• [Hypersensitivity pneumonitis due to venlafaxine].

  Archivos de bronconeumologia 20081001

• Changes in brain function during administration of venlafaxine or placebo to normal subjects.

  Clinical EEG and neuroscience 20081001

• Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia.

  Revista panamericana de salud publica = Pan American journal of public health 20081001

• [Characterization of chemical components of essential oil from flowers of Chrysanthemum morifolium produced in Anhui province].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20081001

• A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.

  The Journal of clinical psychiatry 20081001

• LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.

  Journal of pharmaceutical and biomedical analysis 20080910

• The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.

  The international journal of neuropsychopharmacology 20080901

• Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.

  British journal of pharmacology 20080901

• Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.

  AAPS PharmSciTech 20080901

• The cannabinoid receptor agonist CP-55,940 and ethyl arachidonate interfere with [(3)H]batrachotoxinin A 20 alpha-benzoate binding to sodium channels and inhibit sodium channel function.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080901

• Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression.

  International immunopharmacology 20080901

• Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.

  Addiction (Abingdon, England) 20080901

• Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.

  Journal of neurochemistry 20080901

• Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901

• Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.

  International clinical psychopharmacology 20080901

• Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.

  International clinical psychopharmacology 20080901

• [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--'double depression'].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20080901

• Does odour cross contamination alter olfactory thresholds in certain odours?

  Rhinology 20080901

• Variation of the chemical profile and antioxidant behavior of Rosmarinus officinalis L. and Salvia fruticosa Miller grown in Greece.

  Journal of agricultural and food chemistry 20080827

• Menthol shares general anesthetic activity and sites of action on the GABA(A) receptor with the intravenous agent, propofol.

  European journal of pharmacology 20080820

• Enantiomeric purity of biodegradation products of juvenogens by newly isolated soil bacteria.

  Journal of agricultural and food chemistry 20080813

• Efficient catalytic oxidation of alkanes by Lewis acid/[Os(VI)(N)Cl4]- using peroxides as terminal oxidants. Evidence for a metal-based active intermediate.

  Journal of the American Chemical Society 20080813

• Studies on 1-alkylamine adduct formation in electrospray ionization mass spectrometry for quantitative analysis.

  Journal of pharmaceutical and biomedical analysis 20080805

• [A place for SSRIs in the treatment of severely depressed children and adolescents].

  Nederlands tijdschrift voor geneeskunde 20080802

• Model-based analysis for kinetic complexation study of Pizda and Cu(II).

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080801

• Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20080801

• Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice.

  Synapse (New York, N.Y.) 20080801

• The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease.

  Neuroscience research 20080801

• Ex vivo skin absorption of terpenes from Vicks VapoRub ointment.

  Medical science monitor : international medical journal of experimental and clinical research 20080801

• Desvenlafaxine succinate for the treatment of major depressive disorder.

  Expert opinion on pharmacotherapy 20080801

• Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

  Archives of general psychiatry 20080801

• Neutral octadecyl monolith for reversed phase capillary electrochromatography of a wide range of solutes.

  Journal of separation science 20080801

• Determination of the maximum inhibitory dilution of cetylpyridinium chloride-based mouthwashes against Staphylococcus aureus: an in vitro study.

  Journal of applied oral science : revista FOB 20080801

• Cannabinoids and hamster circadian activity rhythms.

  Brain research 20080730

• [Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].

  Ideggyogyaszati szemle 20080730

• Bundled tungsten oxide nanowires under thermal processing.

  Nanotechnology 20080730

• Oxygen-directed intramolecular hydroboration.

  Journal of the American Chemical Society 20080723

• Direct observation of f-pair magnetic field effects and time-dependence of radical pair composition using rapidly switched magnetic fields and time-resolved infrared methods.

  Physical chemistry chemical physics : PCCP 20080721

• Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.

  Journal of pharmaceutical and biomedical analysis 20080715

• Comparison of a gas chromatography-optical fibre (GC-OF) detector with a gas chromatography-flame ionization detector (GC-FID) for determination of alcoholic compounds in industrial atmospheres.

  Talanta 20080715

• Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.

  Journal of medicinal chemistry 20080710

• Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.

  Psychopharmacology 20080701

• [Palinopsia following discontinuation of venlafaxine].

  Psychiatrische Praxis 20080701

• Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.

  Journal of psychopharmacology (Oxford, England) 20080701

• Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080701

• Affinity monolith-integrated poly(methyl methacrylate) microchips for on-line protein extraction and capillary electrophoresis.

  Analytical chemistry 20080701

• The review by Weinmann and colleagues.

  Psychopharmacology 20080701

• Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.

  Current medical research and opinion 20080701

• A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation.

  Neuropharmacology 20080701

• A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder.

  International clinical psychopharmacology 20080701

• Perinatal depression: treatment options and dilemmas.

  Journal of psychiatry & neuroscience : JPN 20080701

• Photocatalytic activity of MCM-organized TiO(2) materials in the oxygenation of cyclohexane with molecular oxygen.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20080701

• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  Archives of general psychiatry 20080701

• Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice.

  Behavioural pharmacology 20080701

• The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers.

  Pharmacopsychiatry 20080701

• Flat dose-response curves for efficacy: what do they mean to the clinician?

  Journal of psychiatric practice 20080701

• Desvenlafaxine succinate for major depressive disorder.

  Drugs of today (Barcelona, Spain : 1998) 20080701

• Alkaloid and sesquiterpenes from the root tuber of Curcuma longa.

  Yao xue xue bao = Acta pharmaceutica Sinica 20080701

• The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080701

• A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

  International journal of geriatric psychiatry 20080601

• The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.

  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20080601

• Anticholinesterase and pediculicidal activities of monoterpenoids.

  Fitoterapia 20080601

• Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.

  Pharmacology, biochemistry, and behavior 20080601

• Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.

  The Annals of pharmacotherapy 20080601

• A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.

  Journal of clinical psychopharmacology 20080601

• Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.

  The Journal of pharmacy and pharmacology 20080601

• Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.

  Drug development and industrial pharmacy 20080601

• Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

  Journal of managed care pharmacy : JMCP 20080601

• Wine and drug evaluations: lessons on making comparisons of noninferiority.

  Journal of psychopharmacology (Oxford, England) 20080601

• Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.

  Journal of psychopharmacology (Oxford, England) 20080601

• A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20080601

• Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications.

  Journal of psychopharmacology (Oxford, England) 20080601

• [The place of escitalopram in the severe depressive episodes].

  L'Encephale 20080601

• Citrantifidiene and citrantifidiol: bioactive metabolites produced by Trichoderma citrinoviride with potential antifeedant activity toward aphids.

  Journal of agricultural and food chemistry 20080528

• Desvenlafaxine for depression.

  The Medical letter on drugs and therapeutics 20080519

• Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20080515

• Selective publication of antidepressant trials.

  The New England journal of medicine 20080515

• An efficient protocol for the enantioselective preparation of a key polyfunctionalized cyclohexane. New access to (R)- and (S)-4-Hydroxy-2-cyclohexenone and (R)- and (S)-trans-cyclohex-2-ene-1,4-diol.

  The Journal of organic chemistry 20080502

• A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.

  Biological psychiatry 20080501

• Influence of additives on the clouding phenomenon of chlorpromazine hydrochloride solutions.

  Colloids and surfaces. B, Biointerfaces 20080501

• Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.

  European journal of clinical pharmacology 20080501

• Development of tolerance to the dietary plant secondary metabolite 1,8-cineole by the brushtail possum (Trichosurus vulpecula).

  Journal of chemical ecology 20080501

• Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

  International clinical psychopharmacology 20080501

• Desvenlafaxine succinate monohydrate.

  Acta crystallographica. Section C, Crystal structure communications 20080501

• Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.

  Expert review of neurotherapeutics 20080501

• Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder.

  CNS spectrums 20080501

• The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

  Journal of psychopharmacology (Oxford, England) 20080501

• [Drug-induced pneumonitis in a patient treated with venlafaxine and propanolol].

  Revue des maladies respiratoires 20080501

• Do new-generation antidepressants work?

  Irish medical journal 20080501

• Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?

  The Journal of clinical psychiatry 20080501

• Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

  Current drug safety 20080501

• Improved efficiency of focal point conformational analysis with truncated correlation consistent basis sets.

  Journal of computational chemistry 20080430

• Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.

  European journal of pharmacology 20080428

• The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in p450cin.

  The Journal of biological chemistry 20080418

• Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.

  Journal of medicinal chemistry 20080410

• Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.

  Brain research 20080408

• Experimental and computational morphology of three polymorphs of the free base of Venlafaxine: a comparison of morphology prediction methods.

  International journal of pharmaceutics 20080402

• Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.

  Biological psychiatry 20080401

• A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.

  Neuropharmacology 20080401

• The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.

  International journal of clinical practice 20080401

• Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.

  European psychiatry : the journal of the Association of European Psychiatrists 20080401

• Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.

  Neuropharmacology 20080401

• Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

  The Australian and New Zealand journal of psychiatry 20080401

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20080401

• Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

  Journal of clinical psychopharmacology 20080401

• Dose-related increase of intraocular pressure caused by venlafaxine use: case report.

  Journal of clinical psychopharmacology 20080401

• Fatal cardiotoxicity induced by venlafaxine overdosage.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Anticholinergic-type effects following a pediatric venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20080401

• Venlafaxine: Successful treatment in impulsive disorders.

  Psychiatry and clinical neurosciences 20080401

• New antidepressants for older people: a critical review of the evidence base.

  L'Encephale 20080401

• Menopausal symptoms following tamoxifen treatment for breast cancer.

  Oncology (Williston Park, N.Y.) 20080401

• Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.

  Psychopharmacology 20080301

• Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

  The American journal of psychiatry 20080301

• An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers.

  Human psychopharmacology 20080301

• Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.

  Journal of psychopharmacology (Oxford, England) 20080301

• Conformational equilibria of trans -3-X-cyclohexanols (X = Cl, Br, CH3 and OCH3). A low temperature NMR study and theoretical calculations.

  Magnetic resonance in chemistry : MRC 20080301

• Heparin-immobilized pluronic/PVA composite microparticles for the sustained delivery of ionic drug.

  Journal of microencapsulation 20080301

• Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.

  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20080301

• Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.

  The Annals of pharmacotherapy 20080301

• Combined antidepressants and CBT for panic disorder with agoraphobia.

  Journal of psychiatry & neuroscience : JPN 20080301

• A fatal case of venlafaxine overdose.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20080301

• Asystole during electroconvulsive therapy in an elderly woman treated concomitantly with venlafaxine.

  The Australian and New Zealand journal of psychiatry 20080301

• Percutaneous permeation enhancement by terpenes: mechanistic view.

  The AAPS journal 20080301

• Herbal compounds and toxins modulating TRP channels.

  Current neuropharmacology 20080301

• Selective partial hydrogenation of hydroxy aromatic derivatives with palladium nanoparticles supported on hydrophilic carbon.

  Chemical communications (Cambridge, England) 20080227

• Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

  JAMA 20080227

• Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling.

  European journal of pharmacology 20080226

• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

  Biological psychiatry 20080215

• Successful duloxetine use to prevent venlafaxine withdrawal symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Detection of hydrophobic microdomains in anionic polyelectrolytes with tris-(4,7-diphenyl-1,10-phenanthroline)3Cr(III).

  Journal of colloid and interface science 20080215

• A case of extreme paradoxical insomnia responding selectively to electroconvulsive therapy.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20080215

• Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model.

  The international journal of neuropsychopharmacology 20080201

• [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].

  Schmerz (Berlin, Germany) 20080201

• Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.

  Clinical pharmacology and therapeutics 20080201

• Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism.

  American journal of physiology. Endocrinology and metabolism 20080201

• Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.

  Behavioural pharmacology 20080201

• Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study.

  Andrologia 20080201

• [A clinical challenge. Pragmatic treatment of migraine and concomitant depression].

  Schmerz (Berlin, Germany) 20080201

• An open-label trial of venlafaxine in body dysmorphic disorder.

  CNS spectrums 20080201

• Similar effects of tramadol and venlafaxine in major depressive disorder.

  Southern medical journal 20080201

• Comparative SEM evaluation of three solvents used in endodontic retreatment: an ex vivo study.

  Journal of applied oral science : revista FOB 20080201

• Functional crosslinked polymer particles synthesized by precipitation polymerization for liquid chromatography.

  Journal of chromatography. A 20080125

• Viscosity dependence of the kinetic parameters of the radical ion pair in homogeneous solution determined by optically detected X- and ku-band electron spin resonance.

  The journal of physical chemistry. A 20080124

• V2O5/SiO2 surface inspired, silsesquioxane-derived oxovanadium complexes and their properties.

  Dalton transactions (Cambridge, England : 2003) 20080121

• Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.

  Brain research 20080116

• Incorporation of sparingly soluble species in mesostructured surfactant-polymer films.

  Journal of colloid and interface science 20080115

• Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.

  European journal of pharmacology 20080114

• Metallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2'-deoxyuridines.

  Organic & biomolecular chemistry 20080107

• A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.

  Journal of psychiatric research 20080101

• Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

  Journal of substance abuse treatment 20080101

• [Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].

  Actas espanolas de psiquiatria 20080101

• Effectiveness and safety of venlafaxine extended release in elderly depressed patients.

  Archives of gerontology and geriatrics 20080101

• Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

  Neuropharmacology 20080101

• Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.

  Biochemical pharmacology 20080101

• Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

  Bioorganic & medicinal chemistry 20080101

• In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.

  British journal of pharmacology 20080101

• Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives.

  Bioorganic & medicinal chemistry letters 20080101

• Gingival bleeding due to venlafaxine.

  The Annals of pharmacotherapy 20080101

• Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.

  Depression and anxiety 20080101

• Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus.

  Hippocampus 20080101

• Solid-phase microextraction method for in vivo measurement of allelochemical uptake.

  Journal of chemical ecology 20080101

• A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.

  Nuclear medicine and biology 20080101

• Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.

  Obstetrics and gynecology 20080101

• Copper(II) coordination polymers derived from triethanolamine and pyromellitic acid for bioinspired mild peroxidative oxidation of cyclohexane.

  Journal of inorganic biochemistry 20080101

• [Hypertrichosis as a possible adverse reaction to selective amine-reuptake inhibitor antidepressants].

  Atencion primaria 20080101

• Pneumonitis related to venlafaxine.

  Psychosomatics 20080101

• [Is it advisable to combine electroconvulsive therapy (ECT) with psychotropics?].

  Tijdschrift voor psychiatrie 20080101

• [Toxicity in overdoses with new antidepressive agents. A survey of records shows different severity symptoms for different agents].

  Lakartidningen 20080101

• A case from the department of neurology.

  The Mount Sinai journal of medicine, New York 20080101

• Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.

  The Journal of clinical psychiatry 20080101

• Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.

  Clinical drug investigation 20080101

• [Agoraphobia: combined treatment and virtual reality. Preliminary results].

  Actas espanolas de psiquiatria 20080101

• Identifying meaningful differences in vasomotor symptoms among menopausal women.

  Menopause (New York, N.Y.) 20080101

• The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.

  Journal of diabetes and its complications 20080101

• [Velaxin (venlafaxine) in the treatment of anxious depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells.

  Pharmacology 20080101

• Serotonin syndrome: a complex but easily avoidable condition.

  General hospital psychiatry 20080101

• [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

  L'Encephale 20080101

• Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

  Current medicinal chemistry 20080101

• Effects of abiotic stressors on synthesis of the mycosporine-like amino acid shinorine in the Cyanobacterium Anabaena variabilis PCC 7937.

  Photochemistry and photobiology 20080101

• [Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• New drugs: Etravirine, sinecatechins, and desvenlafaxine succinate.

  Journal of the American Pharmacists Association : JAPhA 20080101

• Hedonic taste in Drosophila revealed by olfactory receptors expressed in taste neurons.

  PloS one 20080101

• Are SNRIs more effective than SSRIs? A review of the current state of the controversy.

  Psychopharmacology bulletin 20080101

• Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression.

  Clinical neuropharmacology 20080101

• Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.

  Neuropsychobiology 20080101

• Yeast cell factories for fine chemical and API production.

  Microbial cell factories 20080101

• Mycosporine-like amino acids (MAAs): chemical structure, biosynthesis and significance as UV-absorbing/screening compounds.

  Indian journal of experimental biology 20080101

• Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.

  Psychotherapy and psychosomatics 20080101

• [Hypomania/mania induced by cessation of antidepressant drugs].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20080101

• Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.

  Clinical and experimental rheumatology 20080101

• Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.

  Clinical pharmacokinetics 20080101

• [ Hot flashes and breast cancer: what to do? ].

  Revista da Associacao Medica Brasileira (1992) 20080101

• Desvenlafaxine extended release.

  CNS drugs 20080101

• The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Non-fearful panic disorder in gastroenterology.

  Psychosomatics 20080101

• A case of serotonin syndrome associated with methadone overdose.

  Proceedings of the Western Pharmacology Society 20080101

• Advantages of synthesizing trans-1,2-cyclohexanediol in a continuous flow microreactor over a standard glass apparatus.

  The Journal of organic chemistry 20071221

• Hyperfine coupling dependence of the effects of weak magnetic fields on the recombination reactions of radicals generated from polymerisation photoinitiators.

  Physical chemistry chemical physics : PCCP 20071221

• Model studies of beta-scission ring-opening reactions of cyclohexyloxy radicals: application to thermal rearrangements of dispiro-1,2,4-trioxanes.

  Organic letters 20071220

• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.

  Biological psychiatry 20071215

• Effects of 1,8-cineole on the dynamics of lipids and proteins of stratum corneum.

  International journal of pharmaceutics 20071210

• Unraveling the reactive species of a functional non-heme iron monooxygenase model using stopped-flow UV-vis spectroscopy.

  Inorganic chemistry 20071210

• Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.

  International journal of geriatric psychiatry 20071201

• Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

  Psychopharmacology 20071201

• The orphan receptor GPR55 is a novel cannabinoid receptor.

  British journal of pharmacology 20071201

• Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.

  British journal of pharmacology 20071201

• The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.

  Journal of neurochemistry 20071201

• Venlafaxine to treat severe hypotension.

  Nephrology (Carlton, Vic.) 20071201

• Delivery outcome in relation to maternal use of some recently introduced antidepressants.

  Journal of clinical psychopharmacology 20071201

• The effects of venlafaxine on autonomic functions in healthy volunteers.

  Journal of clinical psychopharmacology 20071201

• Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.

  Journal of clinical psychopharmacology 20071201

• Cannabinoid regulation in identified synapse of terrestrial snail.

  The European journal of neuroscience 20071201

• Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.

  Neuro endocrinology letters 20071201

• Gas chromatography/mass spectrometry analysis of Laurus nobilis essential oil composition of northern Cyprus.

  Journal of medicinal food 20071201

• Essential oil composition of Teucrium scordium L.

  Acta pharmaceutica (Zagreb, Croatia) 20071201

• Chromosomal changes induced in mouse bone marrow cells following six weeks inhalation of cyclohexanol.

  Acta biologica Hungarica 20071201

• Recurrent herpes and post-traumatic stress disorder.

  Herpes : the journal of the IHMF 20071201

• A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.

  Biological psychiatry 20071115

• Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

  European journal of pharmacology 20071114

• PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.

  British journal of pharmacology 20071101

• Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.

  British journal of pharmacology 20071101

• Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.

  The Journal of pharmacology and experimental therapeutics 20071101

• Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.

  British journal of pharmacology 20071101

• A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.

  International clinical psychopharmacology 20071101

• A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

  International clinical psychopharmacology 20071101

• Intranasal trigeminal function in children.

  Developmental medicine and child neurology 20071101

• Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.

  Journal of psychopharmacology (Oxford, England) 20071101

• Managing hot flashes in men being treated for prostate cancer.

  Geriatrics 20071101

• A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

  The Journal of clinical psychiatry 20071101

• Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.

  The Journal of clinical psychiatry 20071101

• ['Triple therapy' with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].

  Lakartidningen 20071101

• [Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits].

  Yao xue xue bao = Acta pharmaceutica Sinica 20071101

• Organocatalytic asymmetric robinson annulation of alpha,beta-unsaturated aldehydes: applications to the total synthesis of (+)-palitantin.

  The Journal of organic chemistry 20071026

• [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071018

• Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4.

  The Journal of biological chemistry 20071012

• Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug.

  European psychiatry : the journal of the Association of European Psychiatrists 20071001

• Degradation of beta-hexachlorocyclohexane by haloalkane dehalogenase LinB from gamma-hexachlorocyclohexane-utilizing bacterium Sphingobium sp. MI1205.

  Archives of microbiology 20071001

• A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

  Psychopharmacology 20071001

• Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.

  The British journal of dermatology 20071001

• Venlafaxine-lithium toxicity: suitability for use in the elderly.

  Journal of clinical pharmacy and therapeutics 20071001

• New products and regimens (since 2003).

  Climacteric : the journal of the International Menopause Society 20071001

• Antinociceptive properties of 1,8-Cineole and beta-pinene, from the essential oil of Eucalyptus camaldulensis leaves, in rodents.

  Planta medica 20071001

• Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

  The Journal of clinical psychiatry 20071001

• Sertraline versus venlafaxine XR in major depressive disorder.

  The Journal of clinical psychiatry 20071001

• [Screening and function analysis of a cyclohexanone-degrading bacterium CN1 from deep sea sediment].

  Wei sheng wu xue bao = Acta microbiologica Sinica 20071001

• Synthesis, spectral, catalytic and antimicrobial studies of PPh3/AsPh3 complexes of Ru(II) with dibasic tridentate O, N, S donor ligands.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070901

• Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.

  Psychopharmacology 20070901

• Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line.

  Journal of neurochemistry 20070901

• Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).

  Pharmacoepidemiology and drug safety 20070901

• Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• Safety profile of treatment in diabetic peripheral neuropathic pain.

  Pain medicine (Malden, Mass.) 20070901

• Cytochrome P450 2D6 genotype variation and venlafaxine dosage.

  Mayo Clinic proceedings 20070901

• Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.

  CNS spectrums 20070901

• Gastric bezoar following venlafaxine overdose.

  Clinical toxicology (Philadelphia, Pa.) 20070901

• Pharmacokinetics of 1,8-cineole, a dietary toxin, in the brushtail possum (Trichosurus vulpecula): significance for feeding.

  Xenobiotica; the fate of foreign compounds in biological systems 20070901

• An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.

  Psychiatry research 20070830

• Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms.

  The Journal of biological chemistry 20070824

• Distribution of dimethoate in the body after a fatal organophosphate intoxication.

  Forensic science international 20070806

• Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.

  Journal of affective disorders 20070801

• The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.

  The pharmacogenomics journal 20070801

• Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.

  British journal of clinical pharmacology 20070801

• Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.

  British journal of pharmacology 20070801

• Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates.

  British journal of pharmacology 20070801

• Severe hypoglycemia following venlafaxine intoxication: a case report.

  Journal of clinical psychopharmacology 20070801

• Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.

  Journal of clinical pharmacy and therapeutics 20070801

• Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20070801

• In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.

  Nuclear medicine and biology 20070801

• Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  Journal of child and adolescent psychopharmacology 20070801

• Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.

  The Journal of clinical psychiatry 20070801

• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

  The Journal of clinical psychiatry 20070801

• Antidepressant response in the elderly.

  Psychiatry research 20070730

• Synthesis, structure, and properties of a mixed-valent triiron complex of tetramethyl reductic acid, an ascorbic acid analogue, and its relationship to a functional non-heme iron oxidation catalyst system.

  Inorganic chemistry 20070723

• Uniformly-sized, molecularly imprinted polymers for (-)-epigallocatechin gallate, -epicatechin gallate and -gallocatechin gallate by multi-step swelling and polymerization method.

  Journal of chromatography. A 20070713

• Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.

  European journal of pain (London, England) 20070701

• Seasonal and geographical variations of sterol composition in snow crab hepatopancreas and pelagic fish viscera from Eastern Quebec.

  Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20070701

• Co-carcinogenic effect of cyclohexanol on the development of preneoplastic lesions in a rat hepatocarcinogenesis model.

  Molecular carcinogenesis 20070701

• In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.

  The Journal of pharmacology and experimental therapeutics 20070701

• Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.

  Journal of psychopharmacology (Oxford, England) 20070701

• Effectiveness of two nickel-titanium rotary instruments and a hand file for removing gutta-percha in severely curved root canals during retreatment: an ex vivo study.

  International endodontic journal 20070701

• Treatment of familial erythromelalgia with venlafaxine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070701

• Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.

  The American journal of psychiatry 20070701

• Using psychostimulants for treating residual symptoms in major depression.

  Journal of psychiatry & neuroscience : JPN 20070701

• Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.

  The Journal of clinical psychiatry 20070701

• [Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: risk of sudden death in epilepsy?].

  Anales de medicina interna (Madrid, Spain : 1984) 20070701

• Venlafaxine and tardive blepharospasm: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• [Why measure drug metabolites?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070628

• Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.

  Biochemical pharmacology 20070615

• Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.

  Neuroscience letters 20070615

• Hydroxylated metabolites of beta- and delta-hexachlorocyclohexane: bacterial formation, stereochemical configuration, and occurrence in groundwater at a former production site.

  Environmental science & technology 20070615

• Reliability of fibres in solid-phase microextraction for routine analysis of the headspace of aromatic and medicinal plants.

  Journal of chromatography. A 20070608

• Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.

  The Journal of pharmacology and experimental therapeutics 20070601

• Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.

  Journal of leukocyte biology 20070601

• Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.

  European journal of pharmacology 20070601

• Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.

  The Journal of pharmacology and experimental therapeutics 20070601

• Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7.

  Molecular pharmacology 20070601

• Biomass in the manufacture of industrial products--the use of proteins and amino acids.

  Applied microbiology and biotechnology 20070601

• Sample stacking for the analysis of catechins by microemulsion EKC.

  Electrophoresis 20070601

• Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides.

  Journal of natural products 20070601

• Inhibitory effect of 1,8-cineol (eucalyptol) on Egr-1 expression in lipopolysaccharide-stimulated THP-1 cells.

  Acta pharmacologica Sinica 20070601

• Extended-release venlafaxine-induced alopecia.

  The Annals of pharmacotherapy 20070601

• Experimental study of the excited-state properties and photostability of the mycosporine-like amino acid palythine in aqueous solution.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20070601

• Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.

  Expert review of neurotherapeutics 20070601

• Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.

  Psychiatria Danubina 20070601

• Essential oil composition of two myrtus communis L. varieties grown in North Tunisia.

  The Italian journal of biochemistry 20070601

• Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Biocompatibility of gutta-percha solvents using in vitro mammalian test-system.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070501

• Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.

  International journal of geriatric psychiatry 20070501

• Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.

  International clinical psychopharmacology 20070501

• Smart textiles: a new drug delivery system for symptomatic treatment of a common cold.

  Journal of clinical pharmacology 20070501

• Venlafaxine hyponatraemia: incidence, mechanism and management.

  The Australian and New Zealand journal of psychiatry 20070501

• Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

  The American journal of psychiatry 20070501

• Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

  The American journal of psychiatry 20070501

• Composition of the essential oil of Salvia officinalis L. from various European countries.

  Natural product research 20070501

• A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20070501

• Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

  The Journal of clinical psychiatry 20070501

• Seasonal variation of the chemical constituents of the essential oil of Santolina etrusca from Italy.

  Chemistry & biodiversity 20070501

• Wide spectrum modulation by KP-544 in models relevant for neuronal survival.

  Neuroreport 20070416

• 5-Alkynyl-2'-deoxyuridines: chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells.

  Bioorganic & medicinal chemistry 20070415

• Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward.

  Progress in neuro-psychopharmacology & biological psychiatry 20070413

• Autoxidation of ethylbenzene: the mechanism elucidated.

  The Journal of organic chemistry 20070413

• Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine.

  Journal of pharmaceutical and biomedical analysis 20070411

• Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?

  Journal of affective disorders 20070401

• Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache.

  Cephalalgia : an international journal of headache 20070401

• Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.

  Psychiatry and clinical neurosciences 20070401

• Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.

  International journal of clinical practice 20070401

• Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.

  Human psychopharmacology 20070401

• STAR*D level IV methodology.

  The American journal of psychiatry 20070401

• Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.

  The European journal of neuroscience 20070401

• Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070401

• Data safety monitoring boards and other study methodologies that address subject safety in 'high-risk' therapeutic trials in youths.

  Journal of the American Academy of Child and Adolescent Psychiatry 20070401

• Activation of cannabinoid receptors reduces allergen-induced oxidative stress damage during asthma-like reaction in sensitised guinea-pigs.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20070401

• Treatment of narcolepsy with cataplexy.

  Lancet (London, England) 20070331

• Properties of 1,8-cineole: a thermophysical and theoretical study.

  The journal of physical chemistry. B 20070329

• Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.

  International journal of pharmaceutics 20070321

• Ligand effects on Ni(II)-catalysed alkane-hydroxylation with m-CPBA.

  Dalton transactions (Cambridge, England : 2003) 20070321

• Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.

  European journal of pharmacology 20070308

• Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.

  Neuroscience letters 20070306

• Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent models.

  Endocrinology 20070301

• Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study.

  Biomedical chromatography : BMC 20070301

• Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.

  British journal of pharmacology 20070301

• The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.

  British journal of pharmacology 20070301

• Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

  Neurochemical research 20070301

• Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.

  Journal of psychopharmacology (Oxford, England) 20070301

• Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.

  CNS spectrums 20070301

• Onset of confusion in the context of late-life depression.

  Journal of psychiatry & neuroscience : JPN 20070301

• Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20070301

• Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.

  Psychiatry research 20070227

• Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors.

  Journal of medicinal chemistry 20070222

• Characterization of cannabinoid-binding sites in zebrafish brain.

  Neuroscience letters 20070221

• Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

  BMJ (Clinical research ed.) 20070203

• Venlafaxine for major depression.

  BMJ (Clinical research ed.) 20070203

• Discontinuation symptoms in depression and anxiety disorders.

  The international journal of neuropsychopharmacology 20070201

• Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.

  The international journal of neuropsychopharmacology 20070201

• Differential physiological effects of a low dose and high doses of venlafaxine in major depression.

  The international journal of neuropsychopharmacology 20070201

• Polyethylene glycol-based cationically charged hydrogel beads as a new microcarrier for cell culture.

  Journal of biomedical materials research. Part B, Applied biomaterials 20070201

• Microbial transformation of benzene to cis-3,5-cyclohexadien-1,2-diols by recombinant bacteria harboring toluene dioxygenase gene tod.

  Applied microbiology and biotechnology 20070201

• Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

  British journal of pharmacology 20070201

• Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.

  Journal of clinical psychopharmacology 20070201

• Venlafaxine discontinuation syndrome and suicidal ideation: a case series.

  Journal of clinical psychopharmacology 20070201

• Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.

  ChemMedChem 20070201

• STAR*D: what have we learned?

  The American journal of psychiatry 20070201

• Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

  The American journal of psychiatry 20070201

• Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.

  The American journal of psychiatry 20070201

• False positive phencyclidine results caused by venlafaxine.

  The American journal of psychiatry 20070201

• Acute heart failure associated with venlafaxine poisoning.

  The American journal of emergency medicine 20070201

• Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.

  The Annals of pharmacotherapy 20070201

• Alternate venlafaxine kinetics in overdose patients.

  Journal of clinical pharmacy and therapeutics 20070201

• Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series.

  The Journal of toxicological sciences 20070201

• Intra-specific biodiversity of Italian myrtle (Myrtus communis) through chemical markers profile and biological activities of leaf methanolic extracts.

  Natural product research 20070201

• Controlling the surface chemistry and chromatographic properties of methacrylate-ester-based monolithic capillary columns via photografting.

  Journal of separation science 20070201

• Characterization and catalytic functionalities of copper oxide catalysts supported on zirconia.

  The journal of physical chemistry. B 20070125

• Single enantiomer epoxides by bromomandelation of prochiral alkenes.

  The Journal of organic chemistry 20070119

• Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20070102

• A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

  Journal of psychiatric research 20070101

• Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants.

  Journal of pharmacological and toxicological methods 20070101

• Validation of a Dutch translation of the fibromyalgia impact questionnaire.

  Rheumatology (Oxford, England) 20070101

• A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

  Depression and anxiety 20070101

• A gene linB2 responsible for the conversion of beta-HCH and 2,3,4,5,6-pentachlorocyclohexanol in Sphingomonas sp. BHC-A.

  Applied microbiology and biotechnology 20070101

• Photophysics of ANS. IV. Electron transfer quenching of ANS in alcoholic solvents and mixtures.

  Biophysical chemistry 20070101

• Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose.

  Intensive care medicine 20070101

• The formation of byproducts in the autoxidation of cyclohexane.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20070101

• Persistent sexual arousal syndrome: a case report and review of the literature.

  Journal of sex & marital therapy 20070101

• Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.

  Depression and anxiety 20070101

• Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.

  General hospital psychiatry 20070101

• Venlafaxine induces P-glycoprotein in human Caco-2 cells.

  Human psychopharmacology 20070101

• Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.

  Human psychopharmacology 20070101

• Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

  Pediatrics 20070101

• Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.

  Calcified tissue international 20070101

• Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.

  The oncologist 20070101

• Differentiation of diastereomeric conduramine derivatives under electron ionization and chemical ionization mass spectral conditions.

  Rapid communications in mass spectrometry : RCM 20070101

• Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

  The Journal of clinical psychiatry 20070101

• Current approaches to the pharmacologic treatment of anxiety disorders.

  Psychopharmacology bulletin 20070101

• Synthesis of cyclohexanol derivatives by zirconocene-mediated ring-contraction reactions of seven-membered cyclic enol ethers.

  Angewandte Chemie (International ed. in English) 20070101

• Gas chromatography-mass spectrometry following pressurized hot water extraction and solid-phase microextraction for quantification of eucalyptol, camphor, and borneol in Chrysanthemum flowers.

  Journal of separation science 20070101

• [Kinetics of Ca2+, NADH, and oxidized flavoproteins in the frog olfactory lining under the effect of odorants].

  Biofizika 20070101

• A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.

  Nordic journal of psychiatry 20070101

• Employing atmospheric pressure photoionization in liquid chromatography/tandem mass spectrometry to minimize ion suppression and matrix effects for the quantification of venlafaxine and O-desmethylvenlafaxine.

  Rapid communications in mass spectrometry : RCM 20070101

• A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia.

  Dementia and geriatric cognitive disorders 20070101

• [Applications and safety of modern antidepressants in patients with liver diseases].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20070101

• Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.

  Pharmacology 20070101

• Effect of natural phenol derivatives on skeletal type sarcoplasmic reticulum Ca2+ -ATPase and ryanodine receptor.

  Journal of muscle research and cell motility 20070101

• [Malignant neuroleptic syndrome and serotoninergic syndrome: two cases].

  Revista clinica espanola 20070101

• [Venlafaxine extended release and alcohol dependence].

  Adicciones 20070101

• [Aminergical regulation of pheromone sensillae in the cockroach Periplaneta americana].

  Zhurnal evoliutsionnoi biokhimii i fiziologii 20070101

• Comparative study of DNA-damaging and DNA-protective effects of selected components of essential plant oils in human leukemic cells K562.

  Neoplasma 20070101

• On the ease of predicting the thermodynamic properties of beta-cyclodextrin inclusion complexes.

  Chemistry Central journal 20070101

• The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease.

  Restorative neurology and neuroscience 20070101

• A convenient approach for access to both carbapentofuranoses and carbahexopyranoses. Stereocontrolled synthesis of enantiopure carba-D-ribofuranoses, carba-D-arabinofuranoses and carba-L-gulopyranose.

  The Journal of organic chemistry 20061222

• The redistribution of selected psychiatric drugs in post-mortem cases.

  Forensic science international 20061220

• Digitalis intoxication induced by paroxetine co-administration.

  Lancet (London, England) 20061202

• Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.

  The Journal of pharmacology and experimental therapeutics 20061201

• Venlafaxine-induced ecchymoses and impaired platelet aggregation.

  European journal of haematology 20061201

• Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.

  Neuropharmacology 20061201

• Cannabinoids reveal importance of spike timing coordination in hippocampal function.

  Nature neuroscience 20061201

• Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.

  Pharmacotherapy 20061201

• Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.

  CNS spectrums 20061201

• Essential oil of croton nepetaefolius and its main constituent, 1,8-cineole, block excitability of rat sciatic nerve in vitro.

  Clinical and experimental pharmacology & physiology 20061201

• Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC.

  Journal of separation science 20061201

• Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.

  Endocrine 20061201

• Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.

  Journal of molecular graphics & modelling 20061101

• Synthesis, characterization, electro chemistry, catalytic and biological activities of ruthenium(III) complexes with bidentate N, O/S donor ligands.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20061101

• Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.

  Neurochemistry international 20061101

• Neonatal seizures from in utero venlafaxine exposure.

  Journal of paediatrics and child health 20061101

• Venlafaxine for treatment of interferon alfa-induced depression.

  The Annals of pharmacotherapy 20061101

• Prescribing of venlafaxine and dosulepin in primary care.

  Journal of psychopharmacology (Oxford, England) 20061101

• Chiral microemulsion electrokinetic chromatography: Effect of cosurfactant identity on enantioselectivity, methylene selectivity, resolution, and other chromatographic figures of merit.

  Electrophoresis 20061101

• Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.

  Current medical research and opinion 20061101

• The role of the hydrophobic group on ring A of chalcones in the inhibition of interleukin-5.

  Archives of pharmacal research 20061101

• A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.

  The Journal of clinical psychiatry 20061101

• Dose-dependent Venlafaxine-induced sinus tachycardia.

  International journal of cardiology 20061026

• Fluorescent detection for cyclic and acyclic alcohol guests by naphthalene-appended amino-beta-cyclodextrins.

  Organic letters 20061026

• cis-3,5-Cyclohexadiene-1,2-diol derivatives: facial selectivity in their Diels-Alder reactions with ethylenic, acetylenic and azo dienophiles.

  Organic & biomolecular chemistry 20061021

• The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.

  European journal of pharmacology 20061010

• Biocatalytic production of enantiopure cyclohexane-trans-1,2-diol using extracellular lipases from Bacillus subtilis.

  Applied microbiology and biotechnology 20061001

• Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.

  Journal of affective disorders 20061001

• Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.

  Psychopharmacology 20061001

• CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.

  Journal of clinical pharmacy and therapeutics 20061001

• A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.

  Journal of clinical psychopharmacology 20061001

• Quetiapine augmentation in lactation: a series of case reports.

  Journal of clinical psychopharmacology 20061001

• NICE guidelines on antidepressants.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20061001

• Defining response and remission in anxiety disorders: toward an integrated approach.

  CNS spectrums 20061001

• Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

  Archives of general psychiatry 20061001

• A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20060930

• Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.

  Bioorganic & medicinal chemistry 20060915

• Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull' effect.

  International journal of pharmaceutics 20060914

• A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.

  Brain research 20060907

• Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.

  Journal of agricultural and food chemistry 20060906

• Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys.

  Journal of psychopharmacology (Oxford, England) 20060901

• Biotransformation of mycosporine like amino acids (MAAs) in the toxic dinoflagellate Alexandrium tamarense.

  Journal of photochemistry and photobiology. B, Biology 20060901

• [Social anxiety disorders].

  Der Nervenarzt 20060901

• Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats.

  Journal of psychopharmacology (Oxford, England) 20060901

• Behavioral responses to odorants in drosophila require nervous system expression of the beta integrin gene myospheroid.

  Chemical senses 20060901

• Phylogenetic fragrance patterns in Nicotiana sections Alatae and Suaveolentes.

  Phytochemistry 20060901

• Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra.

  Acta neuropathologica 20060901

• Kava in generalized anxiety disorder: three placebo-controlled trials.

  International clinical psychopharmacology 20060901

• Escitalopram versus venlafaxine XR in the treatment of depression.

  International clinical psychopharmacology 20060901

• In vitro evaluation of macrophage viability after incubation in orange oil, eucalyptol, and chloroform.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060901

• Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060901

• Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060901

• Volte-face on venlafaxine--reasons and reflections.

  Journal of psychopharmacology (Oxford, England) 20060901

• Keeping our eyes on STAR*D.

  The American journal of psychiatry 20060901

• Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

  The American journal of psychiatry 20060901

• Less mood switching with venlafaxine?

  The American journal of psychiatry 20060901

• Rubrivivax benzoatilyticus sp. nov., an aromatic, hydrocarbon-degrading purple betaproteobacterium.

  International journal of systematic and evolutionary microbiology 20060901

• Avoidance of Abeta[(25-35)] / (H(2)O(2)) -induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K-dependent mechanisms: role of NF-kappaB and p53.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060901

• Enantioselective synthesis of beta-amino esters and its application to the synthesis of the enantiomers of the antidepressant Venlafaxine.

  Chemical communications (Cambridge, England) 20060807

• Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction.

  The international journal of neuropsychopharmacology 20060801

• Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor.

  The Journal of pharmacology and experimental therapeutics 20060801

• Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.

  Psychoneuroendocrinology 20060801

• Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components.

  The Journal of antimicrobial chemotherapy 20060801

• Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.

  Neuropharmacology 20060801

• The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.

  International immunopharmacology 20060801

• Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

  Psychopharmacology 20060801

• A case of recurrent hyponatremia induced by venlafaxine.

  Journal of clinical psychopharmacology 20060801

• Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.

  The American journal of psychiatry 20060801

• Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

  The British journal of psychiatry : the journal of mental science 20060801

• Lithium and venlafaxine interaction: a case of serotonin syndrome.

  Journal of clinical pharmacy and therapeutics 20060801

• Solid-phase microextraction: investigation of the metabolism of substances that may be abused by inhalation.

  Journal of chromatographic science 20060801

• Conflicting demands on detoxification pathways influence how common brushtail possums choose their diets.

  Ecology 20060801

• Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.

  The Journal of clinical psychiatry 20060801

• [Analysis of the essential oils from Amomun kravak Pierre ex Gagnep by GC-MS].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20060801

• Mesoporous silica materials with an extremely high content of organic sulfonic groups and their comparable activities with that of concentrated sulfuric acid in catalytic esterification.

  The journal of physical chemistry. B 20060727

• Steric effects in the uncatalyzed and DMAP-catalyzed acylation of alcohols-quantifying the window of opportunity in kinetic resolution experiments.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060724

• Dispersion and reactivity of copper catalysts supported on Al2O3-ZrO2.

  The journal of physical chemistry. B 20060720

• Linezolid and serotonergic drug interactions: a retrospective survey.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060715

• Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats.

  Brain research 20060707

• Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.

  Molecular immunology 20060701

• Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.

  Molecular pharmacology 20060701

• Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.

  Progress in neuro-psychopharmacology & biological psychiatry 20060701

• Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.

  Experimental brain research 20060701

• Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.

  European journal of pharmacology 20060701

• Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

  Nature medicine 20060701

• Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.

  Human psychopharmacology 20060701

• Four new compounds from the leaves of Acer truncatum.

  Chemistry & biodiversity 20060701

• Mycosporine-like amino acids in the zooxanthella-ciliate symbiosis Maristentor dinoferus.

  Protist 20060601

• CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.

  International journal of geriatric psychiatry 20060601

• Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.

  Journal of clinical psychopharmacology 20060601

• Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.

  Journal of clinical psychopharmacology 20060601

• Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.

  Psychiatry and clinical neurosciences 20060601

• Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

  The journal of pain : official journal of the American Pain Society 20060601

• Metabolism of two analgesic agents, tramadol-n-oxide and tramadol, in specific pathogen-free and axenic mice.

  Xenobiotica; the fate of foreign compounds in biological systems 20060601

• Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.

  Behavioral and cognitive neuroscience reviews 20060601

• Depression in adults.

  Clinical evidence 20060601

• To the core of autocatalysis in cyclohexane autoxidation.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060524

• Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol.

  European journal of pharmacology 20060524

• Narcolepsy-cataplexy associated with precocious puberty.

  Neurology 20060523

• [Anxiety disorders: diagnosis and therapy from the family physician's perspective].

  MMW Fortschritte der Medizin 20060515

• Enhanced activity and selectivity in cyclohexane autoxidation by inert H-bond acceptor catalysts.

  Chemphyschem : a European journal of chemical physics and physical chemistry 20060512

• Cannabinoid system in the budgerigar brain.

  Brain research 20060504

• Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20060503

• Depolarization and Ca(2+) down regulate CB1 receptors and CB1-mediated signaling in cerebellar granule neurons.

  Neuropharmacology 20060501

• Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.

  Journal of neuroscience research 20060501

• (R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.

  Bioorganic & medicinal chemistry letters 20060501

• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  Pharmacology & therapeutics 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Structure of euhalothece-362, a novel red-shifted mycosporine-like amino acid, from a halophilic cyanobacterium (Euhalothece sp.).

  FEMS microbiology letters 20060501

• Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis.

  The British journal of dermatology 20060501

• Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.

  Perspectives in psychiatric care 20060501

• Lamotrigine add-on therapy to venlafaxine treatment in adolescent-onset bipolar II disorder: a case report covering an 8-month observation period.

  International journal of clinical pharmacology and therapeutics 20060501

• Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.

  The Journal of clinical psychiatry 20060501

• QT interval prolongation associated with venlafaxine administration.

  International journal of cardiology 20060428

• [Not neglecting therapy of depression in the elderly].

  MMW Fortschritte der Medizin 20060420

• Direct PEM fuel cell using 'organic chemical hydrides' with zero-CO2 emission and low-crossover.

  Physical chemistry chemical physics : PCCP 20060414

• Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.

  Psychoneuroendocrinology 20060401

• Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials.

  Bioorganic & medicinal chemistry 20060401

• High-valent iron in chemical and biological oxidations.

  Journal of inorganic biochemistry 20060401

• Venlafaxine extended-release in patients older than 80 years with depressive syndrome.

  International journal of geriatric psychiatry 20060401

• A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060401

• Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

  The Journal of clinical psychiatry 20060401

• The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.

  Human & experimental toxicology 20060401

• Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20060401

• [Psychotherapies: what is the impact on the cortical and subcortical levels?].

  L'Encephale 20060401

• Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

  The New England journal of medicine 20060323

• Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320

• Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.

  European journal of pharmacology 20060318

• Resolution of racemic 2-aminocyclohexanol derivatives and their application as ligands in asymmetric catalysis.

  The Journal of organic chemistry 20060317

• A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.

  Biological psychiatry 20060301

• Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20060301

• Dissolving efficacy of organic solvents on root canal sealers.

  Clinical oral investigations 20060301

• Tension-type headache with aura.

  Cephalalgia : an international journal of headache 20060301

• Comparison of subjective perception with objective measurement of olfaction.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20060301

• Managing depressive and anxiety disorders with escitalopram.

  Expert opinion on pharmacotherapy 20060301

• Noradrenergic and serotonergic modulation to treat vasomotor symptoms.

  The journal of the British Menopause Society 20060301

• Treatment of anxiety disorders with venlafaxine XR.

  Expert review of neurotherapeutics 20060301

• Estimation of symptom-free days in generalized anxiety disorder.

  Current medical research and opinion 20060301

• Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

  Journal of psychiatry & neuroscience : JPN 20060301

• Treatment guidelines for mania.

  Journal of psychiatry & neuroscience : JPN 20060301

• Anesthesiologist suicide with atracurium.

  Journal of analytical toxicology 20060301

• Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.

  Addiction biology 20060301

• Chemical composition of volatiles in Sardinian myrtle (Myrtus communis L.) alcoholic extracts and essential oils.

  Journal of agricultural and food chemistry 20060222

• Menopausal symptoms after cessation of hormone replacement therapy.

  Maturitas 20060220

• Rapid protein digestion and identification using monolithic enzymatic microreactor coupled with nano-liquid chromatography-electrospray ionization mass spectrometry.

  Journal of chromatography. A 20060217

• Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.

  Biological psychiatry 20060215

• F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.

  European journal of pharmacology 20060215

• Effect of physicochemical properties of cyclic terpenes on their ex vivo skin absorption and elimination kinetics.

  Journal of dermatological science 20060201

• Atypical membrane topology and heteromeric function of Drosophila odorant receptors in vivo.

  PLoS biology 20060201

• Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20060201

• Venlafaxine and the rapid development of anasarca.

  Journal of clinical psychopharmacology 20060201

• Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms.

  The Annals of pharmacotherapy 20060201

• Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

  Journal of palliative medicine 20060201

• Atomoxetine enhances a short-term model of plasticity in humans.

  Archives of physical medicine and rehabilitation 20060201

• A broadly applicable method for extraction and characterization of mycosporines and mycosporine-like amino acids of terrestrial, marine and freshwater origin.

  FEMS microbiology letters 20060201

• Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

  The American journal of psychiatry 20060201

• Role of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060201

• Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.

  Psychiatry and clinical neurosciences 20060201

• Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.

  The Journal of clinical psychiatry 20060201

• Feeding behavior of lambs in relation to kinetics of 1,8-cineole dosed intravenously or into the rumen.

  Journal of chemical ecology 20060201

• Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060201

• Biological activity and composition of the essential oils of Achillea schischkinii Sosn. and Achillea aleppica DC. subsp. aleppica.

  Journal of agricultural and food chemistry 20060111

• Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.

  Eye (London, England) 20060101

• Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions.

  Journal of psychopharmacology (Oxford, England) 20060101

• Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20060101

• Structural-activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1,2,4-triazole-3-carboxamides.

  European journal of medicinal chemistry 20060101

• Discriminative stimulus properties of tianeptine.

  Psychopharmacology 20060101

• Rapid protein identification using monolithic enzymatic microreactor and LC-ESI-MS/MS.

  Proteomics 20060101

• A computer-based approach to assess the perception of composite odour intensity: a step towards automated olfactometry calibration.

  Physiological measurement 20060101

• Oxcarbazepine-induced thrombocytopenia.

  Psychosomatics 20060101

• Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.

  Current medical research and opinion 20060101

• Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.

  The Journal of clinical psychiatry 20060101

• Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20060101

• Interaction between venlafaxine and caffeine on antinociception in mice.

  Die Pharmazie 20060101

• Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors.

  Current medicinal chemistry 20060101

• The release of bovine serum albumin from polyurethane based hydrophilic and hydrophobic disks and microbiological interactions.

  Bio-medical materials and engineering 20060101

• Polymer-based monolithic microcolumns for hydrophobic interaction chromatography of proteins.

  Journal of separation science 20060101

• Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine.

  Clinical toxicology (Philadelphia, Pa.) 20060101

• Androgens and menopause: more fuel for the fire.

  Menopause (New York, N.Y.) 20060101

• Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.

  Menopause (New York, N.Y.) 20060101

• Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.

  Hippocampus 20060101

• A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.

  Depression and anxiety 20060101

• Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].

  Actas espanolas de psiquiatria 20060101

• [Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].

  Actas espanolas de psiquiatria 20060101

• [Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review].

  Actas espanolas de psiquiatria 20060101

• [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].

  Actas espanolas de psiquiatria 20060101

• Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

  BMC psychiatry 20060101

• Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.

  The American journal on addictions 20060101

• Spectrophotometric determination of certain antidepressants in pharmaceutical preparations.

  Journal of AOAC International 20060101

• [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].

  Tijdschrift voor psychiatrie 20060101

• Topiramate use in alprazolam addiction.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101

• [Primary Human Immunodeficiency Virus infection revealed by psychiatric symptoms].

  L'Encephale 20060101

• Cardioversion of persistent atrial arrhythmia after treatment with venlafaxine in successful management of major depression and posttraumatic stress disorder.

  Psychosomatics 20060101

• A new chloro-monoterpene from the mangrove endophytic fungus Tryblidiopycnis sp. (4275).

  Journal of Asian natural products research 20060101

• Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.

  Journal of experimental therapeutics & oncology 20060101

• In vitro cytotoxic and non-genotoxic effects of gutta-percha solvents on mouse lymphoma cells by single cell gel (comet) assay.

  Brazilian dental journal 20060101

• Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.

  Therapie 20060101

• Tolerability of amine uptake inhibitors in urologic diseases.

  Current drug safety 20060101

• Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.

  European journal of pharmacology 20051228

• The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats.

  European journal of pharmacology 20051228

• Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051227

• The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.

  Proceedings of the National Academy of Sciences of the United States of America 20051227

• Soft or hard ionization of molecules in helium nanodroplets? An electron impact investigation of alcohols and ethers.

  Physical chemistry chemical physics : PCCP 20051221

• Synthesis and antiproliferative activity of A-ring aromatised and conduritol-like steroidal compounds.

  Steroids 20051215

• Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats.

  Neuroscience letters 20051209

• Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.

  Journal of chromatography. A 20051209

• Intrinsic conformational preferences of substituted cyclohexanes and tetrahydropyrans evaluated at the CCSD(T) complete basis set limit: implications for the anomeric effect.

  The journal of physical chemistry. A 20051208

• Design and evaluation of a coupled monolithic pre-concentrator-capillary zone electrophoresis system for the extraction of immunoglobulin G from human serum.

  Journal of chromatography. A 20051202

• Synthesis, characterization and biological activity of oxovanadium (IV) complexes with cyclic polyalcohols.

  Journal of inorganic biochemistry 20051201

• Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.

  The European journal of health economics : HEPAC : health economics in prevention and care 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Moving beyond balance for a better antidepressant.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201

• Fatal venlafaxine overdose with acinar zone 3 liver cell necrosis.

  The American journal of forensic medicine and pathology 20051201

• Rapid absorption of dietary 1,8-cineole results in critical blood concentration of cineole and immediate cessation of eating in the common brushtail possum (Trichosurus vulpecula).

  Journal of chemical ecology 20051201

• Isolation and functional analysis of cytochrome P450 CYP153A genes from various environments.

  Bioscience, biotechnology, and biochemistry 20051201

• Development and validation of a flow-injection assay for dissolution studies of the anti-depressant drug venlafaxine.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20051201

• Relaxant effects of the essential oil of Eucalyptus tereticornis and its main constituent 1,8-cineole on guinea-pig tracheal smooth muscle.

  Planta medica 20051201

• Antidepressant treatment outcomes of psychogenic movement disorder.

  The Journal of clinical psychiatry 20051201

• Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.

  The Journal of clinical psychiatry 20051201

• A short synthesis of (+)-cyclophellitol.

  The Journal of organic chemistry 20051125

• A concise synthetic route to the conduritols from pentoses.

  Organic & biomolecular chemistry 20051121

• Solvent dependence of the molecular order in ion-exchanged self-assembled dialkylammonium monolayers on mica studied with soft X-ray absorption.

  Journal of colloid and interface science 20051101

• Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids.

  The Journal of pharmacology and experimental therapeutics 20051101

• Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

  Psychopharmacology 20051101

• Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.

  Psychopharmacology 20051101

• Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.

  The Journal of pharmacology and experimental therapeutics 20051101

• Allosteric modulation of the cannabinoid CB1 receptor.

  Molecular pharmacology 20051101

• Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

  The Annals of pharmacotherapy 20051101

• Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the 'neuro-immune' system.

  Neurochemical research 20051101

• Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.

  Experimental and clinical psychopharmacology 20051101

• Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051101

• Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.

  Journal of neuroscience research 20051015

• alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.

  Behavioural brain research 20051014

• Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.

  Neuropharmacology 20051001

• Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.

  Psychopharmacology 20051001

• Catalytic oxidation of cyclohexane by a binuclear Fe(III) complex biomimetic to methane monooxygenase.

  Journal of inorganic biochemistry 20051001

• Effects of paroxetine and venlafaxine XR on heart rate variability in depression.

  Journal of clinical psychopharmacology 20051001

• Severe rhabdomyolysis following venlafaxine overdose.

  Therapeutic drug monitoring 20051001

• A quantitative survey of mycosporine-like amino acids (MAAS) in intertidal egg masses from temperate rocky shores.

  Journal of chemical ecology 20051001

• Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.

  The British journal of psychiatry : the journal of mental science 20051001

• Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.

  Journal of palliative medicine 20051001

• Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

  The Journal of clinical psychiatry 20051001

• Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.

  Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology 20051001

• [Love, humor and psychosis in an atypical depression].

  L'Encephale 20051001

• [Cannabis dependence and social phobia].

  L'Encephale 20051001

• Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.

  Maturitas 20050916

• Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.

  Bioorganic & medicinal chemistry letters 20050915

• Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.

  Bioorganic & medicinal chemistry 20050915

• Expedient synthesis of potent cannabinoid receptor agonist (-)-CP55,940.

  Organic letters 20050915

• Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20050914

• Near IR overtone spectral investigations of cyclohexanol using local mode model--evidence for variation of anharmonicity with concentration due to hydrogen bonding.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050901

• Cannabinoids modulate synaptic activity in the rat supraoptic nucleus.

  Journal of neuroendocrinology 20050901

• Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.

  Basic & clinical pharmacology & toxicology 20050901

• SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

  CNS spectrums 20050901

• Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods.

  Behavioural pharmacology 20050901

• The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).

  Behavioural pharmacology 20050901

• Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.

  Behavioural pharmacology 20050901

• Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3.

  Behavioural pharmacology 20050901

• Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.

  Journal of women's health (2002) 20050901

• Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.

  The Netherlands journal of medicine 20050901

• Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

  The Journal of clinical psychiatry 20050901

• [1+1 or 2x1? Another form of dual antidepressive mechanism of action].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050901

• Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.

  Wall Street journal (Eastern ed.) 20050824

• Temperature-induced conformational change at the catalytic site of Sulfolobus solfataricus alcohol dehydrogenase highlighted by Asn249Tyr substitution. A hydrogen/deuterium exchange, kinetic, and fluorescence quenching study.

  Biochemistry 20050823

• Different pharmacological profile of two closely related endocannabinoid ester analogs.

  Life sciences 20050812

• The DMAP-catalyzed acetylation of alcohols--a mechanistic study (DMAP = 4-(dimethylamino)pyridine).

  Chemistry (Weinheim an der Bergstrasse, Germany) 20050805

• Effects of repeated administration with CP-55,940, a cannabinoid CB1 receptor agonist on the metabolism of the hepatic heme.

  The international journal of biochemistry & cell biology 20050801

• The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.

  The Journal of pharmacology and experimental therapeutics 20050801

• The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.

  European journal of pain (London, England) 20050801

• Analyses of phenolic compounds by microemulsion electrokinetic chromatography.

  Electrophoresis 20050801

• Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.

  Therapeutic drug monitoring 20050801

• Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.

  Current medical research and opinion 20050801

• Venlafaxine and cardiac effects.

  Prescrire international 20050801

• Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase.

  Journal of medicinal chemistry 20050728

• Crossmodal interactions between olfactory and visual learning in Drosophila.

  Science (New York, N.Y.) 20050708

• Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor.

  British journal of pharmacology 20050701

• Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

  International clinical psychopharmacology 20050701

• Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.

  Pain 20050701

• Olanzapine plus venlafaxine in treatment-resistant depression.

  Journal of psychopharmacology (Oxford, England) 20050701

• Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.

  Analytical and bioanalytical chemistry 20050701

• Elementary response of olfactory receptor neurons to odorants.

  Science (New York, N.Y.) 20050624

• Preparation and evaluation of a chiral stationary phase covalently bound with chiral pseudo-1 8-crown-6 ether having 1-phenyl-1,2-cyclohexanediol as a chiral unit.

  Journal of chromatography. A 20050617

• The serotonin syndrome.

  The New England journal of medicine 20050609

• Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605

• Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom.

  The European journal of health economics : HEPAC : health economics in prevention and care 20050601

• The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.

  British journal of pharmacology 20050601

• Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.

  Anti-cancer drugs 20050601

• Drosophila olfactory response rhythms require clock genes but not pigment dispersing factor or lateral neurons.

  Journal of biological rhythms 20050601

• The relevant effect of an intramolecular hydrogen bond on the conformational equilibrium of cis-3-methoxycyclohexanol compared to trans-3-methoxycyclohexanol and cis-1,3-dimethoxycyclohexane.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050601

• Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

  Pharmacoepidemiology and drug safety 20050601

• Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.

  Journal of sleep research 20050601

• Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.

  Neuropharmacology 20050601

• Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.

  Neuropharmacology 20050601

• The four-plates test-retest paradigm to discriminate anxiolytic effects.

  Psychopharmacology 20050601

• Causal or casual?

  Pharmacoepidemiology and drug safety 20050601

• (1S*,2S*,4S*,5S*)-Cyclohexane-1,2,4,5-tetrol monohydrate.

  Acta crystallographica. Section C, Crystal structure communications 20050601

• Two new chiral nucleoside analogues: (4R,5R)-4-(4,6-dimethylpyrimidin-2-ylsulfanyl)-5-[(2S,5R)-2-isopropyl-5-methylcyclohexyloxy]-2,3,4,5-tetrahydrofuran-2-one and (4R,5R)-5-[(2S,5R)-isopropyl-5-methylcyclohexyloxy]-4-(4-methyl-1,3-thiazol-2-ylamino)-2,3,4,5-tetrahydrofuran-2-one.

  Acta crystallographica. Section C, Crystal structure communications 20050601

• Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.

  The Journal of clinical psychiatry 20050601

• A redefinition of odor mixture quality.

  Behavioral neuroscience 20050601

• Characterization and reactivity of copper oxide catalysts supported on TiO2-ZrO2.

  The journal of physical chemistry. B 20050519

• Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.

  European journal of pharmacology 20050509

• [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

  Der Nervenarzt 20050501

• Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050501

• Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.

  Psychopharmacology 20050501

• Serotonin toxicity associated with concomitant use of linezolid.

  The Annals of pharmacotherapy 20050501

• Capillary electrochromatography with monolithic stationary phases. 4. Preparation of neutral stearyl-acrylate monoliths and their evaluation in capillary electrochromatography of neutral and charged small species as well as peptides and proteins.

  Electrophoresis 20050501

• Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.

  Journal of neurochemistry 20050501

• Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.

  Experimental eye research 20050501

• Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.

  The Netherlands journal of medicine 20050501

• Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens.

  Naunyn-Schmiedeberg's archives of pharmacology 20050501

• Serotonin syndrome:case report and current concepts.

  Irish medical journal 20050501

• [Trazodone and venlafaxine in treatment of depressive disorders].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050501

• Metabolism of 1,8-cineole by human cytochrome P450 enzymes: identification of a new hydroxylated metabolite.

  Biochimica et biophysica acta 20050415

• Efficient plasmid DNA cleavage by a mononuclear copper(II) complex.

  Inorganic chemistry 20050404

• Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050401

• Increased libido with the combined use of venlafaxine and mirtazapine.

  Journal of clinical psychopharmacology 20050401

• Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT.

  Pain 20050401

• Do venlafaxine XR and paroxetine equally influence negative and positive affect?

  Journal of affective disorders 20050401

• Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.

  Journal of affective disorders 20050401

• Degradation of beta-Hexachlorocyclohexane by Haloalkane Dehalogenase LinB from Sphingomonas paucimobilis UT26.

  Applied and environmental microbiology 20050401

• Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

  Neuropharmacology 20050401

• Retentivity and enantioselectivity of uniformly-sized molecularly imprinted polymers for (S)-nilvadipine in aqueous and non-aqueous mobile phases.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20050401

• Autoxidation of cyclohexane: conventional views challenged by theory and experiment.

  Chemphyschem : a European journal of chemical physics and physical chemistry 20050401

• A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.

  Current medical research and opinion 20050401

• Venlafaxine-associated interstitial pneumonitis.

  Pharmacotherapy 20050401

• Chemical response of Picea glehnii seed-epiphytic Penicillium species to Pythium vexans under in vitro competitive conditions for mycelial growth.

  Journal of chemical ecology 20050401

• Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.

  Journal of medicinal chemistry 20050324

• Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish artemisia species.

  Journal of agricultural and food chemistry 20050309

• Terpene compounds as possible precursors of 1,8-cineole in red grapes and wines.

  Journal of agricultural and food chemistry 20050309

• Structure-function analysis of the vanillin molecule and its antifungal properties.

  Journal of agricultural and food chemistry 20050309

• Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.

  Chinese medical journal 20050305

• Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050301

• Medication-associated somnambulism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20050301

• Fatal cerebral edema after moderate valproic acid overdose.

  Annals of emergency medicine 20050301

• Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.

  International clinical psychopharmacology 20050301

• Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.

  Addiction (Abingdon, England) 20050301

• Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.

  Biological psychiatry 20050301

• Eucalyptol, an essential oil, reduces contractile activity in rat cardiac muscle.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20050301

• Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.

  British journal of pharmacology 20050301

• Using metaanalysis to evaluate evidence: practical tips and traps.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20050301

• Solvent-free preparation of nanosized sulfated zirconia with Brønsted acidic sites from a simple calcination.

  The journal of physical chemistry. B 20050224

• Surface properties of diluted solutions of cyclohexanol and cyclopentanol in ethylene glycol.

  Journal of colloid and interface science 20050215

• In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.

  Bioorganic & medicinal chemistry 20050215

• Photon flux and wavelength effects on the selectivity and product yields of the photocatalytic air oxidation of neat cyclohexane on TiO(2) particles.

  The journal of physical chemistry. B 20050210

• Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.

  The Medical journal of Australia 20050207

• Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons.

  Journal of neurophysiology 20050201

• Venlafaxine, serotonin syndrome, and differential diagnoses.

  Journal of clinical psychopharmacology 20050201

• Proposed involvement of a soluble methane monooxygenase homologue in the cyclohexane-dependent growth of a new Brachymonas species.

  Environmental microbiology 20050201

• Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.

  International journal of andrology 20050201

• Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.

  Biological psychiatry 20050201

• The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.

  Progress in neuro-psychopharmacology & biological psychiatry 20050201

• Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

  Archives of general psychiatry 20050201

• A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

  The Journal of clinical psychiatry 20050201

• The efficacy and safety of venlafaxine in the prophylaxis of migraine.

  Headache 20050201

• Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance.

  Prescrire international 20050201

• Isolation and characterization of allelopathic volatiles from mugwort (Artemisia vulgaris).

  Journal of chemical ecology 20050201

• Adolescents' response to antidepressant treatment in a community mental health center.

  Community mental health journal 20050201

• Biomimetic alcohol oxidations by an iron(III) porphyrin complex: relevance to cytochrome P-450 catalytic oxidation and involvement of the two-state radical rebound mechanism.

  Dalton transactions (Cambridge, England : 2003) 20050121

• Enantiodivergent formal synthesis of (+)- and (-)-cyclophellitol from D-xylose based on the latent symmetry concept.

  The Journal of organic chemistry 20050121

• Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine.

  Journal of controlled release : official journal of the Controlled Release Society 20050120

• Natural ozone scavenger prevents asthma in sensitized rats.

  Bioorganic & medicinal chemistry 20050117

• CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

  Journal of the National Cancer Institute 20050105

• Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

  Psychopharmacology 20050101

• Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.

  Pharmacological research 20050101

• Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks.

  Journal of biomedical materials research. Part A 20050101

• Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication.

  The Annals of pharmacotherapy 20050101

• The role of venlafaxine in the treatment of obsessive-compulsive disorder.

  The Annals of pharmacotherapy 20050101

• Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.

  Progress in neuro-psychopharmacology & biological psychiatry 20050101

• The prevention of post-surgical neuralgia.

  Pain 20050101

• Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.

  Obstetrics and gynecology 20050101

• Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome.

  European psychiatry : the journal of the Association of European Psychiatrists 20050101

• Adsorption of polypropylene from dilute solutions on a zeolite column packing.

  Journal of separation science 20050101

• [Effectiveness of venlafaxine in the treatment of alcohol dependence with comorbid depression].

  Actas espanolas de psiquiatria 20050101

• Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.

  Comprehensive psychiatry 20050101

• Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.

  PharmacoEconomics 20050101

• Capgras syndrome in the modern era: self misidentification on an ID picture.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050101

• A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.

  Clinical therapeutics 20050101

• Ontogenetic changes in the chemistry and morphology of oil glands in Hermannia convexa (Acari: Oribatida).

  Experimental & applied acarology 20050101

• In vitro transcutaneous delivery of ketoprofen and essential polyunsaturated fatty acids from a fish oil vehicle incorporating 1,8-cineole.

  Drug delivery 20050101

• Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.

  Arzneimittel-Forschung 20050101

• Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.

  Neuropsychobiology 20050101

• [Effects of venlafaxine extended release formulation on the clinical management of patients].

  Actas espanolas de psiquiatria 20050101

• [The current challenges of the treatment of depression: venlafaxina extended release and remission outcomes in real-world clinical practice].

  Actas espanolas de psiquiatria 20050101

• Remission from depression : a review of venlafaxine clinical and economic evidence.

  PharmacoEconomics 20050101

• Multimodal therapy of treatment resistant depression: a study and analysis.

  International journal of psychiatry in medicine 20050101

• Electronic properties of amino acid side chains: quantum mechanics calculation of substituent effects.

  BMC chemical biology 20050101

• Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.

  The journal of supportive oncology 20050101

• Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.

  Depression and anxiety 20050101

• Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.

  Depression and anxiety 20050101

• [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

  L'Encephale 20050101

• Reversible hyponatremia and venlafaxine.

  Psychosomatics 20050101

• The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy.

  American journal of therapeutics 20050101

• Effect of different locations on the chemical composition of essential oils of laurel (Laurus nobilis L.) leaves growing wild in Turkey.

  Journal of medicinal food 20050101

• Venlafaxine-induced urinary incontinence resolved after switching to sertraline.

  Clinical neuropharmacology 20050101

• Venlafaxine and asthma.

  Nordic journal of psychiatry 20050101

• Pathways in the degradation of hydrolyzed alcohols of butyl benzyl phthalate in metabolically diverse Gordonia sp. strain MTCC 4818.

  Journal of molecular microbiology and biotechnology 20050101

• Venlafaxine and bladder function.

  Clinical neuropharmacology 20050101

• [Depression and pain: novel clinical, neurobiological and psychopharmacological data].

  Psychiatria polska 20050101

• Computer simulation of partitioning of ten pentapeptides Ace-WLXLL at the cyclohexane/water and phospholipid/water interfaces.

  BMC biochemistry 20050101

• Venlafaxine and serious withdrawal symptoms: warning to drivers.

  MedGenMed : Medscape general medicine 20050101

• [Effectiveness and security of venlafaxine XR in the treatment of major depression].

  Revista medica del Instituto Mexicano del Seguro Social 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Development of early malignant bilateral breast disease in relation to antidepressant treatment.

  Acta chirurgica Belgica 20050101

• Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?

  Psychopharmacology 20041201

• Buspirone to improve compliance in venlafaxine-induced movement disorder.

  The international journal of neuropsychopharmacology 20041201

• Newer antidepressants in pregnancy: prospective outcome of a case series.

  Reproductive toxicology (Elmsford, N.Y.) 20041201

• Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.

  International journal of geriatric psychiatry 20041201

• An open treatment trial of venlafaxine for elderly patients with dysthymic disorder.

  Journal of geriatric psychiatry and neurology 20041201

• Venlafaxine for the treatment of depressive episode during the course of schizophrenia.

  Journal of clinical psychopharmacology 20041201

• S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.

  Journal of clinical psychopharmacology 20041201

• Effects of venlafaxine on ethanol withdrawal syndrome in rats.

  Fundamental & clinical pharmacology 20041201

• Reversible focal myositis in a patient taking venlafaxine.

  Rheumatology (Oxford, England) 20041201

• Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.

  Clinical neurology and neurosurgery 20041201

• Narcolepsy with cataplexy.

  The American journal of psychiatry 20041201

• Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.

  Journal of psychopharmacology (Oxford, England) 20041201

• Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.

  Journal of psychopharmacology (Oxford, England) 20041201

• The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine.

  Journal of neurochemistry 20041201

• Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.

  International journal of clinical pharmacology and therapeutics 20041201

• Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041201

• The isoepoxydon dehydrogenase gene of patulin biosynthesis in cultures and secondary metabolites as candidate PCR inhibitors.

  Mycological research 20041201

• [Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20041201

• [Review of antidepressants from the TCAs to the third generation drugs].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

• Effects of venlafaxine on p90Rsk activity in rat C6-gliomas and brain.

  Neuroscience letters 20041130

• Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.

  European journal of pharmacology 20041128

• Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.

  European journal of pharmacology 20041128

• Functional diversity of cytochrome P450s of the white-rot fungus Phanerochaete chrysosporium.

  Biochemical and biophysical research communications 20041105

• Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

  The Journal of pharmacology and experimental therapeutics 20041101

• Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

  International clinical psychopharmacology 20041101

• Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20041101

• In-vitro transcutaneous delivery of tamoxifen and gamma-linolenic acid from borage oil containing ethanol and 1,8-cineole.

  The Journal of pharmacy and pharmacology 20041101

• Clarification to SSRI table.

  Advance for nurse practitioners 20041101

• The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.

  Pharmacology, biochemistry, and behavior 20041101

• Spontaneous orgasm started with venlafaxine and continued with citalopram.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Venlafaxine-induced mania.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Conduritols as oviposition stimulants for the danaid butterfly, Parantica sita, identified from a host plant, Marsdenia tomentosa.

  Journal of chemical ecology 20041101

• Poly(2-hydroxyethyl methacrylate)-based slabs as a mouse embryonic stem cell support.

  Biomaterials 20041001

• The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.

  The Journal of pharmacology and experimental therapeutics 20041001

• Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.

  The Journal of pharmacology and experimental therapeutics 20041001

• Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.

  The Journal of antimicrobial chemotherapy 20041001

• Pharmacotherapy for cataplexy.

  Sleep medicine reviews 20041001

• A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

  Journal of clinical psychopharmacology 20041001

• Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

  Journal of clinical psychopharmacology 20041001

• Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 20041001

• Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.

  Consumer reports 20041001

• Regulation of wheal and flare by tea tree oil: complementary human and rodent studies.

  The Journal of investigative dermatology 20041001

• Clinical experience with dual action antidepressants in different chronic pain syndromes.

  Human psychopharmacology 20041001

• Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report.

  Bipolar disorders 20041001

• An open trial of venlafaxine for the treatment of late-life atypical depression.

  International journal of geriatric psychiatry 20041001

• The deactivation pathways of the excited-states of the mycosporine-like amino acids shinorine and porphyra-334 in aqueous solution.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20041001

• A possible case of venlafaxine-induced Stevens-Johnson syndrome.

  The Journal of clinical psychiatry 20041001

• Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.

  Psychiatry research 20040930

• Is the ring conformation the most critical parameter in lipase-catalysed acylation of cycloalkanols?

  Organic & biomolecular chemistry 20040921

• Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.

  European journal of pharmacology 20040913

• Daily variation in cellular content of UV-absorbing compounds mycosporine-like amino acids in the marine dinoflagellate Scrippsiella sweeneyae.

  Journal of photochemistry and photobiology. B, Biology 20040908

• Williopsis californica, Williopsis saturnus, and Pachysolen tannophilus: novel microorganisms for stereoselective oxidation of secondary alcohols.

  Biotechnology and bioengineering 20040905

• The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

  Journal of psychopharmacology (Oxford, England) 20040901

• Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

  Journal of psychopharmacology (Oxford, England) 20040901

• A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20040901

• Alumina-based fiber for solid phase microextraction of alcohols from gaseous samples.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20040901

• Natural and synthetic polyesters for musculoskeletal tissue repair: experimental in vitro and in vivo evaluations.

  The International journal of artificial organs 20040901

• Properties of a two-dimensional asphaltene network at the water-cyclohexane interface deduced from dynamic tensiometry.

  Langmuir : the ACS journal of surfaces and colloids 20040831

• Monoliths for microfluidic devices in proteomics.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040825

• Radical autoxidation and autogenous O2 evolution in manganese-porphyrin catalyzed alkane oxidations with chlorite.

  Inorganic chemistry 20040823

• [Lethal diabetic ketoacidosis in a schizophrenic patient].

  Ugeskrift for laeger 20040823

• A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040801

• Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus.

  Neurochemical research 20040801

• Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.

  European psychiatry : the journal of the Association of European Psychiatrists 20040801

• Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.

  Pain 20040801

• Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

  The Australian and New Zealand journal of psychiatry 20040801

• Characterization of a root-specific Arabidopsis terpene synthase responsible for the formation of the volatile monoterpene 1,8-cineole.

  Plant physiology 20040801

• Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

  Human psychopharmacology 20040801

• Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.

  Human psychopharmacology 20040801

• Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.

  The Journal of clinical psychiatry 20040801

• Elevated defibrillation threshold with venlafaxine therapy.

  Pharmacotherapy 20040801

• Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801

• Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.

  Diabetes, nutrition & metabolism 20040801

• High throughput screening and QSAR-3D/CoMFA: useful tools to design predictive models of substrate specificity for biocatalysts.

  Molecules (Basel, Switzerland) 20040731

• Crystal structure of P450cin in a complex with its substrate, 1,8-cineole, a close structural homologue to D-camphor, the substrate for P450cam.

  Biochemistry 20040727

• Two polymorphs of cobalt(II) imidazolate polymers synthesized solvothermally by using one organic template N,N-dimethylacetamide.

  Inorganic chemistry 20040726

• Rational design of original materials for the electrocatalytic hydrogenation reactions: concept, preparation, characterization, and theoretical analysis.

  Langmuir : the ACS journal of surfaces and colloids 20040720

• The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.

  Blood 20040715

• The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

  European journal of pharmacology 20040714

• Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide.

  Life sciences 20040709

• Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.

  The Journal of pharmacology and experimental therapeutics 20040701

• Membrane electrochemical reactors (MER) for NADH regeneration in HLADH-catalysed synthesis: comparison of effectiveness.

  Bioprocess and biosystems engineering 20040701

• Serotonin syndrome due to co-administration of linezolid and venlafaxine.

  The Journal of antimicrobial chemotherapy 20040701

• Management of hot flashes in breast cancer survivors and men with prostate cancer.

  Current oncology reports 20040701

• Reboxetine adjunct for partial or nonresponders to antidepressant treatment.

  Journal of affective disorders 20040701

• Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression.

  Archives of pharmacal research 20040701

• Venlafaxine-associated hypomania in unipolar depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040701

• Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040701

• Predictors of improved mood over time in clinical trials for major depression.

  Psychiatry research 20040630

• Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures.

  Bioorganic & medicinal chemistry letters 20040621

• Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro.

  International journal of pharmaceutics 20040618

• Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.

  Neuroscience letters 20040603

• Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.

  Neuroscience letters 20040603

• Effect of monoterpenes on lipid oxidation in maize.

  Planta 20040601

• Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ('Ecstasy') in rats.

  Neuropharmacology 20040601

• Venlafaxine and sour date nut.

  The American journal of psychiatry 20040601

• Diastereoselective synthesis of D- and L-myo-inositol 3,4,5,6-tetrakisphosphates from D-glucose via dihydroxylation of (+)-conduritol B derivatives.

  Chemical & pharmaceutical bulletin 20040601

• A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20040601

• Tolerability of high-dose venlafaxine in depressed patients.

  Journal of psychopharmacology (Oxford, England) 20040601

• A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.

  Journal of psychopharmacology (Oxford, England) 20040601

• Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.

  The Journal of clinical psychiatry 20040601

• Venlafaxine-induced increase in urinary frequency in 3 women.

  The Journal of clinical psychiatry 20040601

• Venlafaxine XR and chronic pelvic pain syndrome.

  The Journal of clinical psychiatry 20040601

• Depression in children and adolescents.

  Clinical evidence 20040601

• [Study on quality analysis of essential oil from twig and leaf of Baeckea frutescens].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20040601

• Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats.

  Brain research 20040522

• Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.

  Bioorganic & medicinal chemistry letters 20040517

• Flavor release and perception in hard candy: influence of flavor compound-compound interactions.

  Journal of agricultural and food chemistry 20040505

• Flavor release and perception in hard candy: influence of flavor compound-flavor solvent interactions.

  Journal of agricultural and food chemistry 20040505

• Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

  European journal of clinical pharmacology 20040501

• Management of anorexia nervosa revisited: drug treatment suggestions are questionable.

  BMJ (Clinical research ed.) 20040501

• Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

  The American journal of psychiatry 20040501

• Venlafaxine and SSRI remission data revisited.

  The British journal of psychiatry : the journal of mental science 20040501

• Proton-transfer-reaction mass spectrometry as a new tool for real time analysis of root-secreted volatile organic compounds in Arabidopsis.

  Plant physiology 20040501

• Alleviation of erythromelalgia with venlafaxine.

  Archives of dermatology 20040501

• Treatment of pain syndromes with venlafaxine.

  Pharmacotherapy 20040501

• Venlafaxine in the treatment of anxiety disorders.

  Expert review of neurotherapeutics 20040501

• [Vital functions at risk. Dealing with depressions rapidly and comprehensively].

  MMW Fortschritte der Medizin 20040426

• The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

  European journal of pharmacology 20040412

• A highly efficient oxidation of cyclohexane over Au/ZSM-5 molecular sieve catalyst with oxygen as oxidant.

  Chemical communications (Cambridge, England) 20040407

• Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.

  British journal of pharmacology 20040401

• 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20040401

• Value in venlafaxine study.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040401

• 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.

  Journal of biochemistry 20040401

• Venlafaxine + tramadol: serotonin syndrome.

  Prescrire international 20040401

• The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.

  Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20040401

• Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.

  Journal of clinical psychopharmacology 20040401

• Constraint of feeding by chronic ingestion of 1,8-cineole in the brushtail possum (Trichosurus vulpecula).

  Journal of chemical ecology 20040401

• Venlafaxine induced hepatitis.

  The Journal of the Association of Physicians of India 20040401

• Volatile constituents and key odorants in leaves, buds, flowers, and fruits of Laurus nobilis L.

  Journal of agricultural and food chemistry 20040324

• Update: A 75-year-old man with depression.

  JAMA 20040310

• 6'-Azidohex-2'-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.

  European journal of pharmacology 20040308

• Lipase-catalyzed domino dynamic kinetic resolution of racemic 3-vinylcyclohex-2-en-1-ols/intramolecular Diels-Alder reaction: one-pot synthesis of optically active polysubstituted decalins.

  Angewandte Chemie (International ed. in English) 20040305

• Effects of the immunophilin ligand FK506 on nerve regeneration in collagen guides seeded with Schwann cells in rats.

  Neuroscience letters 20040304

• Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.

  European journal of clinical pharmacology 20040301

• Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.

  The Annals of pharmacotherapy 20040301

• Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.

  Pharmacology, biochemistry, and behavior 20040301

• Inhibition of acetylcholinesterase by Tea Tree oil.

  The Journal of pharmacy and pharmacology 20040301

• Venlafaxine versus placebo in the preventive treatment of recurrent major depression.

  The Journal of clinical psychiatry 20040301

• Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.

  Journal of psychopharmacology (Oxford, England) 20040301

• Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20040218

• Is Effexor more effective for depression than an SSRI?

  The Medical letter on drugs and therapeutics 20040216

• Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.

  Psychiatry and clinical neurosciences 20040201

• Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.

  The International journal of neuroscience 20040201

• Time course of clinical response to venlafaxine: relevance of plasma level and chirality.

  European journal of clinical pharmacology 20040201

• Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.

  Journal of clinical psychopharmacology 20040201

• Low-dose venlafaxine-associated liver toxicity in chronic hepatitis.

  The Annals of pharmacotherapy 20040201

• Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.

  Biological psychiatry 20040201

• Simple synthesis of beta-D-glycopyranosides using beta-glycosidase from almonds.

  Chemical & pharmaceutical bulletin 20040201

• Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.

  International journal of geriatric psychiatry 20040201

• Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims.

  Molecular psychiatry 20040201

• Making sense of the evidence regarding nonhormonal treatments for hot flashes.

  Clinical journal of oncology nursing 20040201

• Stimulatory effect of antidepressants on the production of IL-6.

  International immunopharmacology 20040201

• Any value in venlafaxine study?

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040201

• Suicidal ideas with paroxetine or venlafaxine.

  Prescrire international 20040201

• Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.

  Behavioural pharmacology 20040201

• Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.

  Behavioural pharmacology 20040201

• Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.

  Behavioural pharmacology 20040201

• Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome.

  Journal of pain and symptom management 20040201

• Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940.

  Immunology letters 20040130

• Synthesis of (+)-(2R,3S,4R)-2,3,4-trihydroxycyclohexanone from D-glucose.

  Carbohydrate research 20040122

• Thermodynamics of the molecular and chiral recognition of cycloalkanols and camphor by modified beta-cyclodextrins possessing simple aromatic tethers.

  The Journal of organic chemistry 20040109

• Infrared study on solvent-solute interactions of 2-acetylthiophene in binary mixtures.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20040101

• The treatment of depression with different formulations of venlafaxine: a comparative analysis.

  Human psychopharmacology 20040101

• Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine.

  Pharmacotherapy 20040101

• A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20040101

• Chiral discrimination of branched-chain fatty acids by reversed-phase HPLC after labeling with a chiral fluorescent conversion reagent.

  Bioscience, biotechnology, and biochemistry 20040101

• Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040101

• Reactivity of pure Candida rugosa lipase isoenzymes (Lip1, Lip2, and Lip3) in aqueous and organic media. influence of the isoenzymatic profile on the lipase performance in organic media.

  Biotechnology progress 20040101

• [An improved novel method of venlafaxine synthesis].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040101

• Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.

  Journal of the American Medical Directors Association 20040101

• Response to 'Wishful pharmaceutical thinking'.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20040101

• Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

  Journal of psychiatric research 20040101

• Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.

  Depression and anxiety 20040101

• [Venlafaxine extended release for the treatment of chronic pain. A series of 50 cases].

  Actas espanolas de psiquiatria 20040101

• Selective versus multi-transmitter antidepressants: are two mechanisms better than one?

  The Journal of clinical psychiatry 20040101

• Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.

  Archives of gerontology and geriatrics 20040101

• Comparative toxicity of citalopram and the newer antidepressants after overdose.

  Journal of toxicology. Clinical toxicology 20040101

• Worsening of psychosis or topiramate-induced adverse event?

  General hospital psychiatry 20040101

• Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.

  Psychosomatics 20040101

• A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.

  Neuropsychobiology 20040101

• New formulations of existing antidepressants: advantages in the management of depression.

  CNS drugs 20040101

• Off-label prescribing of drugs in specialty headache practice.

  Headache 20040101

• Volatile organic compound (VOC) analysis and sources of limonene, cyclohexanone and straight chain aldehydes in axenic cultures of Calothrix and Plectonema.

  Water science and technology : a journal of the International Association on Water Pollution Research 20040101

• Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial.

  Journal of orofacial pain 20040101

• Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine.

  The pharmacogenomics journal 20040101

• Common pathways of depression and pain.

  The Journal of clinical psychiatry 20040101

• Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes.

  Pulmonary pharmacology & therapeutics 20040101

• Therapeutic drug monitoring of non-tricyclic antidepressant drugs.

  Clinical chemistry and laboratory medicine 20040101

• SNRIs in the management of acute major depressive disorder.

  The Journal of clinical psychiatry 20040101

• Qualitative review of SNRIs in anxiety.

  The Journal of clinical psychiatry 20040101

• Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?

  The Journal of clinical psychiatry 20040101

• Kleptomania after head trauma: two case reports and combination treatment strategies.

  Clinical neuropharmacology 20040101

• Influence of cannabinoids on immunoreactivity of regulatory peptides, produced in rat thyroid C cells; preliminary investigations.

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20040101

• A hot flash on tamoxifen metabolism.

  Journal of the National Cancer Institute 20031203

• Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.

  Neuropharmacology 20031201

• A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20031201

• Synthesis, structure, and catalytic activity of mononuclear iron and (mu-Oxo)diiron complexes with the ligand 2,6-bis(N-methylbenzimidazol-2-yl)pyridine.

  Inorganic chemistry 20031201

• Antidepressant monotherapy for bipolar type II major depression.

  Bipolar disorders 20031201

• Cannabinoids and opioids share cAMP pathway in rat splenocytes.

  Journal of neuroimmunology 20031201

• Hypertensive crisis associated with venlafaxine.

  The American journal of medicine 20031201

• ECT resistance and early relapse: two cases of subsequent response to venlafaxine.

  The journal of ECT 20031201

• Should children take antidepressants?

  The Harvard mental health letter 20031201

• Fatality related to a 30-g venlafaxine overdose.

  Pharmacotherapy 20031201

• Venlafaxine withdrawal in organic anxiety disorder.

  Indian journal of medical sciences 20031201

• Combination strategies to enhance transdermal permeation of zidovudine (AZT).

  Die Pharmazie 20031201

• Treatment considerations for anxiety in the elderly.

  CNS spectrums 20031201

• Wishful pharmaceutical thinking.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20031201

• Hormone therapy after endometrial cancer.

  The journal of the British Menopause Society 20031201

• [Determination of chemical constituents of essential oil from the fruit of Eucalyptus globulus by GC-MS].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20031201

• Calculation of the water-cyclohexane transfer free energies of neutral amino acid side-chain analogs using the OPLS all-atom force field.

  Journal of computational chemistry 20031130

• An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.

  Journal of medicinal chemistry 20031120

• Seasonal and phenological variations of the essential oil from the narrow endemic species Artemisia molinieri and its biological activities.

  Journal of agricultural and food chemistry 20031119

• Regulation of exocytosis from single visualized GABAergic boutons in hippocampal slices.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20031119

• Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood.

  Psychopharmacology 20031101

• Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

  British journal of pharmacology 20031101

• Venlafaxine treatment of fibromyalgia.

  The Annals of pharmacotherapy 20031101

• Venlafaxine hydrochloride for the treatment of hot flashes.

  The Annals of pharmacotherapy 20031101

• A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.

  International clinical psychopharmacology 20031101

• An immunohistochemical study of the thyroid parafollicular (C) cells in rats treated with cannabinoids - preliminary investigations.

  Folia morphologica 20031101

• Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.

  Sleep 20031101

• Single olfactory sensory neurons simultaneously integrate the components of an odour mixture.

  The European journal of neuroscience 20031101

• Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20031101

• Mirtazapine-induced hyponatraemia.

  The Medical journal of Australia 20031020

• Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.

  Biological psychiatry 20031015

• [Pharmacotherapy of generalized anxiety disorder: state of the art].

  Praxis 20031015

• Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.

  Journal of medicinal chemistry 20031009

• Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.

  International journal of pharmaceutics 20031002

• Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

  Brain : a journal of neurology 20031001

• Analysis of the respiratory effects of cannabinoids in rats.

  Naunyn-Schmiedeberg's archives of pharmacology 20031001

• Removal of gutta-percha from root canals using an Nd:YAG laser.

  International endodontic journal 20031001

• A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20031001

• Lithium augmentation in venlafaxine non-responders: an open study.

  European psychiatry : the journal of the Association of European Psychiatrists 20031001

• Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action.

  The European journal of neuroscience 20031001

• Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.

  Life sciences 20030926

• Biosynthetic studies on the alpha-glucosidase inhibitor acarbose: the chemical synthesis of isotopically labeled 2-epi-5-epi-valiolone analogs.

  Carbohydrate research 20030926

• Capillary electrochromatography with monolithic stationary phases. II. Preparation of cationic stearyl-acrylate monoliths and their electrochromatographic characterization.

  Journal of chromatography. A 20030926

• [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

  Nederlands tijdschrift voor geneeskunde 20030920

• Alcohols, ethers, carbohydrates, and related compounds. I. The MM4 force field for simple compounds.

  Journal of computational chemistry 20030901

• Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.

  European journal of clinical pharmacology 20030901

• Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.

  Molecular pharmacology 20030901

• The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?

  Expert opinion on drug safety 20030901

• Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.

  British journal of pharmacology 20030901

• Macroporous monolithic chiral stationary phases for capillary electrochromatography: New chiral monomer derived from cinchona alkaloid with enhanced enantioselectivity.

  Electrophoresis 20030901

• Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.

  Behavioural pharmacology 20030901

• The use of antidepressants to treat attention deficit hyperactivity disorder in adults.

  Journal of psychopharmacology (Oxford, England) 20030901

• Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.

  International journal of clinical practice 20030901

• Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.

  Pharmacopsychiatry 20030901

• Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients: results of a drug utilization observation study.

  Pharmacopsychiatry 20030901

• [Antidepressive treatment and subcapsular splenic hematoma].

  Anales de medicina interna (Madrid, Spain : 1984) 20030901

• Supercritical carbon dioxide extraction of essential oils from Perovskia atriplicifolia Benth.

  Journal of agricultural and food chemistry 20030827

• Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.

  Neurology 20030826

• Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study.

  BMJ (Clinical research ed.) 20030802

• Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

  Brain research 20030801

• Oxidation of cyclohexane catalyzed by metal-ion-exchanged zeolites.

  Journal of colloid and interface science 20030801

• Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis.

  Electrophoresis 20030801

• Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.

  Progress in neuro-psychopharmacology & biological psychiatry 20030801

• Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.

  The Journal of clinical psychiatry 20030801

• Absence of interactive effects of trans-1,2-cyclohexanediol, a major metabolite of the side-chain of candesartan cilexetil, on digoxin-induced arrhythmias in dogs.

  Journal of pharmacological sciences 20030801

• Venlafaxine: a 2003 update.

  Clinical therapeutics 20030801

• Measuring dipolar width across liquid-liquid interfaces with 'molecular rulers'.

  Nature 20030717

• Preferred age for assessment of qualitative and quantitative characteristics of the essential oil of tea tree (Melaleuca alternifolia) seedlings prior to plantation establishment.

  Journal of agricultural and food chemistry 20030716

• [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

  Nederlands tijdschrift voor geneeskunde 20030712

• Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030701

• A case report of paranoid delusion with venlafaxine use.

  Journal of the American Geriatrics Society 20030701

• Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.

  Anti-cancer drugs 20030701

• Suggested guidelines for e-mail communication in psychiatric practice.

  The Journal of clinical psychiatry 20030701

• Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.

  Southern medical journal 20030701

• Effect of 1-O-ethyl-3-butylcyclohexanol on the skin permeation of drugs with different physicochemical characteristics.

  International journal of pharmaceutics 20030618

• Stereoselective synthesis of several azido/amino- and diazido/diamino-myo-inositols and their phosphates from p-benzoquinone.

  Organic & biomolecular chemistry 20030607

• Poloxamer gel as vehicle for transdermal iontophoretic delivery of arginine vasopressin: evaluation of in vivo performance in rats.

  Pharmacological research 20030601

• Effective open-label treatment of premenstrual dysphoric disorder with venlafaxine.

  Psychiatry and clinical neurosciences 20030601

• Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.

  Journal of neural transmission (Vienna, Austria : 1996) 20030601

• Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation.

  The Australian and New Zealand journal of psychiatry 20030601

• Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.

  Pain 20030601

• A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20030601

• Statistical considerations about the question of a selection of discriminating centres in the analysis of clinical trial. In response to the paper: 'A method for controlling for a high response rate in a comparison of venlafaxine XR and diazepan in the short-term treatment of patients with generalised anxiety disorder'.

  European psychiatry : the journal of the Association of European Psychiatrists 20030601

• Venlafaxine for pathological crying after stroke.

  The Journal of clinical psychiatry 20030601

• Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.

  Journal of clinical psychopharmacology 20030601

• The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain.

  Methods and findings in experimental and clinical pharmacology 20030601

• Venlafaxine treatment of obsessive-compulsive disorder: case reports.

  CNS spectrums 20030601

• Opioid activity of C8813, a novel and potent opioid analgesic.

  Life sciences 20030530

• [Reversible and dose-related parkinsonism induced by venlafaxine].

  Medicina clinica 20030524

• Volatile metabolites from Salvia fruticosa as antifungal agents in soilborne pathogens.

  Journal of agricultural and food chemistry 20030521

• The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.

  Neuroscience letters 20030515

• Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.

  Journal of immunology (Baltimore, Md. : 1950) 20030515

• Common-intermediate strategy for synthesis of conduritols and inositols via beta-hydroxy cyclohexenylsilanes.

  Organic letters 20030515

• Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.

  Biochemical pharmacology 20030515

• Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

  QJM : monthly journal of the Association of Physicians 20030501

• Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.

  International clinical psychopharmacology 20030501

• Gabapentin and posttraumatic stress disorder.

  The Annals of pharmacotherapy 20030501

• The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.

  Naunyn-Schmiedeberg's archives of pharmacology 20030501

• Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.

  Journal of neurochemistry 20030501

• Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.

  Journal of the Royal Society of Medicine 20030501

• Shock-like sensations during venlafaxine withdrawal.

  Pharmacotherapy 20030501

• The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.

  Experimental and clinical psychopharmacology 20030501

• Venlafaxine in treatment-resistant obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20030501

• Microemulsion electrokinetic chromatography for the analysis of green tea catechins: effect of the cosurfactant on the separation selectivity.

  Electrophoresis 20030501

• Quantitative rate constants for the reaction of dyes and alkenes with alpha-hydroxyalkyl radicals, measured by laser flash photolysis.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20030501

• SSRIs in IBS: sensing a dash of disappointment.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

• Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

• Binding equilibrium isotope effects for glucose at the catalytic domain of human brain hexokinase.

  Journal of the American Chemical Society 20030423

• Near infrared spectroscopy for cost effective screening of foliar oil characteristics in a Melaleuca cajuputi breeding population.

  Journal of agricultural and food chemistry 20030423

• Tin(II) chloride catalyzed reactions of diazodiphenylmethane with vicinal diols in an aprotic solvent. The reactions with cis- and trans-1,2-cyclohexanediols and 1,2-propanediol.

  Carbohydrate research 20030422

• Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

  Neurology 20030422

• DISAL glycosyl donors for the synthesis of a linear hexasaccharide under mild conditions.

  Organic letters 20030417

• Effects of olfactory function, age, and gender on trigeminally mediated sensations: a study based on the lateralization of chemosensory stimuli.

  Toxicology letters 20030411

• Aroma content of fresh basil (Ocimum basilicum L.) leaves is affected by light reflected from colored mulches.

  Journal of agricultural and food chemistry 20030409

• Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.

  Bioorganic & medicinal chemistry 20030403

• Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.

  Journal of neurochemistry 20030401

• Venlafaxine and increased aggression in a female with autism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030401

• Dual action antidepressants and some important considerations.

  The Australian and New Zealand journal of psychiatry 20030401

• Erotomania induced by venlafaxine: a case study.

  Acta psychiatrica Scandinavica 20030401

• Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.

  American journal of respiratory and critical care medicine 20030401

• Venlafaxine: not yet first in the antidepressant class.

  The Harvard mental health letter 20030401

• Effect of aromatics on lung mucociliary clearance in patients with chronic airways obstruction.

  Journal of alternative and complementary medicine (New York, N.Y.) 20030401

• Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.

  European journal of pharmacology 20030328

• Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.

  European journal of pharmacology 20030319

• Cloning of Baeyer-Villiger monooxygenases from Comamonas, Xanthobacter and Rhodococcus using polymerase chain reaction with highly degenerate primers.

  Environmental microbiology 20030301

• Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.

  Journal of neurochemistry 20030301

• Monoterpenoid accumulation in 1,8-cineole, terpinolene and terpinen-4-ol chemotypes of Melaleuca alternifolia seedlings.

  Phytochemistry 20030301

• Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial.

  Respiratory medicine 20030301

• Venlafaxine-induced delirium.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030301

• Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.

  The Journal of clinical psychiatry 20030301

• Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo.

  Journal of neurotrauma 20030301

• [Supercritical carbon dioxide extraction of essential oil from Cinnamomum migao H. W. Li].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20030301

• Mania associated with venlafaxine discontinuation.

  The international journal of neuropsychopharmacology 20030301

• Influence of drying on the flavor quality of spearmint (Mentha spicata L.).

  Journal of agricultural and food chemistry 20030226

• Elution behavior of polyethylene in polar mobile phases on a non-polar sorbent.

  Journal of chromatography. A 20030221

• 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.

  Bioorganic & medicinal chemistry 20030220

• A case of venlafaxine abuse.

  The New England journal of medicine 20030220

• Cannabinoid-induced Fos expression within A10 dopaminergic neurons.

  Brain research 20030214

• QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.

  Bioorganic & medicinal chemistry letters 20030210

• Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a 'CB3' receptor.

  European journal of pharmacology 20030207

• Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats.

  Pharmacology, biochemistry, and behavior 20030201

• Single-blind comparison of venlafaxine and nortriptyline in elderly major depression.

  Journal of clinical psychopharmacology 20030201

• The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study.

  Journal of clinical psychopharmacology 20030201

• Venlafaxine-induced galactorrhea.

  Journal of clinical psychopharmacology 20030201

• Serotonin syndrome induced by low-dose venlafaxine.

  The Annals of pharmacotherapy 20030201

• Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.

  The American journal of psychiatry 20030201

• Odorant specificity of three oscillations and the DC signal in the turtle olfactory bulb.

  The European journal of neuroscience 20030201

• Depression in children and adolescents.

  American family physician 20030201

• Conductive polymers as new media for solid-phase extraction: isolation of chlorophenols from water sample.

  Journal of chromatography. A 20030131

• Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation.

  Brain research 20030117

• Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.

  Glia 20030115

• Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.

  European journal of pharmacology 20030110

• Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.

  European journal of pharmacology 20030110

• Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits.

  Life sciences 20030103

• Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.

  Psychopharmacology 20030101

• Preparation of porous cobalt and nickel oxides from corresponding alkoxides using a sonochemical technique and its application as a catalyst in the oxidation of hydrocarbons.

  Ultrasonics sonochemistry 20030101

• Antimicrobial activity of essential oils isolated from Portuguese endemic species of Thymus.

  Letters in applied microbiology 20030101

• Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

  American journal of physiology. Gastrointestinal and liver physiology 20030101

• Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.

  International clinical psychopharmacology 20030101

• Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.

  European journal of pharmacology 20030101

• The neural substrates of affective processing in depressed patients treated with venlafaxine.

  The American journal of psychiatry 20030101

• Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20030101

• Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.

  Pharmacogenetics 20030101

• Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.

  Medical care 20030101

• Effects of short-term irradiation on photoinhibition and accumulation of mycosporine-like amino acids in sun and shade species of the red algal genus Porphyra.

  Journal of photochemistry and photobiology. B, Biology 20030101

• [Venlafaxine titration dosage in depressive in-patients. A series of cases].

  Actas espanolas de psiquiatria 20030101

• New hope in the treatment of painful symptoms in depression.

  Current opinion in investigational drugs (London, England : 2000) 20030101

• Treating generalized anxiety disorder.

  The Journal of clinical psychiatry 20030101

• A pharmacoeconomic evaluation of major depressive disorder.

  Managed care interface 20030101

• Differential metabolism of 1,8-cineole in insects.

  Journal of chemical ecology 20030101

• Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.

  Pharmacopsychiatry 20030101

• Alicycliphilus denitrificans gen. nov., sp. nov., a cyclohexanol-degrading, nitrate-reducing beta-proteobacterium.

  International journal of systematic and evolutionary microbiology 20030101

• Seizures associated with venlafaxine, methylphenidate, and zolpidem.

  Psychosomatics 20030101

• Physical symptoms of depression: unmet needs in special populations.

  The Journal of clinical psychiatry 20030101

• Comparison of behavioural effects of venlafaxine and imipramine in rats.

  Arzneimittel-Forschung 20030101

• Severe headache with venlafaxine withdrawal.

  The Annals of pharmacotherapy 20030101

• Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

  Journal of psychiatric research 20030101

• Development of rigid bidisperse porous microspheres for high-speed protein chromatography.

  Biotechnology progress 20030101

• Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil.

  Journal of applied microbiology 20030101

• Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.

  American journal of therapeutics 20030101

• Using absolute and relative reasoning in the prediction of the potential metabolism of xenobiotics.

  Journal of chemical information and computer sciences 20030101

• Antidepressant drug treatment induces Arc gene expression in the rat brain.

  Neuroscience 20030101

• [Quality of life, in depressed patients in Primary Health Care setting. Effectiveness and safety of venlafaxine extended release].

  Actas espanolas de psiquiatria 20030101

• Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.

  The Journal of clinical psychiatry 20030101

• Improving antidepressant adherence.

  The Journal of clinical psychiatry 20030101

• Cannabinoids alter recognition memory in rats.

  Polish journal of pharmacology 20030101

• Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine.

  Journal of toxicology. Clinical toxicology 20030101

• Psychopharmacology news.

  Journal of child and adolescent psychopharmacology 20030101

• [Biotransformation of benzene to cis-1,2-dihydroxycyclohexa-3,5-diene using recombinant Escherichia coli JM109 (pKST11)].

  Sheng wu gong cheng xue bao = Chinese journal of biotechnology 20030101

• Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

  Biological psychiatry 20021215

• Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

  BMJ (Clinical research ed.) 20021207

• (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.

  European journal of pharmacology 20021205

• SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.

  Pharmacology, biochemistry, and behavior 20021201

• Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy.

  Nephron 20021201

• Venlafaxine open-label treatment of patients with obsessive-compulsive disorder.

  The Australian and New Zealand journal of psychiatry 20021201

• Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis.

  Journal of clinical psychopharmacology 20021201

• A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.

  Psychopharmacology 20021201

• Venlafaxine and reversible blepharoedema.

  The international journal of neuropsychopharmacology 20021201

• Alternative venlafaxine kinetics in overdose.

  Journal of clinical pharmacy and therapeutics 20021201

• Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.

  Journal of psychopharmacology (Oxford, England) 20021201

• Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients.

  Journal of psychopharmacology (Oxford, England) 20021201

• Cardiovascular effects of 1,8-cineole, a terpenoid oxide present in many plant essential oils, in normotensive rats.

  Canadian journal of physiology and pharmacology 20021201

• Inhibition of the microsomal metabolism of 1,8-cineole in the common brushtail possum (Trichosurus vulpecula) by terpenes and other chemicals.

  Xenobiotica; the fate of foreign compounds in biological systems 20021201

• Application of solid-phase microextraction to the quantitative analysis of 1,8-cineole in blood and expired air in a Eucalyptus herbivore, the brushtail possum (Trichosurus vulpecula).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125

• Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20021101

• Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.

  International clinical psychopharmacology 20021101

• Stomatal constraints may affect emission of oxygenated monoterpenoids from the foliage of Pinus pinea.

  Plant physiology 20021101

• 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice.

  Pain 20021101

• Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.

  The Journal of clinical psychiatry 20021101

• The brain tells: early signs of depression recovery.

  The Harvard mental health letter 20021101

• Hypokalemia with venlafaxine.

  The Journal of clinical psychiatry 20021101

• Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.

  Pharmacopsychiatry 20021101

• Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives.

  Biochemistry 20021015

• Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine.

  The Annals of pharmacotherapy 20021001

• Interaction between ECT and venlafaxine.

  International journal of geriatric psychiatry 20021001

• Cardiotoxic interaction of metabolites from a prodrug segment cilexetil (cyclohexyloxy-carbonyloxy-ethyl) with digoxin in the canine failing heart.

  Pharmacological research 20021001

• Possible role of mast cells in cineole-induced scratching behavior in mice.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20021001

• [Synthetic studies on sugar-related bioactive substances based on the ring transformation].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20021001

• Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.

  Human psychopharmacology 20021001

• Treatment of posttraumatic stress disorder with tiagabine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021001

• Antifungal activities of selected aromatic plants growing wild in Greece.

  Die Nahrung 20021001

• Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• Study of the catalytic behavior of montmorillonite/iron(III) and Mn(III) cationic porphyrins.

  Journal of colloid and interface science 20021001

• Effect of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol (CP55,940) on intracellular Ca2+ levels in human osteosarcoma cells.

  The Chinese journal of physiology 20020930

• Characterization of essential oils from lamiaceae species by fourier transform Raman spectroscopy.

  Journal of agricultural and food chemistry 20020925

• A highly efficient oxidation of cyclohexane over VPO catalysts using hydrogen peroxide.

  Chemical communications (Cambridge, England) 20020921

• Treatment for hot flushes in women receiving tamoxifen.

  The Medical journal of Australia 20020902

• Studies on the selective transport of organic compounds by using ionic liquids as novel supported liquid membranes.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20020902

• Venlafaxine: a new class of antidepressant.

  Hospital medicine (London, England : 1998) 20020901

• Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.

  The Journal of clinical psychiatry 20020901

• Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.

  The Journal of clinical psychiatry 20020901

• [Pharmacological justification for the use of new antidepressant drugs].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020901

• Functional role of serine residues of transmembrane dopamin VII in signal transduction of CB2 cannabinoid receptor.

  Journal of veterinary science 20020901

• Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020901

• Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.

  MedGenMed : Medscape general medicine 20020821

• Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

  European journal of pharmacology 20020816

• Increasing the ketone selectivity of the cobalt-catalyzed radical chain oxidation of cyclohexane.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20020816

• Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.

  Journal of medicinal chemistry 20020815

• Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.

  Life sciences 20020802

• Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801

• Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.

  Therapeutic drug monitoring 20020801

• Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940.

  Biochemical pharmacology 20020801

• Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.

  British journal of pharmacology 20020801

• Mitral cell temporal response patterns evoked by odor mixtures in the rat olfactory bulb.

  Journal of neurophysiology 20020801

• Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.

  European journal of clinical pharmacology 20020801

• Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.

  Anti-cancer drugs 20020801

• Combining antidepressants for treatment-resistant depression: a review.

  The Journal of clinical psychiatry 20020801

• Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

  The Journal of clinical psychiatry 20020801

• Treating hot flashes with drugs: an update.

  Harvard women's health watch 20020801

• Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports.

  Human & experimental toxicology 20020801

• Acaricidal activity of pine essential oils and their main components against Tyrophagus putrescentiae, a stored food mite.

  Journal of agricultural and food chemistry 20020731

• Quantitative rate constants for radical reactions in the nanopores of cotton.

  Journal of the American Chemical Society 20020724

• Syn stereochemistry of cyclic ether formation in 1,8-cineole biosynthesis catalyzed by recombinant synthase from Salvia officinalis.

  Journal of the American Chemical Society 20020724

• In vitro evaluation of nimodipine permeation through human epidermis using response surface methodology.

  International journal of pharmaceutics 20020708

• Early changes in prefrontal activity characterize clinical responders to antidepressants.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020701

• Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.

  The Journal of pharmacology and experimental therapeutics 20020701

• Once daily sustained release tablets of venlafaxine, a novel antidepressant.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20020701

• Social adjustment in depressed patients treated with venlafaxine and amitriptyline.

  International clinical psychopharmacology 20020701

• Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.

  Clinical therapeutics 20020701

• Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20020701

• Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.

  Brain research. Developmental brain research 20020630

• [Delirium during withdrawal of venlafaxine].

  Nederlands tijdschrift voor geneeskunde 20020629

• Dithienylethenes with a novel photochromic performance.

  The Journal of organic chemistry 20020628

• Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations.

  Journal of pharmaceutical and biomedical analysis 20020615

• Estimating pKa values for pentaoxyphosphoranes.

  Journal of the American Chemical Society 20020612

• PHARMAC and availability of pharmaceuticals.

  The New Zealand medical journal 20020607

• Main agronomic-productive characteristics of two ecotypes of Rosmarinus officinalis L. and chemical composition of their essential oils.

  Journal of agricultural and food chemistry 20020605

• Antimicrobial and bactericidal activities of esters of 2-endo-hydroxy-1,8-cineole as new aroma chemicals.

  Journal of agricultural and food chemistry 20020605

• Gabapentin in complicated school refusal.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020601

• Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.

  Managed care interface 20020601

• A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

  The Journal of clinical psychiatry 20020601

• Rapid onset of antidepressant activity with venlafaxine.

  The Journal of clinical psychiatry 20020601

• Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142.

  Journal of psychopharmacology (Oxford, England) 20020601

• Pharmacological comparison of a recombinant CB1 cannabinoid receptor with its G(alpha 16) fusion product.

  Journal of biomolecular screening 20020601

• Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

  The international journal of neuropsychopharmacology 20020601

• An overview of the clinical efficacy of mirtazapine.

  Human psychopharmacology 20020601

• Facile syntheses of all possible diastereomers of conduritol and various derivatives of inositol stereoisomers in high enantiopurity from myo-inositol.

  The Journal of organic chemistry 20020517

• Improved hardware and software for quick gas chromatography-olfactometry using CHARM and GC-'SNIF' analysis.

  Analytical chemistry 20020515

• Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.

  Chirality 20020505

• Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

  The British journal of psychiatry : the journal of mental science 20020501

• Insecticidal properties of essential plant oils against the mosquito Culex pipiens molestus (Diptera: Culicidae).

  Pest management science 20020501

• Venlafaxine-associated vaginal bleeding.

  Pharmacotherapy 20020501

• Identification of two gene clusters involved in cyclohexanone oxidation in Brevibacterium epidermidis strain HCU.

  Applied microbiology and biotechnology 20020501

• Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites.

  Xenobiotica; the fate of foreign compounds in biological systems 20020501

• [Study of chemical constituents of the essential oil form Pericarpium Zanthoxyli by GC-MS].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20020501

• Extraction of thymol, eucalyptol, menthol, and camphor residues from honey and beeswax. Determination by gas chromatography with flame ionization detection.

  Journal of chromatography. A 20020419

• Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

  Pharmacology, biochemistry, and behavior 20020401

• Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020401

• New isopimarane diterpene and new cineole type glucoside from Nepeta prattii.

  Die Pharmazie 20020401

• Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20020401

• Prevalence of sexual dysfunction among newer antidepressants.

  The Journal of clinical psychiatry 20020401

• Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020401

• Novel effect of CP55,940, a CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels in bladder cancer cells.

  The Chinese journal of physiology 20020331

• A 75-year-old man with depression.

  JAMA 20020327

• Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.

  Journal of neuroscience research 20020315

• Cyclohexadiene-trans-diols as versatile starting material in natural product synthesis: short and efficient synthesis of iso-crotepoxide and ent-senepoxide.

  Chemical communications (Cambridge, England) 20020307

• Mycosporine-2-glycine is the major mycosporine-like amino acid in a unicellular cyanobacterium (Euhalothece sp.) isolated from a gypsum crust in a hypersaline saltern pond.

  FEMS microbiology letters 20020305

• Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.

  The Medical journal of Australia 20020304

• Venlafaxine and bilateral acute angle closure glaucoma.

  The Medical journal of Australia 20020304

• Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.

  International journal of geriatric psychiatry 20020301

• Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020301

• Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

  The Journal of clinical psychiatry 20020301

• Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.

  Journal of neurochemistry 20020301

• Dechlorination of chlorinated phenols by catalyzed and uncatalyzed Fe(0) and Mg(0) particles.

  Journal of hazardous materials 20020214

• Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors.

  Neurochemistry international 20020201

• Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.

  Molecular pharmacology 20020201

• Reporting of randomised trials.

  The British journal of psychiatry : the journal of mental science 20020201

• Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.

  European journal of pharmacology 20020201

• Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor.

  The British journal of dermatology 20020201

• Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat.

  Behavioural pharmacology 20020201

• Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?

  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20020201

• Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum.

  European journal of pharmacology 20020102

• Microwave-assisted preparation of cyclic ketals from a cineole ketone as potential cosmetic ingredients: solvent-free synthesis, odour evaluation, in vitro cytotoxicity and antimicrobial assays.

  International journal of pharmaceutics 20020101

• The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.

  The Journal of pharmacology and experimental therapeutics 20020101

• Changes in brain function of depressed subjects during treatment with placebo.

  The American journal of psychiatry 20020101

• Designing membrane electrochemical reactors for oxidoreductase-catalysed synthesis.

  Bioelectrochemistry (Amsterdam, Netherlands) 20020101

• Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?

  Journal of neural transmission (Vienna, Austria : 1996) 20020101

• Beyond estrogen: new alternatives for the management of hot flashes.

  South Dakota journal of medicine 20020101

• Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.

  The Annals of pharmacotherapy 20020101

• Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.

  Oncology nursing forum 20020101

• Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.

  British journal of clinical pharmacology 20020101

• Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats.

  Psychopharmacology 20020101

• Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

  Journal of psychiatric research 20020101

• Venlafaxine in neuropathic pain following treatment of breast cancer.

  European journal of pain (London, England) 20020101

• False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine.

  Clinical chemistry 20020101

• Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.

  Irish medical journal 20020101

• Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

  Journal of molecular neuroscience : MN 20020101

• Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.

  Journal of the American Geriatrics Society 20020101

• Treatment of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Generalized anxiety disorder in primary care: emerging issues in management and treatment.

  The Journal of clinical psychiatry 20020101

• Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line.

  Oncology reports 20020101

• Masturbatory guilt leading to severe depression and erectile dysfunction.

  Journal of sex & marital therapy 20020101

• Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety.

  International journal of clinical practice 20020101

• Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

  Journal of psychiatric research 20020101

• Management of hot flushes in breast cancer patients.

  Acta oncologica (Stockholm, Sweden) 20020101

• Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.

  Depression and anxiety 20020101

• Women with PTSD: the psychodynamic aspects of psychopharmacologic and 'hands-on' psychiatric management.

  The Journal of the American Academy of Psychoanalysis 20020101

• Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats.

  Neuroscience 20020101

• Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.

  Neuropsychobiology 20020101

• In vitro study of effect of solvent on root canal retreatment.

  Brazilian dental journal 20020101

• [Acute cytolytic hepatitis after taking venlafaxine].

  Gastroenterologie clinique et biologique 20020101

• Long-term treatment strategies in anxiety disorders.

  Psychopharmacology bulletin 20020101

• Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.

  Psychopharmacology bulletin 20020101

• Mechanism of action of antidepressants.

  Psychopharmacology bulletin 20020101

• Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.

  Acta psychiatrica Scandinavica. Supplementum 20020101

• Pharmacotherapy of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Role of neuropeptides in antidepressant and memory improving effects of venlafaxine.

  Polish journal of pharmacology 20020101

• Can monoamine-based therapies be improved?

  The Journal of clinical psychiatry 20020101

• Generalized anxiety disorder: raising the expectations of treatment.

  Psychopharmacology bulletin 20020101

• The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.

  Brain research 20011207

• Central role of the CNGA4 channel subunit in Ca2+-calmodulin-dependent odor adaptation.

  Science (New York, N.Y.) 20011207

• Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain.

  NeuroImage 20011201

• Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011201

• Venlafaxine- and trazodone-induced serotonin syndrome.

  The American journal of psychiatry 20011201

• Venlafaxine and breast-feeding.

  The American journal of psychiatry 20011201

• Composition of the essential oil of two Nepeta species and in vitro evaluation of their activity against Helicobacter pylori.

  Planta medica 20011201

• Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

• Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity.

  Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20011201

• Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.

  European journal of pharmacology 20011123

• Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats.

  Life sciences 20011121

• Continuous enantioselective esterification of trans-2-phenyl-1-cyclohexanol using a new Candida rugosa lipase in a packed bed bioreactor.

  Journal of biotechnology 20011117

• Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily.

  Journal of medicinal chemistry 20011108

• Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.

  Bioorganic & medicinal chemistry letters 20011105

• A pyridone analogue of traditional cannabinoids. A new class of selective ligands for the CB(2) receptor.

  Bioorganic & medicinal chemistry 20011101

• S9 induction by the combined treatment with cyclohexanol and albendazole.

  Mutagenesis 20011101

• Venlafaxine in the treatment of premenstrual dysphoric disorder.

  Obstetrics and gynecology 20011101

• Effects of cannabinoids on adrenaline release from adrenal medullary cells.

  British journal of pharmacology 20011101

• Catalytic mechanisms and reaction intermediates along the hydrolytic pathway of a plant beta-D-glucan glucohydrolase.

  Structure (London, England : 1993) 20011101

• Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.

  The Journal of pharmacy and pharmacology 20011101

• Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.

  The Journal of clinical psychiatry 20011101

• Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

  The Journal of clinical psychiatry 20011101

• The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study.

  BJU international 20011101

• Physicochemical investigations on microemulsification of eucalyptol and water in presence of polyoxyethylene (4) lauryl ether (Brij-30) and ethanol.

  International journal of pharmaceutics 20011023

• Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

  The American journal of psychiatry 20011001

• Addition of olanzapine for treatment-resistant depression.

  The American journal of psychiatry 20011001

• Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages.

  Veterinary immunology and immunopathology 20011001

• A psychophysical study of the relationship between temporal processing in odor mixtures and transduction pathways.

  Brain research. Cognitive brain research 20011001

• Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.

  British journal of pharmacology 20011001

• Pseudodementia. Cognitive decline caused by untreated depression may be reversed with treatment.

  Geriatrics 20011001

• Venlafaxine-induced hypomanic switch in bipolar depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20011001

• Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.

  Xenobiotica; the fate of foreign compounds in biological systems 20011001

• Porous polymer monoliths: simple and efficient mixers prepared by direct polymerization in the channels of microfluidic chips.

  Electrophoresis 20011001

• Venlafaxine and generalised anxiety disorder: new preparation. Minimise recourse to drugs.

  Prescrire international 20011001

• The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

  Postgraduate medicine 20011001

• Postmortem tissue concentrations of venlafaxine.

  Forensic science international 20010915

• Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.

  Archives of biochemistry and biophysics 20010915

• Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.

  Journal of chromatography. B, Biomedical sciences and applications 20010905

• AAA in KAT/DYKAT processes: first- and second-generation asymmetric syntheses of (+)- and (-)-cyclophellitol.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010903

• Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors.

  Naunyn-Schmiedeberg's archives of pharmacology 20010901

• A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus.

  British journal of pharmacology 20010901

• Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.

  British journal of pharmacology 20010901

• The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.

  The journal of ECT 20010901

• Eucalyptus camaldulensis: volatiles from immature flowers and high production of 1,8-cineole and beta-pinene by in vitro cultures.

  Phytochemistry 20010901

• Promoting mechanism of menthol derivative, 1-O-ethyl-3-buthylcyclohexanol, on the percutaneous absorption of ketoprofen.

  Biological & pharmaceutical bulletin 20010901

• Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.

  Pharmacology, biochemistry, and behavior 20010901

• The pharmacoeconomics of venlafaxine in depression.

  The American journal of managed care 20010901

• On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolites.

  Electrophoresis 20010901

• Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.

  Journal of affective disorders 20010901

• Switching of a macromolecular helicity for visual distinction of molecular recognition events.

  Journal of the American Chemical Society 20010822

• CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells.

  Life sciences 20010817

• Microdialysis in freely moving mice: determination of acetylcholine, serotonin and noradrenaline release in galanin transgenic mice.

  Journal of neuroscience methods 20010815

• Successful use of cardiac allograft from serotonin antagonist intoxication.

  Transplantation 20010815

• Capillary electrochromatography in anion-exchange and normal-phase mode using monolithic stationary phases.

  Journal of chromatography. A 20010803

• S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• Enantioconvergent synthesis of (-)-(S)- and (+)-(R)-2-acetyl-3,6-dihydroxycyclohex-2-enone starting from rac-6-hydroxy-3-methoxycyclohex-2-enone.

  Chirality 20010801

• Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

  Journal of clinical psychopharmacology 20010801

• Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.

  Journal of clinical psychopharmacology 20010801

• Flushing in a menopausal woman taking venlafaxine.

  The American journal of psychiatry 20010801

• Metabolites of dietary 1,8-cineole in the male koala (Phascolarctos cinereus).

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20010801

• [14C]Serotonin uptake and [O-methyl-11C]venlafaxine kinetics in porcine brain.

  Nuclear medicine and biology 20010801

• [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer.

  Journal of pharmaceutical sciences 20010801

• Effect of gutta-percha solvents at different temperatures on the calcium, phosphorus and magnesium levels of human root dentin.

  Journal of oral rehabilitation 20010801

• Toxicity, feeding deterrence, and effect of activity of 1,8-cineole from Artemisia annua on progeny production of Tribolium castanaeum (Coleoptera: Tenebrionidae).

  Journal of economic entomology 20010801

• Venlafaxine in the treatment of postpartum depression.

  The Journal of clinical psychiatry 20010801

• Functional analysis of an olfactory receptor in Drosophila melanogaster.

  Proceedings of the National Academy of Sciences of the United States of America 20010731

• Cooperation of solid granule and solvent as porogenic agents. Novel porogenic mode of biporous media for protein chromatography.

  Journal of chromatography. A 20010713

• 'Intermolecular' trapping of a nonheme Fe(IV)=O intermediate.

  Inorganic chemistry 20010702

• Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects.

  Journal of neuroimmunology 20010702

• Venlafaxine-induced hair loss.

  The American journal of psychiatry 20010701

• Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.

  The British journal of psychiatry : the journal of mental science 20010701

• Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.

  Archives of general psychiatry 20010701

• Functional brain circuits in major depression and remission.

  Archives of general psychiatry 20010701

• Neuroimaging profiles and the differential therapies of depression.

  Archives of general psychiatry 20010701

• Hydrogen bonding and dipolar interactions between quinolines and organic solvents. Nuclear magnetic resonance and ultraviolet-visible spectroscopic studies.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20010701

• Perception of trigeminal chemosensory qualities in the elderly.

  Chemical senses 20010701

• [Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic].

  Der Nervenarzt 20010701

• Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.

  The Journal of clinical psychiatry 20010701

• In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets.

  Pharmacopsychiatry 20010701

• Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog.

  Xenobiotica; the fate of foreign compounds in biological systems 20010701

• Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.

  Journal of traumatic stress 20010701

• Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.

  Neuroscience letters 20010629

• Efficient synthesis of enantiopure conduritols by ring-closing metathesis.

  The Journal of organic chemistry 20010629

• Involvement of the cerebellar adenosine A(1) receptor in cannabinoid-induced motor incoordination in the acute and tolerant state in mice.

  Brain research 20010629

• Effects of CP55,940 and methanandamide on detrusor activity.

  Urology 20010601

• Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.

  Journal of psychopharmacology (Oxford, England) 20010601

• The health economic impact of antidepressant usage from a payer's perspective: a multinational study.

  International journal of clinical practice 20010601

• Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.

  Journal of chromatography. A 20010601

• Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

  The international journal of neuropsychopharmacology 20010601

• Expression of benzene dioxygenase from Pseudomonas putida ML2 in cis-1,2-cyclohexanediol-degrading pseudomonads.

  Applied microbiology and biotechnology 20010601

• Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.

  Life sciences 20010525

• Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.

  Journal of neuroscience research 20010515

• Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice.

  The Journal of pharmacology and experimental therapeutics 20010501

• Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart.

  The Journal of pharmacology and experimental therapeutics 20010501

• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.

  Pain 20010501

• Recurrent depression with vagus nerve stimulation.

  The American journal of psychiatry 20010501

• Treatment of neuropathic pain with venlafaxine.

  The Annals of pharmacotherapy 20010501

• Method development for the high-performance liquid chromatographic enantioseparation of 2-cyanocycloalkanols.

  Journal of chromatographic science 20010501

• Simultaneous screen for microsomal stability and metabolite profile by direct injection turbulent-laminar flow LC-LC and automated tandem mass spectrometry.

  Analytical chemistry 20010501

• FTIR sensing of inhomogeneous systems using immobilized organometalcarbonyl probe groups.

  The Analyst 20010501

• Asymmetric synthesis of alpha,alpha-disubstituted alpha-amino acids using (S,S)-cyclohexane-1,2-diol as a chiral auxiliary.

  The Journal of organic chemistry 20010420

• Asymmetric induction of conduritols via AAA reactions: synthesis of the aminocyclohexitol of hygromycin A.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010417

• Zebra finch CB1 cannabinoid receptor: pharmacology and in vivo and in vitro effects of activation.

  The Journal of pharmacology and experimental therapeutics 20010401

• Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans.

  Journal of clinical psychopharmacology 20010401

• Sustained response to open-label venlafaxine in drug-resistant major depression.

  Journal of clinical psychopharmacology 20010401

• Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

  Journal of clinical psychopharmacology 20010401

• Venlafaxine-associated mania.

  Journal of clinical psychopharmacology 20010401

• Lithium augmentation in venlafaxine-refractory depression.

  Journal of clinical psychopharmacology 20010401

• Extent of initial corneal injury as a basis for alternative eye irritation tests.

  Toxicology in vitro : an international journal published in association with BIBRA 20010401

• Prefrontal changes and treatment response prediction in depression.

  Seminars in clinical neuropsychiatry 20010401

• Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe.

  Journal of clinical pharmacology 20010401

• Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.

  Clinical pharmacology and therapeutics 20010401

• Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain.

  Pharmacology & toxicology 20010401

• Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity.

  The European journal of neuroscience 20010401

• Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.

  Naunyn-Schmiedeberg's archives of pharmacology 20010401

• 1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock.

  The Journal of pharmacy and pharmacology 20010401

• Problems with ensuring a double blind.

  The Journal of clinical psychiatry 20010401

• The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20010401

• Microsomal metabolism of the terpene 1,8-cineole in the common brushtail possum (Trichosurus vulpecula), koala (Phascolarctos cinereus), rat and human.

  Xenobiotica; the fate of foreign compounds in biological systems 20010401

• [Reducing the need for cortisone. Does eucalyptus oil work in asthma? (interview by Brigitte Moreano].

  MMW Fortschritte der Medizin 20010329

• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

  The British journal of psychiatry : the journal of mental science 20010301

• Breast cancer and hot flashes. Options for relief.

  Mayo Clinic health letter (English ed.) 20010301

• Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.

  British journal of pharmacology 20010301

• Molecular sieve catalysts for the regioselective and shape- selective oxyfunctionalization of alkanes in air.

  Accounts of chemical research 20010301

• Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20010301

• The influence of essential oils on human attention. I: alertness.

  Chemical senses 20010301

• Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

  The Journal of clinical psychiatry 20010301

• Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.

  The international journal of neuropsychopharmacology 20010301

• Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor 'hybrid' ligands.

  Biochemical and biophysical research communications 20010223

• Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.

  European journal of pharmacology 20010216

• Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.

  The Journal of physiology 20010215

• Radical and non-radical mechanisms for alkane oxidations by hydrogen peroxide-trifluoroacetic acid.

  The Journal of organic chemistry 20010209

• Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20010201

• Psychopharmacologic treatment of adolescent depression.

  Archives of psychiatric nursing 20010201

• Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.

  Journal of clinical psychopharmacology 20010201

• Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

  Psychopharmacology 20010201

• Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites.

  Electrophoresis 20010201

• Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.

  Electrophoresis 20010201

• 1,8-cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats.

  Digestive diseases and sciences 20010201

• Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens.

  European journal of pharmacology 20010126

• Fluoxetine (Sarafem) for premenstrual dysphoric disorder.

  The Medical letter on drugs and therapeutics 20010122

• Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network.

  International journal of pharmaceutics 20010116

• Conduction disturbances associated with venlafaxine.

  Annals of internal medicine 20010116

• Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.

  Neurochemistry international 20010101

• Response properties of isolated mouse olfactory receptor cells.

  The Journal of physiology 20010101

• Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.

  British journal of pharmacology 20010101

• Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20010101

• A near-infrared method for the assay of cineole in eucalyptus oil as an alternative to the official BP method.

  The Journal of pharmacy and pharmacology 20010101

• Critical use of venlafaxine serology to uncover genetic rapid metabolism.

  The Journal of neuropsychiatry and clinical neurosciences 20010101

• Evidence of early onset of antidepressant effect in randomized controlled trials.

  The Journal of clinical psychiatry 20010101

• Possible neurobiological mechanisms underlying faster onset of antidepressant action.

  The Journal of clinical psychiatry 20010101

• Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

  Neuroscience 20010101

• Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice.

  Pharmacology, biochemistry, and behavior 20010101

• Pathology of ocular irritation with acetone, cyclohexanol, parafluoroaniline, and formaldehyde in the rabbit low-volume eye test.

  Toxicologic pathology 20010101

• B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.

  Arthritis research 20010101

• Pharmacology of rapid-onset antidepressant treatment strategies.

  The Journal of clinical psychiatry 20010101

• Do some antidepressants work faster than others?

  The Journal of clinical psychiatry 20010101

• Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.

  Neuroscience 20010101

• Venlafaxine extended-release: a review of its use in the management of major depression.

  CNS drugs 20010101

• Biotransformation of 1,8-cineole by human liver microsomes.

  Natural product letters 20010101

• Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient?

  General hospital psychiatry 20010101

• Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.

  The Journal of clinical psychiatry 20010101

• Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.

  The Journal of clinical psychiatry 20010101

• Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.

  Neuropsychobiology 20010101

• A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20010101

• Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation.

  Advances in experimental medicine and biology 20010101

• Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.

  Psychosomatics 20010101

• The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.

  Neuroimmunomodulation 20010101

• [Lipase-catalyzed kinetic resolution of 2-substituted cycloalkanols].

  Acta pharmaceutica Hungarica 20010101

• Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.

  Medicinski arhiv 20010101

• Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.

  Clinical neuropharmacology 20010101

• [Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study].

  Fortschritte der Medizin. Originalien 20010101

• [Family physician's interventions and prescribing practice. Results of the GAD-P study].

  Fortschritte der Medizin. Originalien 20010101

• An organic psychosis due to a venlafaxine-propafenone interaction.

  International journal of psychiatry in medicine 20010101

• Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

  Polish journal of pharmacology 20010101

• Confocal fluorescence microscope studies of the adsorptive behavior of dioctadecyl-rhodamine B molecules at a cyclohexane-water interface.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20010101

• Pharmacokinetically induced benzodiazepine withdrawal.

  Psychopharmacology bulletin 20010101

• A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.

  Psychopharmacology bulletin 20010101

• Lethal combination of tramadol and multiple drugs affecting serotonin.

  The American journal of forensic medicine and pathology 20001201

• Seizures associated with therapeutic doses of venlafaxine and trimipramine.

  The Annals of pharmacotherapy 20001201

• Serotonergic antidepressants and urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20001201

• The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.

  Archives of biochemistry and biophysics 20000815

• Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.

  The Journal of biological chemistry 20000526

• The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.

  European journal of clinical pharmacology 20000501

• Benztropine for venlafaxine-induced night sweats.

  Journal of clinical psychopharmacology 20000401

• Venlafaxine serum levels and CYP2D6 genotype.

  Therapeutic drug monitoring 20000401

• Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

  The Journal of clinical psychiatry 20000401

• Venlafaxine-associated hepatitis.

  Annals of internal medicine 20000307

• Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.

  The Journal of pharmacology and experimental therapeutics 20000301

• [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].

  La Revue de medecine interne 20000301

• Venlafaxine treatment of cocaine abusers with depressive disorders.

  The American journal of drug and alcohol abuse 20000201

• Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

  The Journal of clinical psychiatry 20000201

• Neuroleptic malignant syndrome after venlafaxine.

  Lancet (London, England) 20000122

• Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.

  The Journal of biological chemistry 20000107

• Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1).

  Journal of psychiatry & neuroscience : JPN 20000101

• Antidepressant efficacy of venlafaxine.

  Depression and anxiety 20000101

• The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.

  European journal of pharmacology 19991112

• Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland.

  Neuroendocrinology 19990801

• Dystonia as a side effect of nonneuroleptics.

  Journal of the American Academy of Child and Adolescent Psychiatry 19990701

• Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.

  European journal of pharmacology 19990625

• Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).

  The Journal of pharmacology and experimental therapeutics 19990601

• Venlafaxine-associated hepatitis.

  Annals of internal medicine 19990601

• Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

  Proceedings of the National Academy of Sciences of the United States of America 19990511

• Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.

  International clinical psychopharmacology 19990501

• Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.

  FEBS letters 19990409

• Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.

  Psychopharmacology 19990401

• The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells.

  The Journal of pharmacology and experimental therapeutics 19990301

• Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

  British journal of pharmacology 19990201

• Mirtazapine: clinical overview.

  The Journal of clinical psychiatry 19990101

• Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.

  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 19980815

• Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.

  Neurology 19980701

• Comparative receptor binding analyses of cannabinoid agonists and antagonists.

  The Journal of pharmacology and experimental therapeutics 19980401

• Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain.

  Brain research. Molecular brain research 19980330

• SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

  The Journal of pharmacology and experimental therapeutics 19980201

• Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.

  Journal of neurochemistry 19980101

• Serotonin syndrome secondary to phenelzine-venlafaxine interaction.

  Pharmacotherapy 19980101

• Pharmacological profile of venlafaxine, a new antidepressant, given acutely.

  Polish journal of pharmacology 19980101

• A case of serotonin syndrome caused by venlafaxine and lithium.

  Pharmacopsychiatry 19971101

• Withdrawal syndrome after discontinuation of venlafaxine.

  The American journal of psychiatry 19971001

• Mast cell involvement in the rat paw oedema response to 1,8-cineole, the main constituent of eucalyptus and rosemary oils.

  European journal of pharmacology 19970723

• Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.

  The Netherlands journal of medicine 19970601

• Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.

  Journal of clinical psychopharmacology 19970201

• Seizure resulting from a venlafaxine overdose.

  The Annals of pharmacotherapy 19970201

• Urinary retention with venlafaxine-haloperidol combination.

  Pharmacopsychiatry 19970101

• Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors.

  Life sciences 19970101

• Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.

  Journal of medicinal chemistry 19961025

• Serotonin syndrome from venlafaxine-tranylcypromine interaction.

  Veterinary and human toxicology 19961001

• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  The Journal of pharmacology and experimental therapeutics 19960901

• Venlafaxine.

  Nursing 19960301

• Serotonin syndrome induced by administration of venlafaxine and phenelzine.

  The Annals of pharmacotherapy 19960101

• Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

  The Biochemical journal 19951201

• Toxic interaction of venlafaxine and isocarboxazide.

  Lancet (London, England) 19951111

• Induction of protein droplet (alpha 2 mu-globulin) nephropathy in male rats after short-term dosage with 1,8-cineole and l-limonene.

  Toxicology letters 19951001

• Phenelzine and venlafaxine interaction.

  The American journal of psychiatry 19950901

• Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.

  The Journal of biological chemistry 19950609

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

  FEBS letters 19940822

• Cloning and sequencing of a 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase gene involved in the degradation of gamma-hexachlorocyclohexane in Pseudomonas paucimobilis.

  Journal of bacteriology 19940601

• Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.

  Molecular pharmacology 19921101

• Alpha-isoenzyme of alcohol dehydrogenase from monkey liver. Cloning, expression, mechanism, coenzyme, and substrate specificity.

  The Journal of biological chemistry 19920625

• Molecular cloning of a human cannabinoid receptor which is also expressed in testis.

  The Biochemical journal 19911001

• Effects of bepridil and CERM 4205 (ORG 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers.

  The American journal of cardiology 19900901

• Enzyme reactions involved in anaerobic cyclohexanol metabolism by a denitrifying Pseudomonas species.

  Archives of microbiology 19890101

• Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids.

  Arzneimittel-Forschung 19880701

• Severe cerebral depression after intoxication with tramadol in a 6-month-old infant.

  European journal of clinical pharmacology 19840101

• Isoepoxydon, a new metabolite of the patulin pathway in Penicillium urticae.

  The Biochemical journal 19790815

• The metabolism of cyclohexanol by Acinetobacter NCIB 9871.

  European journal of biochemistry 19751201